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Abstract 
The thymus is the primary lymphoid organ responsible to generating a self-restricted and 
self-tolerant repertoire of peripheral T-cell receptors. This process is collectively called 
thymopoiesis and depends on dynamic interactions between the developing T-cells 
(thymocytes) and the thymic stroma. The main functional element of the thymic stroma is the 
thymic epithelial cell (TEC), which mediate T-cell lineage development and T cell repertoire 
selection. 
Modelling thymopoiesis in vitro is currently limited to two techniques. The original technique 
is termed reaggregate thymic organ culture (RTOC) and is the only method of culturing ex 
vivo TEC. Unfortunately, the scarcity of TEC makes RTOC very low throughput. To 
overcome this limitation OP9 cells were engineered to ectopically express the Notch ligand 
DLL1. OP9-DLL1 cells recapitulate the initial phase of thymopoiesis, T-cell lineage 
commitment, but not central tolerance induction. 
In 2014, our lab published a direct lineage reprogramming strategy that was able to generate 
cells that could mediate all stages of thymopoiesis from an abundant cell type. The strategy 
reprograms murine embryonic fibroblasts into induced thymic epithelial cells (iTEC). This 
thesis outlines experiments through which I optimised the iTEC protocol into a standardised 
process suitable for scale-up and uses novel synthetic polymer matrices to culture iTEC in 
both two- and three-dimensions. 
Synthetic polymers emulate native extra cellular matrices (ECMs) but have key advantages 
such as tuneable physical and chemical properties and controllable degradation. This thesis 
identifies polyacrylates that are capable of supporting both ex vivo TEC and iTEC in culture 
in vitro. Investigation into the behaviour of iTEC on the selected polymers demonstrate more 
consistent behaviours than had previously been achieved and therefore this is the first step 
in creating a defined protocol for iTEC manufacture that reduces the inherent variablity of 
reprogramming strategies.  
This thesis also proposed and tested a new method for the culture of thymic stroma, which 
aims to occupy an underdeveloped technical niche. Miniaturisation of the reaggregate thymic 
iii
organ culture process starting from both native TEC and iTEC allowed production of 
hundreds micro-physiological thymi able to support T cell development. This provides proof-
of-principle for a new in vitro thymic organ culture technology compatible with high-
throughput screening technologies, whilst requiring a small fraction for the total tissue 
requirement of RTOC. Evidence is presented that this reductionist system will be able to 
query specific hypotheses by producing precise observations, in higher throughput, than 
currently used techniques. 
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Lay Summary 
T-cells are an important part of the immune system. This type of white blood cell is
established very early in life to protect the body against disease. T-cells develop in a special 
organ called the thymus, through interactions with a type of cell called thymic epithelial cells 
(TEC). In early life, when the T-cell population is being established, the thymus is very 
active, but once the immune system does not require new T-cells, the thymus begins to 
reduce in size and degenerate. This process is called age-related involution and represents 
healthy shrinking of the thymus. 
However, people live longer and travel more frequently than in the past. This means people 
have greater chance of developing age-related diseases like cancers and encountering new, 
exotic pathogens when traveling as adults. Age-related involution prevents the thymus from 
developing new T-cells to counter these problems, which makes the elderly more susceptible 
to diseases they have not already encountered. 
To overcome this, our laboratory proposes to create a large source of transplantable TEC. 
Currently, we have established a mouse model for this system, called induced thymic 
epithelial cells (iTEC). The ultimate goal is to transplant iTEC into adults, or children born 
without a thymus, so they can establish new T-cells to protect against disease.  
In this thesis, I address two challenges that limit the potential of iTEC. I outline a method that 
increased the number of iTEC that could be produced at any given time, which is required to 
make transplantable tissues and to reduce the variation shown between batches. I then 
identify new tools to culture iTEC in the laboratory and show these new tools can improve 
how iTEC are currently developed. Finally, I propose a novel method of testing cells in the 
laboratory by creating many miniature thymi in the dish, with the aspiration this technique will 
one day aid thymus-related drug discovery. 
v
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1.1.A. Definition of Thymocyte Sub-Populations and Thymic Structure 
The thymus is the obligate site of T-cell development. Its stromal compartment provides a 
series of unique microenvironments required to mediate the complex sequential processes 
that produce a mature, functional T-cell repertoire (Figure C1.1). T cell development can be 
broken down into a series of events based on the expression of key surface markers on the 
developing T-cells, or thymocytes. The two coreceptors for the T-cell receptor (TCR), cluster 
of differentiation (CD) 4 and CD8, are usually used for this purpose (Petrie and Zúñiga-
Pflücker, 2007). Thymocytes progress from CD4-CD8- double negative (DN) phases, into the 
CD4+CD8+ double positive (DP) phase, wherein they undergo a lineage fate decision to 
generate the CD4+CD8- or CD4-CD8- single positive (SP) thymocytes that eventually egress 
from the thymus (Taniuchi, 2018). During each of these phases, thymocytes undergo 
maturational changes that ensures the thymus contributes a pool of T cells that each 
express a unique TCR, but collectively express a diverse repertoire of self-restricted, self-
tolerant TCR, to the peripheral immune system (Takahama, 2006). Overall, the development 
of this T cell repertoire is termed thymopoiesis (Figure C1.1). 
Cells begin thymopoiesis as DN thymocytes (Figure C1.1). In 1993, this was characterised 
into four stages based upon expression of CD25 and CD44 (Godfrey et al., 1993). The initial 
stage was termed DN1 and is characterised by as CD25-CD44+, thymocytes then progress 
into DN2 and upregulate CD25. In DN3 thymocytes downregulate CD44 and finally DN4 
thymocytes downregulate CD25 to become CD25-CD44- (Figure C1.1). In the years since the 
original publication, the heterogeneity within each of these subpopulations has been further 
characterised (Bhandoola et al., 2007; Falk and Eichmann, 2002). However, understanding 
the role of these sub-populations is not central to this thesis and, therefore, these 
subpopulations are not discussed further herein except for an important sub-population 
within DN1 thymocytes. Within DN1, the most immature thymocyte population is called the 
Early Thymic Progenitor (ETP) and is believed to represent the canonical T cell progenitor. It 
is defined as CD117(cKit)+CD25- CD4-CD8-TCRβ-TCRγ-Nk1.1-CD11b-Gr-1-CD19-CD11c-
Ter119- (Bhandoola et al., 2007). Whilst the ETP is not a homogeneous population in itself, 
2
this thesis will largely assume it to be the initiation point of thymopoiesis (De Obaldia et al., 
2013).  
The tightly controlled and sequentially ordered process of thymopoiesis is established by the 
thymic stroma, the main effectors of which are Thymic Epithelial Cells (TEC) (Abramson and 
Anderson, 2017).Within the thymus, two broad sub-populations of TEC are found, and are 
segregated into cortical and medullary regions. Haematopoietic precursors enter the thymus 
through blood vessels situated at the junction between these regions, the corticomedullary 
junction (CMJ) (Figure C1.1) (Buono et al., 2016; Itoi et al., 2001). Interaction with NOTCH 
ligands enforces T-cell lineage commitment as thymocytes move through the cortex towards 
its edge at the subcapsular region (Benz et al., 2004). Once a thymocyte has developed a 
unique TCR, it begins to migrate back towards the CMJ. Interactions with cTEC ensure only 
those thymocytes with a TCR that interacts with peptide in the context of self-major 
histocompatibility complexes (MHC) within a particular affinity range are conferred survival 
signals. This is termed positive selection (Takada et al., 2017) (Figure C1.1). Thymocytes 
that survive are licensed to migrate into the medulla of the thymus, which is populated with 
medullary TEC (mTEC). Interactions with mTEC, and medullary dendritic cells (DCs), 
remove thymocytes with TCRs that bind peptide:self MHC complexes at high affinity, or 
select such cells to become T regulatory cells (Tregs). Deletion of self-reactive T cell clones is 
termed negative selection (Cosway et al., 2017), whilst the wider process is termed central 
tolerance induction (Figure C1.1). Once this process is complete thymocytes emigrate from 




































Figure C1.1: A Map of  T-cell Thymopoiesis
Blood
Vessel
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4 8
DP
Representation of thymopoiesis with respect to only the key markers used to track thymocytes 
progressing through thymopoiesis at each phase. Cells enter the thymus at the corticomedullary 
junction. Upon receiving Notch signaling, thymocytes progress through the DN phases, which is 
tractable with CD25 and CD44. DN thymocytes must produce a unique TCR  chain to progress 
into the DP phase. In the DP phase thymocytes must complete the TCR by producing a TCR  
chain. Interactions with cTEC ensure only thymocytes with a self-restricted TCR survive and enter 
the SP phase. SP thymocytes are licensed to migrate into medulla, in which interactions with 
mTEC ensure only thymocytes with a self-tolerant TCR are allowed to emigrate into the periphery. 






1.1.B. Colonisation of the Thymus by Haematopoietic Progenitor Cells 
The first event in thymopoiesis is recruitment of bone marrow-resident precursors into the 
thymus from the blood system (Martins et al., 2012). Various candidates have been 
proposed for the identity of this precursor, all of which are downstream progeny of bone 
marrow-derived haematopoietic stem cells (HSCs) (Sultana et al., 2012). While it is still not 
possible to isolate a pure population of HSCs by flow cytometry or any other method, a 
population enriched for HSC may be obtained by a sorting protocol which excludes mature 
cells from most haematopoietic lineages (using an antibody ‘cocktail’ commonly referred to 
as ‘lineage (lin)’), and positively selecting cells from the remaining population of CD45+ cells 
using the surface makers c-KIT and Spinocerebellar ataxia type 1 (SCA-1) (Spangrude et al., 
1988). Within CD45+Lin-c-KIT+SCA-1+ cells, expression of FMS-like tyrosine kinase receptor-
3 (Flt3) further defines three distinct populations: self-renewing HSC (FLT3-), multipotent 
progenitors (FLT3low) and lymphoid-primed multipotent progenitors (FLT3high) (Sultana et al., 
2012). Also downstream of HSCs are common lymphoid progenitors (FLT3high, IL-7Rα+). 
Both populations express two key chemokine receptors: C-C motif receptor (CCR) 7 and 
CCR9 (Zlotoff et al., 2010). Knockout models heavily implicate CCR7, CCR9 and C-X-C 
motif (CXC) Receptor 4, and associated ligands CCL21, CCL25 and CXCL12, in thymic 
homing, making these precursors candidates for thymic seeding (Calderón and Boehm, 
2011; Liu et al., 2006; Schwarz et al., 2007; Sultana et al., 2012; Zlotoff et al., 2010). 
Transcriptomic analyses comparing the ETP, to the lymphoid-primed multipotent progenitors 
(LMPP) and common lymphoid progenitors (CLP) found the ETP was more similar to the 
LMPP, making this population the likely thymus-seeding cell (Allman et al., 2003; Bell and 
Bhandoola, 2008; Lu et al., 2005; Luc et al., 2012; Wada et al., 2008). 
In the late fetal and adult thymus, haematopoietic cells are thought to enter the thymus at the 
CMJ by extravasation from post capillary venules (Takahama, 2006). While the mechanism 
of action is undescribed, Petrie and Zúñiga-Pflücker (2007) propose a similar mechanism to 
the common lymphocyte extravasation mechanism: the leukocyte adhesion cascade. In this 
model, colonisation would take place via a three-stage process in which lymphocyte 
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progenitors first migrate to the thymus through the blood system and, upon arrival, tether to 
the endothelium and enter the thymus as the CMJ (Vestweber, 2015). 
1.1.C. Early Thymocyte Development 
1.1.C.I. ETPs 
ETPs have been shown via clonal level studies to have the potential to differentiate into T-
cell, B-cell and granulocyte-macrophage but not megakaryocyte-erythroid lineages (Luc et 
al., 2012). Commitment of ETPs to the T-cell lineage is imposed by NOTCH signalling, and 
is as an essential function of cTEC (Hozumi et al., 2008; Koch et al., 2008). Buono and 
colleagues (2016) present compelling data that ETPs occupy a unique niche provided by c-
KIT+ endothelial cells at the CMJ. Like cTEC, these endothelial cells provide localised 
membrane bound-KIT Ligand (m-KITL) to support ETPs. The availability of KITL is reduced 
as thymocytes move into the cortex, which has a microenvironment established increasing 
by cTEC that express less c-KIT than the thymic endothelial cells. This gradient controls the 
release of ETPs from the CMJ as they progress further through thymopoiesis and 
downregulate c-KIT by DN3. Evidence for this proposition was gathered when the authors 
deleted exon seven of the Kitl gene, which codes the transmembrane domain. The result 
was a functional and stable variant of the protein that was unable to be anchored at the 
cellular membrane and was secreted, perturbing the KITL gradient that established the CMJ 
niche.  
Mammals have four Notch receptors, all of which are expressed during thymopoiesis 
(Dzhagalov and Phee, 2012; Petrie and Zúñiga-Pflücker, 2007). ETPs predominately 
express NOTCH 1, and conditional knock out studies established that signalling through 
NOTCH 1 is required for T cell commitment (Radtke et al., 1999). There are five ligands that 
associate with the NOTCH receptors: Delta-like ligand (DLL) -1, -3 and -4 and Jagged (JAG) 
1 and 2 (Fiorini et al., 2009). Two studies from Koch (2008) and Hozumi (2008) et al. 
demonstrated that DLL4 is indispensable for T cell lineage commitment, by characterising 
TEC-specific DLL4 knockout mice (Foxn1Cre:Dll4flox/flox). Without DLL4 expression in cTEC, B-
cells rather than T cells developed in the thymus. It is surprising that redundancy with other 
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Notch ligands was not observed, as in vitro data indicate that DLL4, DLL1 and to a lesser 
extent JAG2, are able to mediate T cell lineage commitment (Mohtashami et al., 2010; Van 
De Walle et al., 2011).  
ETPs have huge proliferative capacity and respond to proliferative signalling environment of 
the thymus to undergo a 1000-fold expansion over a period of approximately 10 days 
(Martins et al., 2012; Shortman et al., 1990). Rodewald and colleagues (1995) showed that 
c-KIT (ckit-/-) deficient models have 50% fewer total thymocytes with the DN1 and DN2 
thymocyte sub-populations exhibiting a 40-fold reduction compared to wild-type littermates. 
Notably, thymocyte subset distribution was not affected. This highlights that the perturbation 
was most focused on the early proliferative processes. Kenins and colleagues (2010) 
showed that FLT3 is non-reductant for maintenance of ETPs. Fetal thymic organ cultures 
produced from mice with dysfunctional FLT3 (Flt3-/-) had reduced ETP populations compared 
to those from wild type (WT) mice. This perturbation was only observed in immature 
populations as more mature subsets had recovered, implying other regulatory mechanisms 
compensated for FLT3 deficiency. TEC secrete interleukin-7 (IL-7), a non-redundant 
cytokine that contributes to almost all stages of thymopoiesis and is also implicated at this 
early stage (Petrie and Zúñiga-Pflücker, 2007). ETPs express relatively low levels of the IL-7 
receptor CD127, which then increases, peaking at DN2 (Yu et al., 2004), after which it is 
transcriptionally downregulated in DP cells through suppressor of cytokine signalling one 
(SOCS-1), a process vital for thymocyte death by neglect during positive selection (Yu et al., 
2006, 2004).  
1.1.D. Double Negative Two 
Upon receipt of NOTCH signal, DN1 thymocytes upregulate CD25 to transition to the DN2 of 
thymocyte development, characterised by initiation of Variable (Diversity) Joining (V(D)J) 
region recombination at the TCR γ, δ and β loci (Figure C1.1). Development of the TCR is 
dependent upon expression and rearrangement of the four TCR chains: α and β, γ and δ. 
These characterise the two distinct T-cell populations: αβ T-cells express a heterodimer of 
αTCR and βTCR, while γδ T-cells express γTCR and δTCR chains (Wilson et al., 1994). 
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Lineage dictates the peripheral function of T-cells. αβ T-cells are a key component of the 
adaptive immune system, while γδ T-cells are hypothesised to bridge the innate and 
adaptive immune systems with the γδ-TCR not being restricted to recognising peptides 
within the context of MHC (Gogoi and Chiplunkar, 2013).  
The immune system requires a diverse αβ TCR repertoire and this is generated through 
combinatorial recombination of the segmented TCR loci. This V(D)J exon recombination is 
regulated by expression of the recombinase activating (RAG) proteins RAG-1 and RAG-2 
(Livák et al., 1999). At DN2, recombination of γTCR, δTCR and βTCR genes begins 
(Notarangelo et al., 2001). IL-7 is implicated in γδ T-cell maturation and has been linked to 
chromatin accessibility for RAG-mediated cleavage in the V(D)J recombination of γTCR 
chain (Huang et al., 2001; Ye et al., 2001). Note that not all DN2 thymocytes acquire T-cell 
lineage, some retain potential for, and mature into, natural killer cells (NK) and DCs (Lu et 
al., 2005).  
DN2 thymocytes migrate toward the subcapsular region of the cortex where, upon arrival, 
they will develop into DN3 thymocytes (Takahama, 2006) (Figure C1.1). This sequential 
movement is maintained by chemokine gradients and has been linked to CCR7/CCL21, 
CCR9/CCL25 and CXCR4/CXCL12 that increase toward the outer edge of the cortex (Benz 
et al., 2004; Misslitz et al., 2004; Plotkin et al., 2003). How DN2 thymocytes achieve this 
migration was investigated by Prockop and colleagues (2002) who assessed the affinity of 
DN1, DN2 and DN3 thymocytes for fibronectin (FN) and laminin-1 binding using static 
adhesion experiments. DN1 and DN3 thymocytes showed high affinity for FN while DN2s 
showed a similar or lower affinity for FN as for polystyrene beads coated in bovine serum 
albumin. As the DN2 stage can be considered a transition between DN1, located at the CMJ, 
and DN3, located in the subcapsular region, this supports the notion DN2 thymocytes use 
cellular adhesion rather than matrix adhesion to facilitate migration (Petrie and Zúñiga-
Pflücker, 2007; Shukla et al., 2017). Immunohistochemistry and competitive inhibition assays 
confirmed this interaction utilises Vascular Cell Adhesion protein 1 (VCAM-1) expressed on 
cTEC and its receptor on thymocytes (Prockop et al., 2002; Shukla et al., 2017). 
Furthermore, E-cadherin is a homotypic adhesion molecule that mediates thymocyte 
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adhesion to TEC (Petrie and Zúñiga-Pflücker, 2007). Antibodies that blocked this interaction 
prevented transition of DN thymocytes into DP thymocytes, while blocking thymocyte to 
Extracellular Matrix (ECM) interactions, through integrin αEβ7, did not perturb thymopoiesis 
in Fetal Thymic Organ Culture (FTOC) (Müller et al., 1997). This highlights the importance of 
thymocyte to TEC interactions, over thymocyte to ECM.  
1.1.E. Double Negative Three Thymocytes 
The migration of DN2 thymocytes toward the subcapsular region ends with downregulation 
of CD44 to transition into DN3 (Koch and Radtke, 2011). TCRβ recombination is initiated in 
most thymocytes during the DN2 phase and in all by DN3 (Koch and Radtke, 2011). Schmitt 
and colleagues (2004) showed that Notch signalling was required until the DN3 stage, at 
which point NK and DC potential is lost. Whether DN3 thymocytes continue down γδ or αβ T-
cell lineage depends on which TCR chains have successfully recombined. This is likely to be 
a competitive event as there is evidence of βTCR recombination in γδ T-cells and of αβ TCR 
chains in γδ T-cells (Livák et al., 1999). Successful recombination of γδ TCR concurrent with 
activation of the extracellular signal-related kinase (ERK)-early growth response (EGR)-
inhibitor of DNA binding 3 (ID3) pathway facilitates γδ lineage commitment and NOTCH-
independent maturation (Lauritsen et al., 2009). Most thymocytes enter the αβ lineage, via a 
process called β-selection (Dzhagalov and Phee, 2012). β-selection occurs when a 
productively rearranged TCRβ chain pairs with the invariant pre-αTCR (pTα) and CD3 
complex proteins to form the pre-TCR, and initiation of this process is characterised by 
upregulation of CD27 concomitant with expression of TCRβ (Taghon et al., 2006). Signalling 
through the pre-TCR is ligand-independent, although affected by receipt of Notch and 
CXCR4 signals, and initiates a cascade of downstream processes including down-regulation 
of Cd25, pre-Tα, Rag1 and Rag2 inhibition of further βTCR V(D)J recombination, 
proliferation, differentiation and rescue from apoptosis (Janas and Turner, 2010; Koch and 
Radtke, 2011; Michie and Zúñiga-Pflücker, 2002). Note that β-selection is a key check point, 
thymocytes that do not successfully produce a βTCR are not conferred survival signals via 
the pre-TCR and apoptose (Petrie et al., 1995).Thymocytes that undergo β-selection 
transition to the DN4 stage of development, while thymocytes that do not successfully 
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produce the pre-TCR and are also not selected to become αβT-cells are selected against 
and undergo programmed cell death (Koch and Radtke, 2011; von Boehmer, 2005). 
Onset of β-selection predominantly occurs in DN3 thymocytes at the subcapsular region 
(Petrie and Zúñiga-Pflücker, 2007). In addition to providing migratory signals, 
CXCR4/CXCL12 act as co-stimulators for β-selection (Plotkin et al., 2003). Trampont and 
colleagues (2010) engineered a conditional Cxcr4 knockout model in which Cxcr4 is deleted 
once thymocytes reach the DN2 stage using LckCre (LckCre:Cxcr4flox/flox). This resulted in 
disruption of the migratory path of DN2 thymocytes but also reduced the relative population 
sizes of DN4 against DN3 compared to controls. This implied that removal of CXCR4 
inhibited β-selection, with more DN3 thymocytes failing the β-selection check point. γδ T-cell 
development remained intact, conforming to this hypothesis. Furthermore, when looking at 
whether CXCR4 conferred survival signals to DN3 thymocytes, Trampont and colleagues 
(2010) found that DN3 thymocytes without CXCR4 in OP9-DL1 co-cultures lost viability 
faster than those with CXCR4 signalling intact. The authors concluded that this was due to 
loss of expression of the pre-TCR-induced pro-survival molecule: BCL-2A1.  
Notch signalling also plays a non-redundant role in β-selection by regulating cellular 
metabolism through activation of the Akt pathway phosphatidylinositol 3-kinase (Ciofani and 
Zúñiga-Pflücker, 2005; Maillard et al., 2006). RBP-J deficiency in DN3 thymocytes 
dramatically reduced absolute cell numbers at all subsequent stages of thymopoiesis 
(Tanigaki et al., 2004).  
1.1.F. Double Negative Four Thymocytes 
Cells that pass the β-selection gate transition to the DN4 stages of development, which is 
characterised by a rapid proliferative burst. There is conflicting evidence regarding whether 
the proliferation during the DN4 phase is directly affected by pre-TCR signalling, or is 
instigated by an independent mechanism (Michie and Zúñiga-Pflücker, 2002; Petrie et al., 
2000; Petrie and Zúñiga-Pflücker, 2007). Counterintuitively to the nomenclature, from the 
DN3 stage, thymocytes begin upregulation of CD4 and CD8, which marks the beginning of 
the transition into DP thymocytes (Petrie et al., 1990).  
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The subcapsular region provides extrinsic factors stimulating proliferation. The GTPase, 
RHO has been associated with all stages of thymopoiesis as it implicated for β1 and β2 
integrin activation required for thymocyte adhesion (Vielkind et al., 2005). Galandrini and 
colleagues (1997) produced a model with conditional expression of the RHO inhibitor C. 
botulinum C3 once thymocytes reach DN2 stage (LckC. botulinum C3). These mice showed 
delayed production of SP thymocytes until one week post-natal, as compared to E15.5 in WT 
mice, which was attributed to increased apoptosis at the DN3 stage (Vielkind et al., 2005). 
Furthermore, inhibition of RHO caused defects in cell cycle progression in DN4 thymocytes 
(Galandrini et al., 1997). Therefore, integrin expression and activation, mediated through 
RHO, are implicated in pro-survival signals of DN3 and proliferation of DN4.  
The integrin heterodimer α6β4 is upregulated during the DN3 phase and shows affinity for 
laminin-5, which is abundant in subcapsular region (Kim et al., 2000). MAP kinases are 
specifically activated via α6β4, directly linking α6β4 with proliferation and survival of DN3s 
and DN4s. In FTOC experiments, Kim and colleagues (2000) showed that blocking laminin-5 
produced a 40% reduction in total intrathymic thymocyte population with a 75-90% reduction 
in DN2 and DN3 populations compared with untreated controls.  
1.1.G. Double Positive Thymocytes 
Once they reach the DP phase, thymocytes begin migrating back towards the thymic 
medulla (Koch and Radtke, 2011) (Figure C1.1). The initial event during this phase is V(D)J 
recombination of the Tcrα locus, with thymocytes instigating a second wave of RAG 
expression (Petrie et al., 1995). Once a productive TCRα rearrangement has been made, 
TCRα complexes with the TCRβ (replacing pTα) to form the αβTCR (Klein et al., 2009). DP 
thymocytes that express an αβTCR heterodimer then undergo a process termed positive 
selection, which occurs as during the migration back to the CMJ (Penit, 1988).  
Positive selection occurs when a DP thymocyte expressing a αβTCR interacts with a 
peptide:self-MHC expressed by a cTEC (Figure C1.1). At this stage of development, the 
strength of the interaction determines whether, or not, the thymocyte is conferred survival 
signals. 95% of DP thymocytes express αβTCRs with too great or too weak affinity for self-
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MHC, and these cells undergo apoptosis (Hogquist et al., 2005). Those thymocytes with a 
αβTCR that binds self-MHC presented on cTEC in the right affinity window undergo positive 
selection and are signalled to survive. Positive selection is closely associated with the SP4 
and SP8 fate choice, which is also made at the DP stage of development (Littman, 2016). 
Classical instructive explanations of thymopoiesis suggest that when a αβTCR interacts with 
MHC Class I (MHC1) the thymocyte downregulates CD4, while if it interacts with MHC Class 
II (MHC2) the thymocyte downregulates CD8 (Germain, 2002). Two seminal publications in 
1995 made it evident that the above model was a simplification of a multifaceted process 
(Littman, 2016). Suzuki and colleagues (1995) presented observations that, while 
commitment to SP4 was dependent on MHC signalling, SP8 commitment was MHC 
independent. Furthermore, Lundberg and colleagues (1995) used transplantation studies to 
show that CD4+CD8midTCRmid thymocytes give rise to both SP8 and SP4 thymocytes but 
CD4lowCD8+ exclusively only give rise to further CD8 SP thymocytes. This led to Singer and 
colleagues (Brugnera et al 2000) proposing the kinetic signalling model, which is now 
accepted by the field (Littman, 2016). First, successful TCR engagement results in 
downregulation of CD8 at the transcriptional level generating an intermediate thymocyte 
population: CD4+CD8low. Those thymocytes with a αβTCR that recognises MHC2 will 
continue to receive active TCR signalling, which leads to further upregulation of CD4 and 
progression into SP4 thymocytes. The remaining thymocytes that do not have a TCR 
capable of recognising MHC2 and have downregulated CD8, cannot recognise MHC1 and 
do not receive continued TCR signalling. This initiates a process called coreceptor reversal, 
an IL-7-dependent and TCR-independent mechanism, to generate SP8 thymocytes 
(Taniuchi, 2018). The nomenclature refers to the different kinetics in TCR activation. Loss of 
the CD8 coreceptor prevents TCR that recognise peptide:MHC1 from having sustained 
activation, while TCRs that recognise peptide:MHC2 maintain TCR activation despite 
absence of CD8. Therefore, it is the regulation of CD4 and CD8 expression that dictates 
lineage decision.  
Many regulatory elements have been identified to affect expression of the cd4, cd8α and 
cd8β genes. Most notable is the Cd4 transcription silencer S4 and two of the transcription 
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factors that bind to its sequence. Members of the Runt-related transcription factor (RUNX) 
family activate S4 while the T helper–inducing POZ/Krüppel-like factor (THPOK) prevents its 
activity (Taniuchi, 2018). Thymocytes with a TCR specific to MHC2 maintain TCR signalling 
and upregulate THPOK, preventing S4 activation, to become SP4 thymocytes. Thymocytes 
with a TCR specific to MHC1 cannot maintain TCR signalling and so upregulate the RUNX 
factors and activate S4, which represses cd4 and the thymocytes progress to SP8. In 
addition to IL-7 mediating coreceptor reversal, there is evidence IL-7 encourages thymocyte 
proliferation in SP thymocytes (Tani-ichi et al., 2013). 
Notably, the nature of thymocyte adhesion interactions changes, transitioning away from 
integrins with affinity for VCAM-1 toward those affinity for Intercellular Adhesion Molecule 
(ICAM)-1 (Witt et al., 2005). These interactions yield different functionalisation. DP 
thymocytes arrest the cell cycle and do not require proliferative signalling (Penit, 1988). Also, 
for the first time, thymocytes do not require Notch signalling from the thymic stroma 
(Tanigaki et al., 2004). Instead, DP thymocytes migrate toward the medulla via random 
walking (Witt et al., 2005). This is hypothesised to encourage the multiple interactions with 
cTEC necessary to perform positive selection (Petrie and Zúñiga-Pflücker, 2007).  
1.1.H. Single Positive Thymocytes  
Thymocytes that have successfully undergone positive selection are licenced to migrate into 
the outer region of the thymic medulla, an area rich in DC cells and mTEC (Shortman and 
Naik, 2007). Interactions with both mTEC and DC provide cognate TCR-peptide:MHC 
interactions essential for imposing central tolerance on the developing repertoire. The main 
objective of negative selection is to remove any thymocytes with a self-MHC restricted TCR 
that recognises self-peptide. Thus any thymocytes that display affinity to such peptides are 
induced into apoptosis, a process termed clonal deletion, or are committed to the regulatory 
T-cell lineage (Klein et al., 2014; Kyewski and Peterson, 2010). In order to perform clonal 
deletion effectively, mTEC express a very wide repertoire of genes that are normally tissue 
or developmentally restricted, through a process termed promiscuous gene expression, 
which controls expression of so-called tissue restricted antigens (TRAs). Two transcription 
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factors mediate this process: a major regulator of TRA expression in the thymus is the 
autoimmune regulator AIRE, which is expressed in mTEC. More recently, the Fez family 
zinc finger 2 (FEZF2) has been purported to play a role in AIRE-independent TRA 
expression (Takaba et al., 2015). However, there is some controversy regarding the original 
publication (Cosway et al., 2017). DCs can also present these mTEC-expressed antigens via 
the process of cross-presentation (Klein et al., 2009).  
Migration through the medulla is regulated by chemokines. SP thymocytes upregulate CCR4 
and CCR7. This encourages directed migration towards CCL19 and CCL21, which are 
secreted by mTEC (Cowan et al., 2014; Witt et al., 2005). ICAM-1 is essential to mediate 
thymocyte to stromal adhesion, which is necessary for negative selection (Kishimoto et al., 
1996). Furthermore, there is evidence that DCs secrete CCL17, which binds CCR4, to 
actively attract thymocytes (Lieberam and Förster, 1999). Throughout negative selection, 
thymocytes migrate deeper into the medulla, away from the DC rich outer edge (Kurobe et 
al., 2006). During this migration, thymocytes are presented with peripheral peptides by 
mTEC and DC. Cognate TCR-peptide:MHC instigate a pro-apoptotic event that eliminates 
any autoreactive thymocytes (Petrie and Zúñiga-Pflücker, 2007). There is substantial 
evidence that thymocytes require more than MHC interactions to reach maturation (Dyall and 
Nikolic-Zugić, 1999). Tang and colleagues (2016) showed that a specific subset of DCs 
called plasmacytoid DCs express IL-27 within the thymic medulla and when this is knocked 
out, thymocytes are unable to complete thymopoiesis. Moreover, the addition of endogenous 
IL-27 rescued the phenotype during in vitro assays. 
SP thymocytes transition through several intermediate stages before completing negative 
selection (Li et al., 2007). Xing and colleagues (2016), show that there are three 
subpopulations of both CD4 and CD8 SP thymocytes, identified via flow cytometric analysis 
of CD69 and MHC1. Importantly, the authors demonstrate district functional differences 
between these subpopulations with respect to the effect of TCR stimulation, ability to secrete 
cytokines and capacity for thymic egression: Semi-mature thymocytes (CD69+MHC1-) 
represent thymocytes most recently positively selected; Mature 1 (CD69+MHC1+) 
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thymocytes acquire the ability to proliferate after TCR stimulation; Mature 2 (CD69-MHC1+) 
thymocytes demonstrated both TCR-stimulated proliferation and a competency to secrete 
cytokines. Strikingly, Mature 2 thymocytes upregulate key genes for thymic egress such as 
sphingosine 1 phosphate receptor 1 (S1PR1). Conditional knockout of S1PR1 in thymocytes 
(LckCre:S1PR1flox/flox) significantly reduced the number of T-cells in the periphery and 
accumulated within the thymus (Allende et al., 2004; Matloubian et al., 2004). In keeping with 
these data, James and colleagues (2018) postulated a mechanism of egression in which, 
upon reaching the Mature 2 phase, thymocytes upregulate Forkhead Box Protein O1 
(FOXO1) and Krüpple Like Factor 2 (KLF2), which in turn upregulates S1PR1 and CD62L 
and downregulates CD69 (Alfonso et al., 2006; Bai et al., 2007; Bankovich et al., 2010; 
Fabre et al., 2008). This process then directs thymocytes to follow a S1P gradient towards 
the CMJ to exit the thymus and begin peripheral maturation (Figure C1.1). 
1.2. Thymic Organogenesis  
1.2.A. Overview of Thymic Organogenesis 
Thymopoiesis is mediated through thymocyte interaction with the microenvironment. Thymic 
stromal cells establish and maintain this environment, which allows a transient thymocyte 
population to follow a defined maturation pathway (Figure C1.1). The chief effectors of this 
are TEC. Therefore, understanding how thymopoiesis is established and maintained is 
closely associated with the developmental processes that establish TEC. This thesis breaks 
down TEC development into two phases, based upon expression of a single transcription 
factor. Forkhead Box N1 (FOXN1), a member of the Forkhead or winged helix superfamily, 
can be considered the master transcription factor of the TEC developmental program (Figure 
C1.2). Null mutations in Foxn1 cause hairlessness and athymia in the classical nude 
(Foxn1null) phenotype. Experimentation suggested that the nude thymic phenotype resulted 
from a block in the TEC developmental program at Embryonic day (E) 11.5, ultimately 
leading to retention of a cystic thymic rudiment without haematopoietic colonisation or 
normal TEC structures (Blackburn et al., 1996). Bleul and colleagues (2006) confirmed this 
hypothesis using a revertible null allele of Foxn1, showing that reversion of the Foxn1 null 
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allele in a single cell was sufficient to instigate TEC development resulting in generation of a 
small thymic lobe capable of supporting thymopoiesis and containing both cortical and 
medullary TEC populations. This supports a two-phase model of organogenesis: a FOXN1 
independent phase, in which third pharyngeal pouches (3PP) are specified to the TEC 
lineage and in which the thymic rudiment forms and migrates, and a FOXN1 dependant 
phase in which TEC differentiation and maintenance confers thymic functionality (Vaidya et 
al., 2016). Therefore, thymic organogenesis can be parsed into the establishment of the 
thymic rudiment as the FOXN1 independent phase and development of the TEC program as 
the FOXN1 dependant phase.  
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Representation of the third pharyngeal pouch between E10.5 and E12.5. At E11.5 Foxn1 
expression is initiated in the ventral domain of the common thymus-parathyroid primordium. 
Over time, Foxn1 expression spreads into the central domain. At E12.5 the rudiments have 
separated and the thymus begins migration. Images adapted from Vaidya, Briones Leon and 
Blackburn, 2016. 
Thymus domain / primordium
Parathyroid domain / primordium
Neural Crest-Dervied Mesenchyme
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1.2.B. FOXN1 Independent Establishment of the Thymic Rudiment 
The thymus derives from the endoderm of the 3PP, which can be observed from ~E9.0 as 
bilateral buddings of the foregut (Vaidya et al., 2016). The 3PP generates both the 
parathyroid gland and the epithelial compartment of the thymic rudiment (Figure C1.2). This 
is observable using expression of the transcription factors: Glial cell missing 2 (Gcm2) in the 
dorsal anterior, parathyroid-fated region and Forkhead Box G1 (Foxg1) and ISL LIM 
Homeobox 1 (Isl1) in the ventral posterior, thymic-fated region (Bain et al., 2016; Gordon et 
al., 2001; Wei and Condie, 2011). This process is governed by a network of transcription 
factors including HOXA3, PAX1/9, EYA1, SIX1 and SIX4 network and dysfunction in any 
gene results in impaired organogenesis (Manley and Condie, 2010; Xu et al., 2002). 
Gordon and colleagues (2004) were first to show that mammalian TEC are generated 
exclusively the endoderm of the 3PP by isolating the endoderm component from E8.5 to 
E9.0 3PP and engrafting it under the kidney capsule of nude mice. This fragment was 
sufficient to establish a fully functional thymus with complete thymocyte populations and 
cortical and medullary architecture. This functional evidence, along with lineage tracing in 
whole embryo culture, established that the thymus originates from the endoderm of the 3PP, 
independently from the surrounding ectoderm, and that the rudiment is already specified to 
the thymic development program at the early timepoint of E8.5-9.0 (Le Douarin and 
Jotereau, 1975). 
1.2.C. FOXN1 Dependent Development of the TEC Program 
At E11.25, the thymus-specified 3PP endoderm strongly upregulates expression of Foxn1 
(Gordon et al., 2001; Nehls et al., 1994). As previously discussed, whilst not essential for 
specification of the TEC lineage or establishment of the thymic rudiment, FOXN1 is essential 
for differentiation of TEC and thus for development of a functional thymus able to support 
thymopoiesis (Blackburn et al., 1996; Bleul et al., 2006; Gordon et al., 2004; Nowell et al., 
2011; Ripen et al., 2011).  
The mechanisms regulated by FOXN1 are sufficient to recapitulate TEC functionality in 
unrelated cell-types. Bredenkamp and colleagues (2014) enforced Foxn1 expression in 
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murine embryonic fibroblasts (MEFs), largely recapitulating the FOXN1-dependant phase of 
thymic development. Importantly, upon transplantation under the kidney capsule of nude 
(Foxn1null) or syngeneic mice, these cells, termed Induced Thymic Epithelial Cells (iTEC), 
differentiated into both cortical and medullary TEC and emulated thymopoiesis by populating 
the recipient with T-cells.  
FOXN1 is also able to restore functionality to TEC that have undergone healthy, age-related 
degeneration called thymic involution (Bredenkamp et al., 2014). Downregulation of Foxn1 
was hypothesised to be a main driver of involution and it is an early hallmark of the process 
(Ortman et al., 2002). In itself this implicates FOXN1 in thymic homeostasis, without which 
TEC fail to maintain functionality (Chen et al., 2009). Bredenkamp and colleagues (2014) 
upregulated high levels of functional FOXN1 expression in post-involution TEC, 
demonstrating that this intervention was sufficient to reverse age-related thymic involution 
and restore T-cell output and TEC phenotype and architecture to close to juvenile levels. 
This effect was observed in both the cortical and medullary compartments, with key genes 
being progressively downregulated during involution and then, upon FOXN1 upregulation, 
being restored close to pre-involution levels. Therefore, FOXN1 is essential for TEC 
functionality, development and maintenance and Foxn1 downregulation is a hallmark of 
thymic involution and loss of function. However some notable effectors of thymopoiesis are 
maintained interpedently of FOXN1, such as IL-7 (Zamisch et al., 2005).  
Despite the significant contribution of FOXN1 to the functionality of the thymus, the upstream 
elements governing and establishing Foxn1 expression are poorly characterised. Foxn1 has 
been shown to positively autoregulate, although whether this is direct or indirect is yet to be 
elucidated (Bredenkamp et al., 2014; Vaidya et al., 2016; Zook et al., 2011). Members of the 
E2F family of transcription factors have demonstrated the capacity to bind to the presumptive 
Foxn1 promoter region. Retinoblastoma tumour suppressor (RB) proteins negatively regulate 
EF2: knocking out 5/6 members of the RB family increased Foxn1 expression and thymus 
size in a murine model. Furthermore, E2F, which is negatively regulated by RB, was shown 
to bind the Foxn1 promoter in chromatin immunoprecipitation assays. 
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1.2.D. Mesenchymal Influences on the Developing Thymus 
By E12.5 the thymic rudiment has begun to separate from the pharynx and the parathyroid 
domain to begin migrating to its final position above the heart (Abramson and Anderson, 
2017). During this process the TEC population proliferates and expands, with the proportion 
of Ki67+ TEC peaking around E14.5 (Jenkinson et al., 2007). The thymic stroma contains 
many cell types, in addition to TEC. Neural Crest Cell (NCC) – derived mesenchyme 
develops in close association to the epithelial compartment. Two studies have lineage traced 
the contribution of NCC-derived mesenchyme in thymus organogenesis. These both used 
conditional expression of Yellow Fluorescent Protein to indelibly mark cells, and their 
progeny, that expressed Sox10 (Sox10Cre:eYFPflox/flox) or Wnt1 (Wnt1Cre:eYFPflox/flox) (Wnt1Cre 
- Foster et al., 2008; Sox10Cre - Müller et al., 2008). At E11.5 Yellow Fluorescent Protein 
(YFP)+ cells (using the SOX10 system) had encapsulated, but not infiltrated, the epithelium 
of the thymic rudiment (Müller et al., 2008). By E13.5, although most YFP+ cells were 
present in the capsule of the thymus, there was evidence of YFP+ cells within the epithelium. 
This proportion grew through E15.5 to E17.5 at which point there was evidence that the 
YFP+ cells were organising within the thymus into Three-Dimensional (3D) structures. 
Comparing thymi taken from new-born and three-months postnatal mice, over time there 
were fewer YFP+ cells in the capsule with most cells being within the organ itself, organising 
into a network associating with vasculature (Foster et al., 2008). This was also reported in 
thymi from eight-months postnatal mice (Müller et al., 2008).  
It is interesting to note that YFP+ cells infiltrated the epithelium after E11.5, but before E13.5. 
In a study investigating the effect of FOXN1 on haematopoietic colonisation of the rudiment, 
Itoi and colleagues (2001), showed that fibronectin expressing cells did not infiltrate the nude 
(Foxn1null) thymus between E11.5 and E13.5. Furthermore, in a hypomorphic Foxn1 variant 
(Foxn1R/R), this process was delayed (Nowell et al., 2011). Therefore, FOXN1 upregulation 
at E11.5 appears to instigate NCC-derived mesenchymal infiltration of the thymic anlage. 
Collectively, it was concluded that NCC-derived cells contributed to the pericyte population 
that support the endothelia of the thymus (Foster et al., 2008; Müller et al., 2008). Both 
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studies observed a switch from Platelet-Derived Growth Factor Receptor 
(PDGFR)α+PDGFRβ+ to PDGFRα-PDGFRβ+ expression pattern, spatially between YFP+ 
cells in the capsule and within the thymus and over time. Foster and colleagues (2008) 
postulated that this process marked the switch between supporting the proliferation of the 
epithelium to the vasculature. This is support by knockout models, PDGFRα deficiencies 
produces hypocellular but functional thymi while PDGFRβ dysfunction predisposes toward 
microvascular haemorrhaging, affirming the importance of these proteins in these roles (Itoi 
et al., 2007; Jenkinson et al., 2007; Levéen et al., 1994; Soriano, 1994).  
Griffith and colleagues (2009) presented evidence that NCC deficiency, in a Pax3 null 
(Pax3Splotch) mouse model, affected the patterning of the E10.5 3PP into thymus and 
parathyroid domains. By E11.5 the Pax3 null model had a larger proportion of cells specified 
to a thymic-fate and a smaller parathyroid domain than WT controls. The loss of NCC did not 
affect cell death or proliferation, demonstrated by maintaining a consistent overall 3PP 
volume between the mutant and controls, it shifted the border between the parathyroid and 
thymic domains. The authors noted similarities between this model and a model deficient in 
Sonic Hedgehog (SHH) and proposed that NCC-derived cells could be contributing to SHH 
signalling, which is implicated in establishing the parathyroid domain. Furthermore, it was 
observed that thymic rudiment fails to detach and thus becomes ectopic in the Pax3 null 
mutants. While the exact mechanism that mediate this process is known it appears likely to 
result from perturbation of the NCC-derived mesenchyme (Griffith et al., 2009).  
The most accepted role played by perithymic mesenchyme is the secretion of factors that 
promote TEC proliferation and growth such as Fibroblast Growth Factor (FGF) 7 and FGF10, 
which have a common receptor, FGFR2IIIb (Abramson and Anderson, 2017). FGFR2IIIb 
deficient (Fgfr2IIIb -/-) models show extreme hypocellularity within the thymus: comparatively, 
the WT thymus greatly increased in size until E17.5 while the mutant remained the same 
(Revest et al., 2001). Jenkinson and colleagues (2007), performed kidney grafting 
experiments of both whole E12.5 thymic lobes and lobes with the encapsulating layer of 
mesenchyme removed. Grafted Lobes without mesenchyme retained the capacity to support 
TEC differentiation but the graft did not expand, highlighting both the importance of thymic 
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mesenchyme (TM) in controlling TEC proliferation but also the ability of the rudiment to 
develop independently (Auerbach, 1960). The authors noted that all grafted lobes became 
colonised with kidney capsule-derived mesenchyme. To probe why this was not able to fully 
compensate for the discarded thymic-derived mesenchyme, the authors examined 
differences in gene expression, and showed that TM uniquely express IGF1, IGF2, FGF7 
and FGF10. 
1.2.E. Haematopoietic Colonisation of the Thymus 
Expression of Foxn1 is essential for colonisation of the thymic rudiment by haematopoietic 
progenitors (Itoi et al., 2001). The progenitors first arrive in the mesenchymal layer at E11.5 
and begin to migrate into the epithelium at ~E12.0, with this migration being strictly 
dependent on FOXN1(Luis et al., 2016). Haematopoietic colonisation is linked to expression 
of CCL25, CCL21 and CXCL12 in the rudimental TEC and absence of these chemokines 
leads to loss of haematopoietic colonisation of the thymic rudiment (Calderón and Boehm, 
2011). These represent FOXN1 targets and there is evidence that loss of haematopoietic 
colonisation in nude models (Foxn1null) is effect via loss of these chemokines (Žuklys et al., 
2016). 
Ineffective colonisation of the thymus not only prevents the formation of a T-cell repertoire, 
but also perturbs TEC development, post-E15.5. This dynamic communication between the 
epithelial and haematopoietic compartments is termed cross-talk (Shores et al., 1991). In 
studies on severe combined immunodeficiency (SCID) mice, Singer and colleagues (1991) 
first observed that the presence of TCR expressing lymphocytes was essential for 
development of medullary regions in postnatal thymi. This phenotype was reversed upon 
transplantation of wild-type bone marrow, with the presence of thymocytes stimulating 
development of a medullary compartment. In a later study, Klug and colleagues (2002) 
showed that early embryonic TEC patterning occurs correctly in Rag2 and common cytokine 
receptor γ-chain-deficient (Rag-/-Tcrγ-/-) mice. It was not until E17.5 that the mutants’ keratin 
profiles became distinguishable from WT mice and showed hypoplastic thymi with perturbed 
TEC patterning. Therefore, crosstalk is dispensable for the initiation of TEC patterning to 
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generate the cTEC and mTEC sub-lineages and for generation of the cortical compartment, 
but is essential for further development of an expanded, functional medullary (Klug et al., 
2002).  
As discussed above, mTEC express a range of TRAs and present peptides derived from 
these proteins to SP thymocytes during negative selection. The ability of mTEC to provide 
TRAs is called promiscuous gene expression. The transcription factor AIRE has been 
identified as a key regulator of this process (Anderson et al., 2002) and is detectable by E16 
(Lopes et al., 2015). To date, two lymphoid contributors have been implicated in the cross-
talk process required to establish Aire expression in mTEC: the lymphoid tissue inducer (LTi) 
(CD3−CD4+IL-7Rα+) and the invariant Vγ5+TCR+ dendritic epidermal T-cell (DETC) 
progenitor (Roberts et al., 2012). Knocking out LTi using RAR-related orphan receptor 
gamma deficient (Rorc-/-) mice or DETC using TCRδ knockout (Tcrδ-/-) mice resulted in a 
significant reduction of Aire+ mTEC by E17. Double knockout mice had a further reduction, 
confirming the importance of both lymphocytes in establishing a functioning medulla. It is 
interesting to highlight that the double knockout did not abolish Aire expression and that 
therefore additional uncharacterised mechanisms may also regulate Aire expression.  
The current model for mTEC development suggests a stepwise differentiation process, with 
cells progressively differentiating through phenotypically defined mTEC progenitor stages. 
Activation of the Nuclear Factor Kappa-B (NFκ-B) signalling pathway by Receptor Activator 
of Nuclear Factor kappa-B (RANK), a member of the Tumour Necrosis Factor (TNF) 
superfamily, and Lymphotoxin β is crucial for generation of AIRE+ mTEC; ablation of RANK 
on mTEC or RANK-ligand (RANKL) on lymphoid cells resulted in a suppression of AIRE 
expression in the embryonic thymus (Akiyama et al., 2016, 2008; Cosway et al., 2017). Note, 
that this section only covers the haematopoietic influences on medullary formation. The 
specification of mTEC will be discussed in greater detail, which aims to discuss the 
developmental pathways of TEC. 
1.2.F. Molecular Mechanisms Dictating Thymic Organogenesis 
1.2.F.I. Thymic Morphogenesis 
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Other than FOXN1, Bone Morphogenetic Protein 4 (BMP4), Wingless/Integrated (WNT) and 
SHH are heavily implicated in thymic development. Bmp4 is expressed in the ventral thymic-
fated 3PP endoderm and surrounding mesenchyme between E10.5 and E12.5, whilst its 
antagonist Noggin is expressed in the dorsal, parathyroid region of the 3PP (Patel et al., 
2006). Gordon and colleagues (2010), used three conditional models to knock out Bmp4 in 
the 3PP epithelium and mesenchyme from E9.5 using Foxg1Cre, in TEC from E11.5 using 
Foxn1Cre and in the NCC-derived mesenchyme using Wnt1Cre. The Foxg1Cre model led to 
perturbations in morphogenic events such as: separation of the thymic from the parathyroid 
primordium; migration of the E12.5 thymus; colonisation by haematopoietic cells and 
formation of the mesenchymal thymic capsule, while cell differentiation, specification and 
Foxn1 expression remained intact but delayed. This phenotype was not present when Bmp4 
was deleted solely in TEC from E11.5. Furthermore, deletion of Bmp4 solely in the 
mesenchyme using Wnt1Cre did not result in a phenotype. Collectively, these data suggest 
that Bmp4 is necessary for only a short window of time, during the FOXN1-independent 
phase of thymic development, and that expression in the 3PP endoderm rather than in the 
surrounding mesenchyme is essential for normal thymus development. 
Note, that removing Bmp4 expression using the Foxg1Cre did not ablate BMP signalling 
within the rudiment. There was no difference when the mutant and WT littermates were 
stained for phosphorylated SMAD 1/5/8, which was used as a readout of active BMP 
signalling. Therefore, the described effects should be attributed to loss of BMP4 originating 
in the 3PP epithelium and mesenchyme rather than complete abolition of BMP signalling. 
Furthermore, the expression pattern of Foxg1Cre in the mesenchyme was inconsistent, with 
differences being noted between embryos and between the left and right rudiments within 
the same embryo.  
1.2.F.II. Regulation of Foxn1 expression 
Prior to the above publication, there was evidence linking BMP4 to positive regulation of 
Foxn1 (Bleul and Boehm, 2005; Soza-Ried et al., 2008; Tsai et al., 2003). The Foxg1Cre 
model was associated with a delay in organ separation, lumen closure and haematopoietic 
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colonisation. Therefore, the model might reduce but not ablate BMP signalling to diminish 
positive regulation of Foxn1 and slow, rather than prevent the mechanics, of these FOXN1-
dependent processes (Gordon et al., 2010). 
A more recent publication further probed the cooperative interaction between BMP4 and 
Foxn1 (Swann et al., 2017a). Noggin is an antagonist of BMP4 and if the above mechanism 
is true, therefore a negative regulator of Foxn1. By placing Noggin under control of the 
Foxn1 promotor (Foxn1Noggin), the authors created a system in which Foxn1 activation is 
representative of WT but once activated its becomes repressed by production of Noggin and 
inhibition of BMP2, 4 and 7 signalling (Bleul and Boehm, 2005). In this model, the E15.5 
thymus was a mosaic of Foxn1+ and Foxn1- TEC. This expression pattern is notable when 
compared to reducing the amount of FOXN1 within the system by introducing a null allele 
(Foxn1-). Mice heterozygous with the Foxn1 null allele (Foxn1-/+) have smaller thymi without 
the population of Foxn1- TEC. Therefore, a comparison between these two systems 
highlights the differences between TEC expressing less Foxn1 from the point of initiation and 
TEC that expressed WT levels of Foxn1 at the point of initiation but, as the levels of Noggin 
steady increased, were unable to positively regulate its expression via BMP signalling. The 
mosaic pattern of Foxn1+ and Foxn1- TEC of the (Foxn1Noggin) mouse shows that some TEC 
fail to maintain Foxn1 expression in the absence of BMP signalling.  
The role played by WNT signalling in regulating Foxn1 expression is not completely 
understood. In 2002, Balciunaite and colleagues demonstrated Wnt4 and Wnt5b mRNA 
expression in 3PP cells obtained by laser-capture microdissection. The same authors 
demonstrated by over expression assays in cell lines that stimulation of WNT signalling 
resulted in increased Foxn1 expression. However, a more recent study, did not support 
these findings (Swann et al., 2017b). These investigators knocked out β-catenin, the obligate 
intracellular regulator of canonical WNT signalling, in all TEC from ~E12.0 using Foxn1Cre 
(Foxn1Cre:Ctnnbflox/flox) and also studied constitutive Nlk deficient (Nlk-/-) mice in which 
noncanonical WNT signalling is abrogated. At E15.5 both models had correctly positioned 
thymi, with cortical and medullary architecture and robust Foxn1 expression, but with 
reduced total cellularity and a proportional reduction in cTEC.  
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In addition, these investigators tested the hypothesis that Wnt overexpression upregulates 
Foxn1. The authors produced models with TEC- specific over-expression of WNT4 
(Foxn1Wnt4) and stabilised β-catenin (Foxn1Ctnnb). No thymic tissue was detectable in the 
thoracic cavity of new-born mice with TEC- specific over-expression of β-catenin 
(Foxn1Ctnnb). Using a LacZ reporter (Foxn1lacZ) an ectopic rudiment was traced to the cervical 
region, approximately level with the thyroid cartilage. In E15.5 embryos of the TEC-
conditional expression of β-catenin (Foxn1Ctnnb), the characteristic TEC networks were 
replaced with cystic structures of squamous epithelium and migration of the rudiment was 
found to be arrested laterally to the carotid artery. Early E12.5 tissues were also heavily 
perturbed with the thymus and parathyroid domains failing to separate from each other. At 
both embryonic ages, levels of FOXN1 was reduced compared to those found in WT tissues 
as shown on both the mRNA and protein level (using a Foxn1EGFP reporter). In turn this 
prevented haematopoietic colonisation of the rudiment, which persisted to adulthood. Note 
that this model (Foxn1Ctnnb) perturbed the migration but not function of the parathyroid. 
The TEC-specific WNT4 over-expression model (Foxn1Wnt4) had a less pronounced 
phenotype, which is in keeping with model producing a weaker activation of WNT target 
genes than the β-catenin over-expression model (Foxn1Ctnnb). Migration of the rudiment was 
still perturbed, in E15.5 embryos it was situated adjacent to the trachea and level with the 
thyroid cartilage. However, there was evidence of reticulated TEC architecture and 
haematopoietic colonisation. Focusing on new-born tissues, there was a reduced total 
cellularity within the transgenic thymi including TEC, compared to the WT. Notably, the 
cortical (Ly51+) and medulla (UEA1+) TEC patterning was perturbed with a relative increase 
in the number of unassigned TEC (Ly51-UEA1-) and aberrant populations with intermediate 
staining profiles. The authors concluded that WNT overexpression dysregulated TEC 
differentiation or selective survival of atypical TEC subsets. 
Given the proposition that the TEC-specific overexpression of β-catenin (Foxn1Ctnnb) 
produces a greater over expression of WNT targets than the TEC-specific WNT4 over-
expression model (Foxn1Wnt4), it can be stated that as WNT signalling was more excessively 
expressed, the perturbation of thymic organogenesis was increased. This can be linked to 
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FOXN1, both directly as demonstrated in the overexpression of β-catenin (Foxn1Ctnnb) model 
on the mRNA and protein level, compared to WT, and the inhibition of key FOXN1-
associated features of thymic organogenesis such as haematopoietic colonisation and 
organisation of the TEC structure in the β-catenin over-expression (Foxn1Ctnnb) compared to 
the WNT4 over-expression model (Foxn1Wnt4). Therefore, the above is evidence that WNT 
signalling negative regulates FOXN1. 
It was also demonstrated that the TEC-specific WNT4 over-expression model (Foxn1Wnt4) 
prevented TEC from differentiating from a presumptive non-patterned state (Ly51-UEA1-) 
and/or heavily selected for the survival/proliferation of this population at the expense of the 
other subsets found in new-born thymus. Furthermore, TEC-specific loss of β-catenin 
(Foxn1Cre:Ctnnbflox/flox) and therefore activation of WNT associated target genes, reduced 
total cellularity of the thymus and increased the proportion of cTEC over mTEC. Collectively, 
increasing WNT prevented TEC from correctly differentiating while decreasing WNT 
increased the number of mTEC compared to cTEC from initiation of Foxn1 to E15.5.  
The role of canonical WNT signalling in the activation of FOXN1 was not investigated in the 
above study. However early work from Mulroy and colleagues (2002) provide evidence that 
Wnt1 and Wnt4 double knockout (Wnt1-/-Wnt4-/-) mice have thymi capable of supporting 
thymopoiesis, with significantly less total cellularity, until the phenotype results in death at 
birth, suggesting it is not required for thymic function or Foxn1 expression but expansion of 
either the whole thymus or haematopoietic compartment.  
All three members of the Hedgehog family are expressed in the thymus (Saldaña et al., 
2016). Focusing on SHH, there is evidence that it is instrumental in deciding the parathyroid 
– thymus fate boundaries. Model with a constitutive SHH knockout (Shh-/-), do not develop a 
parathyroid domain as shown by Foxn1 expression extending to the pharynx of the shared 
rudiment (Moore-Scott and Manley, 2005). Gain of function studies were used to assess 
whether overexpression of SHH would alter the boundaries between the rudiment. Most 
notably, SHH was conditionally activated in the endoderm (Foxa2CreERt2Rosa26 
floxSTOPflox:SmoM2) by enforcing expression of an active form of Smoothened (SmoM2). This 
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induced expression of GCM2 (glial cells missing transcription factor 2) in the central domain, 
partially extending into the ventral domain of the shared rudiment. Expression of Tbx1 was 
negatively associated with Foxn1, which suggests that SHH acts to negatively regulate 
Foxn1 via TBX1. As noted above BMP4 is an essential positive regulator of FOXN1, 
enforced activation of the SHH signalling pathway in the endoderm 
(Foxa2CreERt2:Rosa26floxSTOPflox:SmoM2) did not affect BMP4, leading the authors to postulate 
that BMP4 inhibits TBX1, which ensured the ventral domain of the rudiment retained Foxn1 
and thymus specification (Bain et al., 2016). 
Saldaña and colleagues (2016) found that SHH deficient (Shh-/-) E15.5 embryos had a 
smaller thymus with a significantly lower proportion of cTEC to mTEC than WT littermates, 
but retained Foxn1 expression. Due to embryonic lethality, the E15.5 thymi were cultured 
using a FTOC system, the mutant cultures developed fewer total TEC and a reduced 
proportion were mTEC. Interestingly, MHC2 was higher in mutant FTOC. To isolate the 
effect of SHH to the FOXN1-dependant phase, the authors used a TEC-specific conditional 
knockout (Foxn1CreShhflox/flox) model. The TEC phenotype paralleled that of the constituent 
knockout FTOC. When examining the effect on thymopoiesis, the mutated thymi contained a 
higher proportion of SP4 and SP8 against DP thymocytes with higher expression of CD3 and 
CD5. This conclusion was confirmed by a recent study on Gli3 knockout (Gli3-/-) mutants 
highlighting the Shh repression promotes thymocyte differentiation and positive selection 
(Solanki et al., 2018). That both constituent and TEC-conditional SHH deficiency models 
report a similar phenotype highlights that the correct Shh - Gli3 interplay is essential 
throughout organogenesis. 
1.2.F.III. Bipotent Progenitor TEC 
Patterning of the thymus into functionally distinct cortical and medullary regions occurs early 
in thymic development (Klug et al., 2002; Nowell et al., 2011; Rodewald, 2008). Klug and 
colleagues used Keratin expression to track the emergence of cTEC and mTEC throughout 
organogenesis, using Keratin 8 (K8) to identify cTEC and Keratin 5 (K5), mTEC (Klug et al., 
2002, 1998). These authors showed that at E11.5 3PP endoderm was exclusively K8+K5-. 
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However as early as E12.5, the central region of the rudiment contained a population of 
K8+K5+ TEC. This double positive population was maintained until E15.5 when K8-K5+ TEC 
emerge to form the earliest TEC population with an mTEC-like Keratin profile. However, later 
papers show evidence that emergence of the medulla lineage occurs earlier (Baik et al., 
2016; Nowell et al., 2011; Rodewald et al., 2001). It is now clear that, during thymus 
organogenesis, a common thymic epithelial progenitor cell (TEPC) can exist. As discussed 
above, Boehm colleagues (2006), using a mouse model homozygous for a revertible null 
Foxn1 allele, showed that a single TEPC could produce small thymi containing both cTEC 
and mTEC progeny. Concurrently, Rossi and colleagues (2006) showed that when a single 
E12.5 TEC was injected into a host E12.5 thymus and grafted on to the kidney capsule, it 
was able to contribute to both the medulla and the cortex of the graft. 
The putative existence and identity of the bipotent TEPC was presented four years 
previously. Bennett and colleagues (2002) showed that dissociated E12.5 PLET1+ TEC were 
able to form functional thymi with normal cortical and medullary architecture, when grafted 
under the kidney capsule in nude mice (Bennett et al., 2002; Depreter et al., 2008). A later 
study determined that E12.5 TEC almost uniformly (95%) expressed PLET1, aligning the 
data presented by Rossi, and Bennett, et al. (Rossi et al., 2006). The same functionality was 
extended to E15.5 PLET1+MHC2+ TEC, which were able to constitute a patterned thymus 
capable of mediating thymopoiesis when grafted onto the kidney capsule of syngeneic mice 
(Gill et al., 2002).  
Controversy arose around whether PLET1+ TEPC were a sub-population of progenitor TEC 
or whether early TEC contain transient bipotency that was lost throughout development. 
Rossi and colleagues (2007), performed kidney graft experiments using PLET1+ and PLET1- 
TEC from E14.5, E16.5 and E18.5. Strikingly in the E14.5 and E16.5 timepoints, both 
PLET1+ and PLET1- TEC produced patterned grafts. Furthermore, using E18.5 tissue, 
PLET1+ TEC were unable to form grafts while PLET1- were.  
Whilst it is clear that PLET1 marks bipotent founder TEC in the early thymic primordium, 
whether or not it marks TEPC (either bipotent or sub-lineage restricted) at later stages 
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should be re-evaluated with contemporary understanding of self-organisation (Gjorevski et 
al., 2014). Given the evidence that the medulla emerges early in the TEC developmental 
program, both Gill (2002) and Rossi (2007) contributed both progenitor and pre-patterned 
TEC into the grafts. This makes it difficult to distinguish between whether the successful 
formation of the grafts can be attributed to the progenitors, which differentiated into 
functioning cortical and medulla compartments, or the pre-patterned TEC self-organising into 
functioning cortical and medulla compartments. The more mature the input thymic tissue, the 
more vulnerable the experiment is to this error (Baik et al., 2016; Nowell et al., 2011; 
Rodewald et al., 2001). Self-organisation also explains the contrasting result that Gill and 
colleagues were unable to successfully recover grafted E15.5 PLET1- TEC while Rossi and 
colleagues were able to recover 83.3% of E14.5 and 100% of E16.5 PLET1- grafts. Rossi 
and colleagues used 100,000 TEC in each graft while Gill and colleagues used 2,500. The 
large disparity in input number highlights that Rossi and colleagues’ experimental design 
was more vulnerable to incorrectly attributing graft survival as a consequence of progenitor 
action, rather than self-organisation of a large body of pre-patterned TEC. Collectively, these 
studies conclusively show that at E12.5, PLET1 marks progenitor TEC, while at E18.5, most 
PLET1+ TEC do not appear to function as TEPC. The role of TEPC and of PLET1 throughout 
thymic organogenesis requires further elucidation. However, a more recent study 
demonstrated that the only bipotent progenitor TEC population that could be identified in the 
adult thymus using a clonal-resolution, transplantation assay, was PLET1+ (Ulyanchenko et 
al., 2016). 
1.2.G. mTEC Divergence from the Common Progenitor 
How mature lineage-restricted TEC are generated from bipotent TEPC is not clear. Some 
evidence suggests that cortical / medullary divergence is FOXN1-independent and does not 
require haematopoietic-derived cross-talk, with further evidence suggesting that for the 
mTEC lineage, emergence is independent of RELB (Baik et al., 2016; Klug et al., 2002; 
Nowell et al., 2011). There is evidence that mTEC lineage is the progeny of cells that 
expressed markers associated with cortical function. The hypothesis that all TEC pass 
through a β5t+ stage was strongly supported by two in vivo lineage tracing studies. Here, 
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β5t+ TEC were heritably labelled using a doxycycline-regulatable Cre in conjunction with β5t-
rtTA (Mayer et al., 2016) or by knocking Cre into β5t (Ohigashi et al., 2013). Both studies 
found that a substantial proportion of mTEC had arisen from progenitors that once 
expressed β5t. 
Evidence exists for mTEC-restricted progenitors. The lineage-restricted hypothesis was 
initiated from early evidence that each medullary islet was the progeny of an individual cell 
(Rodewald et al., 2001). In 2014, Sekai and colleagues (2014), proposed and phenotypically 
characterised lineage-restricted progenitors using expression of the tight junction 
components Claudin-3 and Claudin-4 (CLDN3/4) and functionally validated them using the 
aly/aly mouse model, which has defective NF-κB–inducing kinase (NIK) and thus impaired 
mTEC development. This phenotype was rescued in RTOC experiments in which E14.5 
aly/aly TEC were mixed with sorted CLDN3+CLDN4+ WT TEC. The graft contained functional 
AIRE+ mTEC that prevented development of multiorgan autoimmunity and did not contribute 
to the cortex. Given that Cldn3 and Cldn4 are expressed in mature mTEC, to better 
characterise the progenitor population the authors proposed the marker SSEA1. When 
reaggregated with age-matched dissociated thymic cells and grafted under the kidney 
capsule, E14.5 SSEA1+CLDN3+CLDN4+ cells had significantly greater reconstitution 
potential then SSEA1-CLDN3+CLDN4+ cells. While these cells were proposed as mTEC 
stem cells, convincing evidence for self-renewal of this population has not been shown 
(Sekai et al., 2014). 
In 2016, two papers investigated the role of NF-κB in the differentiation of the proposed 
mTEC stem cell (Akiyama et al., 2016; Baik et al., 2016). In an effort to characterise the 
effect of RANK on these, Baik and colleagues (2016) engineered a RankVENUS reporter 
model and found that SSEA1+CLDN3+CLDN4+ mTEC did not express RANK. Throughout 
organogenesis, within the CLDN3+CLDN4+ TEC population, RANK expression emerged as a 
nonoverlapping population with SSEA1+ mTEC. When spiked into an age-matched RTOC, 
RANK+SSEA1-CLDN3+CLDN4+ preferentially contributed mTEC progeny. Therefore, the 
authors hypothesised that RANK expression is essential for downstream differentiation in a 
RELB dependant mechanism (Baik et al., 2016).  
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Akiyama and colleagues (2016) presented evidence of a similar progenitor population that 
exhibited RANK expression. However, this population also bound Ulex Europaeus Agglutinin 
I (UEA1), which is regarded as a pan-mTEC marker. Akiyama and colleagues showed that 
grafted-RTOC (gRTOC) generated from aly/aly thymi and spiked with 
UEA1+RANKhighMHC2midCD80– TEC (termed pMECs) were also able to generate AIRE+ 
medullary regions and rescue the autoimmune phenotype. It was shown that canonical NF-
κβ (Traf6-/-) and noncanonical NF-κβ (Relb-/-) deficient models blocked pMEC differentiation 
at different stages. In Traf6-/- thymi, mTEC differentiation was blocked at the pMEC stage 
(UEA1+RANKhighMHC2midCD80–), while in Relb-/- thymi mTEC differentiation was blocked at a 
UEA1+RANKloMHC2loCD24hi stage (termed pro-pMECs), which was proposed to represent 
an earlier stage of mTEC development. Pro-pMECs were able to differentiate into functional 
AIRE+ mTEC when spiked into aly/aly gRTOC. Collectively, these data suggested a model in 
which RANK and LTβR activation of RELB induce pro-pMECs to differentiate to generate 
pMEC and then RANK activation of TRAF6 is required for pMECs to differentiate into mature 
AIRE+ mTEC. However, the picture of mTEC differentiation is far from complete. 
1.2.H. cTEC Lineage Specialisations  
Despite evidence that the all TEC, are progeny from cells expressing markers that persist 
through the cTEC lineage and are essential for its function, the cTEC are not a persistent 
bipotent progenitor population (Mayer et al., 2016; Ohigashi et al., 2013). As discussed 
previously, cTEC are specialist cells responsible for enforcing T-cell lineage upon recent 
haematopoietic immigrants and for mediating positive selection, in which cTEC employ 
unique peptide processing and presentation machinery (Figure C1.3) (Hozumi et al., 2008; 
Kincaid et al., 2016; Koch et al., 2008). This can be separated into processes that generate 
the peptide repertoire for presentation to SP8 thymocytes on MHC1 and to SP4 thymocytes 
on MHC2. 
Newly formed MHC2 proteins contain an invariant chain (Ii) in the prospective peptide 
binding domain (Takada et al., 2017). Once transferred to a late endosome, Ii is 
proteolytically degraded leaving a peptide formed of amino acids 81 to 104 bound to the 
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MHC2 peptide binding groove (Nakagawa et al., 1998). This short peptide is termed CLIP. In 
a process catalysed by H-2M in mouse and HLA-DM in humans, CLIP is replaced with 
peptides present in the endosome for presentation on MHC2 (Honey et al., 2002; Takada et 
al., 2017) (Figure C1.3).  
In cTEC there are two unique proteins that shape the MHC Class II peptide repertoire. 
Thymus-specific serine protease (TSSP) plays a critical yet undefined role in peptide 
processing as shown by TSSP deficient (Prss16-/-) mouse models (Gommeaux et al 2009) 
(Figure C1.3). The TSSP deficient thymus had reduced MHC2high cTEC, but similar thymic 
and peripheral T-cell cellularity at 10-11 weeks postnatal mice. The proportions of SP4 / SP8 
thymocytes were also reported to be similar although these data were not shown. However, 
when crossed onto the Class II-restricted TCR transgenic lines Marilyn and OT II, there was 
a loss of SP4 T-cells compared to both Prss16+/+ and Prss16-/+ controls. This indicates that 
TSSP deficient cTEC either present a smaller variety of peptides or do not effectively modify 
peptides to have the desired avidity for TCR, which is compensated for by TCR diversity in 
WT mice but is observable in TCR transgenic strains. Notably, there was no phenotype 
when crossed onto the OT-I TCR transgenic line, confirming that TSSPs role is exclusive to 
MHC2 and SP4 T-cell generation (Gommeaux et al., 2009). Later studies show that TSSP 
deficiency affects the peripheral function of SP4 T-cells, which express an altered TCR 
repertoire that lead to poorer antigen responses and resistance of NOD models to colitis-
associated colorectal tumour formation and diabetes compared to controls (Brisson et al., 
2015; Serre et al., 2015; Viret et al., 2015).  
Another key protein is cathepsin L in the mouse (the human homolog is cathepsin V or 
cathepsin L2), which plays a vital role in proteolytic degradation of Ii into CLIP to process 
self-peptides for presentation (Figure C1.3). Its expression is unique to cTEC (Honey et al., 
2002; Nakagawa et al., 1998), with other APCs, including mTEC, expressing alternative 
proteins such as cathepsin S (Shi et al., 1999; Takada et al., 2017). Nakagawa and 
colleagues (1998) characterised the cathepsin L deficient mouse model (Ctsl-/-), highlighting 
that the thymic and peripheral SP4 T-cell counts were 60-80% reduced and demonstrated 
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weaker responses to antigen stimulation compared to heterozygous (Ctsl+/-) littermates. T-
cells remained self-tolerant, providing evidence that Cathepsin L affects SP4 T-cell 
generation and positive selection but not negative selection. Subsequently, the Rudensky 
group published a report showing Cathepsin L mediated this effect both via the degradation 
of Ii into CLIP and also by regulating the processing of peptides for MHC2 presentation 
(Honey et al., 2002). Furthermore, the group engineered a CIITA-expressing fibroblast cell 
line to compare the peptides generated by cathepsin L and cathepsin S, and concluded that 
each produced an overlapping but non-redundant peptide repertoire (Hsieh et al., 2002).  
cTEC also express unique peptide processing mechanisms to generate self-peptides for 
expression in the context of MHC1, for positive selection (Figure C1.3). The leading model of 
positive selection is the affinity model, which suggests that the affinity of the TCR-
peptide:MHC interaction determines whether a thymocyte successfully undergoes positive 
selection (Takada et al., 2017). In 1994, Hogquist and colleagues reported observations from 
the OT-I TCR transgenic model, in which thymocytes express a TCR that recognises the 
chicken ovalbumin peptide 257-264 (SIINFEKL) in the context of MHC Class I. Amino acid 
substitutions were used to increase or decrease the affinity of the peptide to the transgenic 
TCR. The authors showed higher affinity peptides biased toward negative selection while 
lower affinity induced positive selection (Hogquist et al., 1994; Takada et al., 2017).  
Most nucleated cells present self-peptides upon MHC1 as part of immunosurveillance. Many 
of these are derived from cytoplasmic self-proteins, which are degraded by proteasomes 
before being tagged to the endoplasmic reticulum via Transporter Associated with Antigen 
Processing (TAP) (Figure C1.3). The peptides are loaded upon MHC1 and relocated to the 
cellular membrane for presentation (Takada et al., 2017). cTEC employ a specialised 
proteasome which generates a unique peptide repertoire for presentation upon MHC1 
(Figure C1.3). There are three types of proteasome. All three types contain four heptameric 
rings aligned into a barrel shape with two outer α-rings and two inner β-rings (Groll et al., 
1997; Unno et al., 2002). It is the composition of the β-ring that differentiates the 
proteasomes. The constituent proteasome has β1 to β7 subunits, the immunoproteasome 
has IFN-γ–inducible subunits β1i, β2i, β5i in place of the numerical counterparts. In the 
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thymus, the thymoproteasome substitutes in β5t (Psmb11) in place of β5i, and is unique to 
cTEC (Murata et al., 2007; Ripen et al., 2011). Kincaid and colleagues (2016) engineered 
knockout mice that lacked β1i (Psmb9-/-), β2i (Psmb10-/-), β5i (Psmb8-/-) and β5t (Psmb11-/-), 
and in which the thymoproteasome was thus replaced with the constituent proteasome in 
cTEC. The peptide repertoire generated by the constituent proteasome was unable to 
mediate positive selection, as demonstrated by a >90% loss of TCRβ+ SP8 T-cells in this 
model. 
To compare the effect of the immunoproteasome to the thymoproteasome, Murata and 
colleagues (2007) replaced the single exon of Psmb11 with the Venus Fluorescent protein, 
to engineer the β5t deficient mouse (Psmb11-/-). In this mouse, cTEC expressed β5i rather 
than β5t; effectively substituting the thymoproteasome for the immunoproteasome. β5t 
deficient cTEC were shown to have a functioning, MHC1-loading, peptide processing 
pathway. However, the peptide repertoire presented to thymocytes was altered (Takada et 
al., 2017). The loss of β5t and its associated peptide repertoire substantially diminished the 
size of the SP8 T-cell population in both the thymus and periphery demonstrating a clear role 
for β5t in SP8 thymocyte generation. Within the thymus, the β5t deficient model produced, 
on average 24% less SP8 thymocytes which were associated with less TCRβhigh cells 
(50.2%) compared to WT (80.7%). Follow up studies found T-cells positively selected on 
immunoproteasome-derived peptides also displayed weaker immune responsiveness and 
TCR diversity (Nitta et al., 2010; Takada et al., 2015). Collectively, these data have 
established that, while the thymoproteasome is not essential for SP8 T-cell generation, it is 
required for normal positive selection and production of a functional SP8 T cell repertoire. 
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Figure C1.3: Peptide Processing in cTEC
A. Representative diagram of the composition of the -rings of the constitutive proteasome, 
immunoproteasome and thymoproteasome. The 5t sub-unit is unique to the 
thymoproteasome, which is exclusively expressed in cTEC. B. The organisation of the -
rings and -rings in the 20s proteasome. C. The peptide processing in cTEC. Invariant chain 
(Ii), endoplasmic reticulum (ER), major histocompatibility complex (MHC), transporter 
associated with antigen processing (TAP), thymus-specific serine protease (TSSP). Images 



















Constitutive Proteasome Immunoproteasome Thymoproteasome


























Peptide Processing in cTEC
36
1.3. Strategies for Supporting T cell Development in vitro 
Development of an in vitro culture system that fully recapitulates the thymus functions 
required to support T cell differentiation and repertoire selection has not yet been achieved. 
Currently used methods are unable to preserve key in vivo characteristics of primary thymic 
stromal cells and established cell lines fail to recapitulate the original tissue (Anderson et al., 
1998; Anderson and Jenkinson, 2007; Auerbach, 1960; Jenkinson and Anderson, 1994). 
Auerbach described a system for culturing whole thymic lobes in vitro, that was able to 
sustain thymopoiesis (Auerbach, 1960; Jenkinson and Owen, 1990). Subsequent 
investigators refined this technique by including a dissociation, selection and reaggregation 
process, hence developing a system that could be used to determine individual contributions 
to thymopoiesis (Anderson et al., 1993). Attempts to simplify this approach have largely 
hinged around establishing thymic stromal cell lines, able to support some or all elements of 
thymopoiesis in monolayer culture conditions, but to date these have essentially been 
unsuccessful.  
To circumvent this problem, and Schmitt and colleagues (2002) showed that transgenic 
expression of the Notch ligand DLL1 in the OP9 bone marrow stromal cell line enabled this 
line to mediate T-cell lineage commitment of haematopoietic precursors, and to support 
subsequent thymopoiesis to the double positive stage of development. This in vitro model 
has facilitated investigation of T-cell lineage development and has prompted the creation of 
other cell-line based systems (Montel-Hagen et al., 2019; Seet et al., 2017; Shukla et al., 
2017; Simons et al., 2018). Additionally, some progress has been made towards producing 
thymic stromal cells in vitro using directed differentiation and direct lineage reprogramming 
strategies (Bredenkamp et al., 2014; Lai and Jin, 2009; Su et al., 2015). The above 
strategies are each discussed in detail below, in relation to their ability to support native 
thymopoiesis and their current technical limitations.  
1.3.A. Culture systems recapitulating the Native Thymic Environment 
1.3.A.I. FTOC and RTOC 
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Early attempts to recapitulate T cell development in vitro utilised explant culture of fetal 
thymic lobes, and this model is still used today (Anderson et al., 1993; Auerbach, 1960; 
Jenkinson et al., 1982). In brief, dissected whole embryonic thymic rudiments are cultured at 
the liquid-air interface, supported by a porous membrane that mediates nutrient exchange 
between the lobe and tissue culture medium. The position of the lobe, exposed to air, was 
found to be beneficial to αβ T-cell development, a metabolically active process hypothesized 
to have a high oxygen demand (Germeraad et al., 2003). This culture system is called 
FTOC. Strikingly, FTOC allows not only the lymphoid cells initially contained within the 
explanted thymus, but also exogenously supplied lymphoid progenitors, to undergo 
thymopoiesis, even when the two components are harvested from different species (Fisher 
et al., 1990). This was first demonstrated in experiments in which the explanted lobe was 
initially depleted for lymphoid cells, by culture in 1.35 mM 2-deoxyguanosine (2-dGuo) for 
five-days, and subsequently supplied with T-cell precursors from a different genetic 
background (Jenkinson et al., 1982). This accessible system for supporting thymopoiesis 
from a defined starting haematopoietic population proved an essential tool for understanding 
thymic biology. For example, Godfrey and colleagues (1993) used this methodology to 
characterise the progression of thymocytes through T-cell lineage specification based upon 
CD25 and CD44 expression, which remains standard nomenclature (Petrie and Zúñiga-
Pflücker, 2007).  
Jenkinson and colleagues (1992) developed an important extension to the FTOC approach, 
by including a step that allowed examination of the role of individual stromal and 
haematopoietic components in the regulation of thymopoiesis. This was achieved by 
dissociating fetal thymic lobes into a single cell suspension, then reaggregating selected 
thymic elements and culturing the reaggregated fetal thymic tissue as required (Anderson et 
al., 1993). This technique is termed Reaggregate Thymic Organ Culture (RTOC). RTOC may 
also be grafted into an ectopic location in a recipient mouse (grafted RTOC; gRTOC). The 
site most often used is the kidney capsule, which allows the RTOC to develop, with host-
derived vasculature supporting haematopoietic immigration and emigration (Bennett et al., 
2002; Rodewald et al., 2001). This process is widely used to investigate aspects of thymus 
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biology including TEC differentiation, and engrafting into immunodeficient mice allows 
observation of how thymopoiesis affects peripheral TCR repertoire composition and function 
(Bennett et al., 2002; Rodewald et al., 2001). Notably, unlike their in vitro counterparts, 
gRTOC undergo self-organisation such that clear cortical and medullary compartments are 
present in the recovered grafts (Bennett et al., 2002; Rodewald et al., 2001). 
TEC are highly sensitive to their microenvironment, and have been shown to dramatically 
alter their gene expression profiles when removed from the thymic niche (Anderson et al., 
1998). It was demonstrated that upon culture in skin stem cell conditions, some TECs were 
reprogrammed into a multipotent skin stem cell-like state, that could contribute to the skin 
and hair follicle in the skin morphogenetic assay, whilst losing the ability to mediate 
thymopoiesis (Bonfanti et al., 2010). This suggests that one of the principals underlying the 
success of FTOC is that preservation of the thymic niche preserves TEC function.  
It should be noted that the degree to which RTOC recapitulate native thymus functionality 
has not been fully quantified. Given the precise molecular cascades governing TEC 
differentiation, the sensitivity of TEC to the surrounding microenvironment and the highly 
disruptive nature of RTOC generation, it is pertinent to assume that TEC differentiation is at 
least partially perturbed when creating RTOC. This is a potentially confounding variable 
when generalising from the behaviour of TEC in gRTOC to that of the native thymus, 
including around TEC progenitor regulation. Thus, in vitro assays cannot be considered 
conclusive evidence of native TEC behaviours in vivo. 
RTOC remains the only system in which T-cell differentiation, central tolerance and TEC 
differentiation can all be modelled (Anderson and Jenkinson, 2007; Jenkinson and 
Anderson, 1994). Why RTOC recapitulate behaviours of the native thymus, while other 
culture techniques such as monolayer culture are not able to, remains poorly understood 
(Mohtashami and Zuniga-Pflucker, 2006). Notably, successful RTOC is widely considered to 
rely on the use of thymic tissue from the early stages of organogenesis: by E19.5 or P0: 
organ cultures rapidly lose total viable cell numbers within four to five days (Ueno et al., 
2005). This suggests that the capacity for generating a functional organoid operates during a 
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defined window of development, with either the cellular compartment losing the intrinsic 
ability, or later microenvironments failing to nurture, TEC functionality. Experimental 
observation of this was reported by Rossi and colleagues (2007) who observed reduced 
differentiation potential of TEC taken from E12.5 compared to E18.5 gRTOC. 
McCune and colleagues demonstrated that the murine kidney capsule could support a 
xenografts of human thymic material (McCune et al., 1988). Tissue was donated from the 
ninth gestational week and transplanted under the kidney capsule for 13 weeks. SCID mice 
were used as the recipients of the grafts, as these mice cannot establish a lymphoid system. 
As shown in gRTOC created from murine tissue, the graft was infiltrated by the host’s 
vasculature system. The functionality of this was demonstrated by providing human fetal liver 
cells to the blood system of the SCID mouse recipient. The human cells were able to 
colonise the graft, undergo thymopoiesis and emigrate from the thymus. Remarkably, this 
did not produce graft vs host disease, which was taken as evidence that the emigrating T-
cells had been exposed to both donor and recipient peptides during central tolerance. 
Farley and colleagues (2013) first demonstrated that human fetal tissue was compatible with 
gRTOC. Tissue was collected from the eighth week of gestation, dissociated, reaggregated 
with MEFs and cultured as RTOC for 24 hours before grafting under the kidney capsule of a 
Non-Obese Diabetic (NOD)/SCID mouse. The human-gRTOC was regionalised into UEA1+ 
and human leukocyte antigen (HLA) class2high regions. 
Chung and colleagues (2014) argue that gRTOC is suitable to culture post-natal human 
tissues from ages ranging between 10 days and five months. However, the conclusions of 
the study are confounded by a poorly characterised 2D expansion protocol. The authors 
expanded tissue fragments in two different medium, one selecting for TM and the other for 
TEC. Strikingly, after three to four weeks both cultures retained expression of key genes of 
the native tissue, including the TEC-selective culture showing maintained expression of both 
FOXN1 and AIRE. However, no time zero controls were included and therefore no 
comparisons can be made regarding the relative expression levels of these genes as a 
consequence of the culture method. 
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After this expansion, the authors placed cells from TEC-selective medium, cells from TM-
selective medium and 95% pure CD34+ cord blood cells into RTOC and observed the 
emergence of CD3+ DP, SP4 and SP8 thymocytes after four weeks. Again, no purified 
passage zero controls were used and so the experiment is confounded by the poorly defined 
nature of the input cell populations particularly from the TEC-selective medium, which 
comprised of only 39.1% EpCAM+ cells. Grafted under the kidney capsules in an 
NOD/SCID/gamma (NSGTM) mouse model with a humanised blood system, the gRTOC- 
recruited bone marrow precursors and contributed T-cells into the periphery with evidence of 
TCRβ diversity. However, no T-cell functionality or central tolerance assays were performed.  
1.3.A.II. Decellularised Thymic ECM 
ECM is an essential component of the extracellular microenvironment and has been shown 
to direct cellular behaviours in other organ and tissue systems (Gjorevski et al., 2014). The 
hypothesis that presenting a complete, native thymic ECM to TEC is beneficial for 
maintaining ex vivo function has been explored by two papers using decellularized tissue as 
a scaffold for cell culture. 
The first publication claiming to have completed this was confounded by poor experimental 
design and absence of controls. Fan and colleagues (2015) used a detergent-perfusion 
system to decellularise three to four-week postnatal thymi. They then seeded the resulting 
decellularized ECM with a CD45+ cell-depleted thymic stroma cell preparation plus HSC and 
grafted this reaggregate into a nude recipient (H-2b). The enriched thymic stroma preparation 
contained ~18% SP thymocytes (H-2b/g7). Therefore, since these cells could proliferate within 
the periphery of the haplotype-matched nude (H-2b) and reject mismatched (H-2k) but not 
matched (H-2b and H-2g/7) skin grafts, it cannot be concluded that the engrafted 
decellularised scaffold contributed anything more than releasing the already present mature 
thymocytes into the periphery once the graft was vascularised. 
Hun and colleagues (2017), used a different detergent-perfusion based decellularisation 
process termed 3-[(3-Cholamidopropyl)dimethylammonio]-2-Hydroxy-1-Propanesulfonate 
(CHAPSO) to produce scaffolds from seven week old postnatal thymi. No in vitro data were 
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reported as the authors focused on kidney grafting experiments. The CHAPSO-scaffolds 
were seeded with E14.5 TEC (CD45-EpCAM+) and TM (CD45-EpCAM-) and were able to 
mediate thymopoiesis from recruited haematopoietic precursors after five weeks. Compared 
to standard control gRTOC, the CHAPSO-scaffold-based grafts showed significantly 
improved TEC and TM proliferation. This led to a three-fold increase in the number of total 
CDSP4 T-cell and SP8 T-cells in the blood, taken as a proportion of total CD45+ cells, five 
weeks after engraftment with either gRTOC or the CHAPSO-scaffold. However, there was 
no direct investigation of whether this affected T-cell function or central tolerance. The 
authors also sectioned grafts recovered after five weeks of transplantation, to investigate the 
TEC structure. Staining for keratin 5, keratin 8 and LY51 found that the CHAPSO-scaffolds 
was predominantly populated by mTEC, with the structures containing very few cTEC. The 
authors employed a clonogenic 3D culture system first described by Wong and colleagues 
(2014) to test whether exposing embryonic TEC to ECM derived from postnatal thymi 
affected TEC behaviour. When supplemented to the clonogenic assay, the addition of 
postnatal thymic ECM decreased Foxn1 expression and promoted medullary differentiation, 
reinforcing the earlier observation that CHAPSO-scaffolds were predominantly populated 
with mTEC.  
1.3.A.III. Artificial Scaffold Materials 
Using decellularised ECM-scaffolds invites cells to adapt a pre-existing pattern, which might 
constrain cellular behaviours if the appropriate cells are not seeded into the appropriate pre-
created niche (Gjorevski et al., 2014). Furthermore, use of decellularized ECM is 
compounded by problems of tissue supply and variability, and therefore some investigators 
have begun to test the outcome of using synthetic biocompatible matrices in the generation 
of RTOC.  
The Rosenzweig group published two studies that used synthetic matrix to culture ex vivo 
thymic stroma, CellFoam and Cytomatrix® (Marshall et al., 2003; Poznansky et al., 2000).. 
Focusing on the later Cytomatrix® report, four- to six-week postnatal thymi were processed 
into two mm3 explants and placed on top of the matrix. The stromal cells infiltrated the matrix 
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and, once at confluency, were irradiated before seeding with Lin-Sca+ haematopoietic 
progenitors from either the thymus or bone marrow. Given that the initial thymic explants 
contained haematopoietic cells, the authors used CD45.1 or CD45.2 to distinguish between 
the seeding populations. No effort was made to characterise effects of the culture system on 
the thymic stroma, with the authors focusing on thymopoiesis, which did not substantially 
improve compared to RTOC. Therefore, the use of a defined matrix did not improve the 
reliability of in vitro thymopoiesis over RTOC. A subsequent publication by Clark and 
colleagues (2005) that found that human keratinocytes and fibroblasts cultured within 
CellFoam, upregulated key TEC genes and gained the ability to mediate thymopoiesis 
including central tolerance. However, this was subsequently found to be unreproducible 
(Meek et al., 2011).  
More recently, Pinto and colleagues (2013) tested the use of a hydrogel for culturing TEC, 
with the aim of identifying conditions for mTEC that preserved promiscuous gene expression. 
Jettex, a viscose, fibrous material, was supplemented with thrombin and fibrinogen and 
human dermal fibroblasts were encapsulated inside. The hydrogel was placed in a trans-well 
to separate it from the tissue culture medium, while allowing nutrient exchange through the 
porous membrane. mTEC from one- to seven-day postnatal mice were cultured on top of the 
hydrogel and were unable to infiltrate it during the culture. This allowed proliferation and 
maintenance of mTEC, on top of the hydrogel, with evidence of promiscuous gene 
expression. However, the authors did not present evidence of functionality, for instance by 
testing whether the target mTEC population could rescue the aly/aly phenotype in kidney 
grafting experiments (Akiyama et al., 2016; Sekai et al., 2014).  
Thus, whilst there has been effort to incorporate defined scaffolds into in vitro thymopoiesis 
assays, the studies reported to date do not show conclusive improvements over classical 
RTOC, although direct side-by-side comparison was not presented in all the above studies. 
Two papers have reported that TEC progenitors can be cultured in spheres of clonally 
expanded cells and could differentiate into cTEC and mTEC progeny (McQualter et al., 
2010; Ucar et al., 2014; Wong et al., 2014). These papers reported that the sphere-initiating 
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cells originated from fundamentally different starting populations. Ucar and colleagues 
(2014) claimed this population was FOXN1-EpCAM- while Wong and colleagues (2014) 
claimed that the starting cell population was FOXN1+EpCAM+. With respect to the former 
publication, a recent study failed to confirm the main findings, concluding instead that the 
FOXN1-EpCAM- population was mesenchymal and recruited bystander TEC into the spheres 
from the heterogeneous starting population (Sheridan et al., 2017). The FOXN1+EpCAM+ 
population reported by Wong and colleagues (2014) displayed limited ability to be passaged, 
but could contribute to gRTOC when mixed with fetal thymic tissue. Further functional 
characterisation of TEC cultured in this system was not explored. 
Therefore, FTOC and RTOC are still the only tissue culture techniques that successfully 
emulate thymic function. Notably this includes maintenance of Foxn1 expression within TEC, 
which is not observable in monolayer conditions (Mohtashami and Zúñiga-Pflücker, 2006). 
The mechanism via which RTOC maintain Foxn1 expression is not characterised. However, 
it is known that tissue age and ability to successfully form RTOC is negatively correlated 
(Rossi et al., 2007; Ueno et al., 2005). Whether that is due to a change intrinsic to TEC or 
within the environment is also unclear but exposure of embryonic tissue to postnatal ECM 
reduced Foxn1 expression in TEC and biased differentiation toward the medulla lineage, 
(Hun et al., 2017). 
1.3.B. Notch-Engineered Feeder Cell lines 
In 2002, a novel methodology was published by Schmitt and Zúñiga-Pflücker that allowed in 
vitro thymopoiesis without ex vivo TEC. This circumvented key technical limitations 
associated with RTOC: namely, the scarcity of TEC and the technical difficulty and resulting 
inconsistency associated with preparing RTOC. In brief, these investigators utilised the 
mouse bone marrow stromal cell line OP9, that expresses key factors for thymopoiesis, 
including IL-7, CXCL12 and KIT-L but not bone marrow associated factors essential for other 
haematopoietic lineages such as Colony Stimulating Factor 1 (CSF1) (Smith et al., 2015), 
and was known to support B cell development from haematopoietic progenitors (Carlyle et 
al., 1997). They engineered this line to ectopically express the NOTCH ligand DLL1, since 
44
NOTCH signalling was known to dictate T-cell lineage commitment (Radtke et al., 1999), and 
tested whether this would confer the capacity to support T cell development on the OP9 
cells. This proved to be the case: in 2D co-culture, the OP9-DLL1 system was able to confer 
T-cell lineage commitment upon HSC, and to support efficient T cell differentiation up to the
DP stage of development, with some SP8s being generated. Note that SP4 cells are not 
generated as the OP9 line does not express MHC2, a unique feature of TEC outside the 
haematopoietic system. Subsequently, the OP9-DLL1, and the more recently developed 
OP9-DLL4, systems have been at the forefront of investigation of thymopoiesis in vitro, with 
T-cells being generated from a range of starting cell types ranging from HSCs and ETPs to
embryonic stem cells and induced pluripotent stem cells in both mouse and human (Brauer 
et al., 2016).
In an extension of this strategy, Seet and colleagues (2017) engineered the mouse bone 
marrow stromal cell line MS5 to ectopically express human-DLL1. Unlike OP9-DLL1, the 
MS5-hDLL1 system was inefficient at generating T-cells in a monolayer culture system. 
Therefore, the authors applied the cell line to an RTOC-inspired reaggregation and culture 
method. The resulting culture was termed an artificial thymic organoid (ATO) and 
demonstrated a markedly improved efficiency in generating CD3+ SP4 and SP8 T-cells from 
human HSCs compared to the monolayer OP9-DLL1 system.
As discussed above, thymopoiesis can be broken into four parts: T-cell lineage commitment, 
-selection, positive-selection and central tolerance induction/negative selection and the
thymus has evolved specialised molecular mechanisms that are essential mediators of 
positive selection and negative selection. Both the OP9-DLL1 and MS5-hDLL1 systems can 
mediated lineage commitment and β-selection. However, effective negative selection 
requires promiscuous gene expression to remove TCRs that recognise tissue-restricted 
antigens (TRA) (Lopes et al., 2015), and which, as discussed above, depends on the 
expression of AIRE and FEFZ2 in mTEC. The capacity for promiscuous gene expression is 
not present in OP9 or MS5 cells and, as T-cells generated in these systems will not be 
exposed to the full range of peptides present in the native thymic medulla, these systems will 
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produce T cell repertoires that contain autoreactive T-cells, similarly to mice with 
dysfunctional promiscuous gene expression (Aire-/-) (Ramsey, 2002).  
Once a thymocyte has completed its αβTCR, interactions with cTEC mediate positive 
selection and lineage fate decision (Figure C1.1). TCR activation minimally requires a 
peptide:MHC interaction from cTEC. Whether the OP9-DLL1 and MS5-hDLL1 can generate 
appropriate self-peptide pools will be discussed later. Firstly, whether OP9-DLL1 and MS5-
hDLL1 express appropriate MHC will discussed and how this related to thymocyte fate 
decision. The MS5 and OP9 are both cell lines created from the murine bone marrow stroma 
and do not express MHC2 (Schmitt and Zúñiga-Pflücker, 2002; Seet et al., 2017). Without 
interactions with peptide:MHC2 to provide constant TCR signalling, it is not possible for a 
thymocyte to a adopt the SP4 lineage (Brugnera et al., 2000; Littman, 2016; Taniuchi, 2018). 
However, both systems report mediation of SP4 thymocyte generation. In the MS5-hDLL1 
paper, Seet and colleagues hypothesise that a small population of DC are created from the 
input human haematopoietic progenitors. This population slowly accumulates, which 
describes the relatively slower emergence of SP4 thymocytes, and begins to provide 
peptide:MHC2 interactions that mediate both the active TCR signalling for positive selection 
and lineage diversion of SP4 thymocytes (Seet et al., 2017). Furthermore, this protocol used 
a human haematopoietic system, in which DP thymocytes also express MHC2, which will 
further contribute to haematopoietic – thymocyte TCR activation (Zinkernagel and Althage, 
1999). This mechanism reflects those found within xenografted thymi, in which a recipient 
haematopoietic system can complete thymopoiesis in a donor thymus, interact with TEC 
expressing donor MHC complexes but emerge restricted to- and tolerant of- both donor and 
recipient MHC. Evidence was observed that the selection processes, which produced 
restriction to- and tolerance of- recipient peptide:MHC arose between haematopoietic-
derived, recipient cells, while restriction to- and tolerance of- donor peptide:MHC arose 
through the canonical TEC-thymocyte interaction (Van Coppernolle et al., 2009; Zinkernagel 
and Althage, 1999). Therefore, this explanation is plausible. However, while the functional 
consequences of this remains to be characterised, it must be reinforced that in this process 
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the OP9-DLL1 and MS5-hDLL1 are not recapitulating cTEC mediated-positive selection 
(Takada et al., 2017). 
How relative differences in peptide processing between cTEC and the OP9-DLL1 and MS5-
hDLL1 systems affects the avidity of TCR-peptide:MHC can be understood by looking a 
knockout models, in which the peptide processing machinery of the cTEC are disturbed 
(Honey et al., 2002; Hsieh et al., 2002; Kincaid et al., 2016; Murata et al., 2007; Nakagawa 
et al., 1998). This has been discussed in detail above and it is likely that absence of key 
proteins β5t, TSSP and cathepsin L, will compromise the efficiency of positive selection and 
the functionality of generated thymocytes (Takada et al., 2017). 
Although the engineered cell-line based methods described above overcome limitations 
associated with tissue availability to partially support in vitro thymopoiesis, these systems do 
not faithfully recapitulate the specialist thymus functions needed for physiological positive 
selection or central tolerance induction. Without promiscuous gene expression T-cells 
generated in this fashion cannot be tolerant to TRA. There are also substantial differences in 
peptide processing between OP9, MS5 and cTEC, which should reduce the efficiency of 
positive selection and peripheral T-cell functionality in T cell repertoires generated on these 
cell lines.  
This does not diminish the important contributions to understanding T-cell lineage 
development that these systems have made. Additionally, there is increasing clinical interest 
in these technologies for producing T-cell lineage-restricted progenitors for transplantation. 
Evidence has indicated that transplantation of pro-T-cells improves thymic rebound after total 
body irradiation, and it is often argued that in vitro T-cell generation has potential for 
Chimeric antigen receptor T-cells (Montel-Hagen et al., 2019; Singh and Zúñiga-Pflücker, 
2018). In a follow up paper focusing on potential clinical applications of the MS5-hDLL1 
system, Montel-Hagen and colleagues (2019) demonstrated the ability of the ATO to 
produce SP8 T-cells from transgenic TCR-derived induced pluripotent stem cells. 
Furthermore, further developments from these methodologies that can support T-cell lineage 
commitment and hence generate large number of proT-cells in feeder cell-free systems are 
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now becoming available (Gehre et al., 2015; Shukla et al., 2017; Simons et al., 2018). This 
eliminates both the complications highlighted here as the target pro-T-cell population exists 
before positive or negative selection is executed.  
1.3.C. Cellular Reprogramming Strategies 
1.3.C.I. Directed Differentiation 
Understanding thymic organogenesis has led to development of directed differentiation 
strategies to generate target cell populations from pluripotent stem cells (Li et al., 2017). This 
process has the aim of overcoming the scarcity of TEC and also generating patient-specific 
cells for personalised medicine (Lai et al., 2011). The first attempt to differentiate murine 
Embryonic Stem Cells (mESC) into TEPC was published by Lai and Jin in 2009. 
Subsequently, some progress towards making TEC from human Pluripotent Stem Cells 
(hPSC) has been reported (Parent et al., 2013; Soh et al., 2014; Su et al., 2015; Sun et al., 
2013). Focusing on the human Embryonic Stem Cells (hESC) protocols, all involve initial 
differentiation into definitive endoderm-like cells using Activin A either alone or in 
combination with WNT3a. Methodologies then focus on upregulating FOXN1 and HOXA3, 
akin to native thymic development. All studies used retinoic acid and BMP4, with Sun and 
colleagues (2013) providing IWR1 (WNT1 inhibitor); Parent and colleagues (2013) also 
supplemented with WNT3a, FGF8, Cyclopamine (SHH inhibitor) and LY364947 (TGFβ 
inhibitor) and Su and colleagues (2015) used FGF7, FGF10, and EGF to compensate for 
loss of mesenchymal signalling in the culture. However, only Parent and colleagues 
(2013) provided direct evidence of functionality, showing that T cells generated in the 
grafts were able to mediate alloreactive skin graft rejection. Of note, all methods 
produced cells that did not remain viable for substantial lengths of time, reported 
substantial variability in the differentiation protocols and required engraftment. These 
present large technical obstacles to clinical application. 
1.3.C.II. Induced Thymic Epithelial Cells 
In a distinct approach, our laboratory used direct lineage reprogramming to enforce Foxn1 
expression in MEFs, which mediated reprogramming and resulted in conversion of the MEFs 
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to a TEC phenotype (Bredenkamp et al., 2014). The induced TEC (iTEC) used a genetic 
reprogramming strategy. A CreERt2 fusion protein was knocked into the parental Rosa26 
allele while Foxn1 and GFP, separated with an internal ribosome entry site, were knocked 
into the maternal Rosa26 allele with a floxed transcriptional pause site allowing Cre-
mediated activation of the transgene (Rosa26CreERt2:Rosa26iFoxn1) (Bredenkamp et al., 2014). 
Notably, this process did not necessitate gRTOC to complete reprogramming, which allowed 
for investigation of the iTEC phenotype in vitro. iTEC were co-cultured with embryonic ETPs 
in a monolayer. After 12-days, the ETPs had progressed into DP, SP4 and SP8 thymocytes 
complete with up regulation of CD3ε and TCRβ. However, unlike both the OP9-DLL1 and 
MS5-hDLL1 systems, iTEC were shown to express β5t and MHC2. Therefore, iTEC utilised 
the thymoproteasome and native MHC2 expression to mediate peptide processing and 
presentation, respectively, which likely recapitulated the native processes in positive 
selection. When incorporated into a gRTOC methodology to replace the ex vivo TEC 
component, iTEC were able to form an organised and functional thymus. Cortical and 
medulla regionalisation of recovered gRTOC were shown using the cortical markers CD205 
and β5, alongside medullary markers cytokeratin 14 (K14) and UEA1. The medullary 
phenotype was reinforced by finding evidence of promiscuous gene expression in AIRE+ 
iTEC. Analysis of the thymocyte populations of the graft demonstrated that iTEC were 
competent to mediate the generation of DP, SP4 and SP8 thymocytes when engrafted onto 
the kidney capsule and that recipient blood vasculature infiltrated the graft to facilitate the 
emigration of T-cells in the periphery. However, the differentiation capacity of iTEC in vitro 
were not defined, with no evidence of the system being able to produce cells capable of 
promiscuous gene expression. Furthermore, cortical function was only compared to the 
OP9-DLL1 system, which as discussed above does not aim recapitulate native TEC. There 
was no direct comparison between iTEC and ex vivo TEC and therefore as it stands the in 
vitro potential of the system in undefined.  
1.3.D. Conclusion 
In conclusion, currently, the approach that most faithfully emulates native TEC function in 
vitro is RTOC. Tissue scarcity and practical difficulties associated with this system provided 
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motivation for generating cell line based in vitro systems. The best of these are currently the 
OP9-DLL1/OP9-DLL4 and MS5-hDLL1 systems. However, these systems do not faithfully 
recapitulate positive selection or central tolerance induction. Directed differentiation and 
reprogramming strategies have aimed to generate large numbers of TEC in vitro and thus 
overcome the limitation of both techniques. Of these, currently, only the iTEC protocol has 
been shown to support generation of an intact thymus in the absence of any WT ‘carrier’ 
TEC. Tissue engineering aims to created functional organotypic systems for that either 
recapitulate key behaviours in vitro or can be implanted in the body and provide a source of 
transplantable material. The iTEC remains the system with the most potential for tissue 
engineering techniques that aim to recapitulate thymopoiesis in vitro and to scale up the size 
of engineered tissue to be suitable for transplantation in the human body. 
1.4. Thesis Aims 
The overall aim of the work performed in this thesis was to test the hypothesis that iTEC in 
conjunction with synthetic matrices, could be used generate thymic organoids that 
recapitulate the fundamental processes via which TEC mediate T cell differentiation and 
repertoire selection. 
Specifically, I set out to test the following hypotheses: 
In Chapter Three, I tested the hypothesis that the iTEC system could produce a large 
quantity of cells competent to recapitulate ex vivo TEC function in vitro. The work described 
addresses this hypothesis in two phases - firstly, maximising the scale-up capacity of iTEC, 
whilst focusing on generating standardised batches of cells, and secondly, testing the extent 
that this optimised iTEC system can recapitulate ex vivo TEC when cultured as RTOC. 
In Chapter Four, I investigated the hypothesis that using defined culture substrates could 
create a more consistant iTEC phenotype, with respect to the essential functions of TEC. To 
achieve this, I identify synthetic polymers able to bind to both iTEC and ex vivo TEC and 
then to compare the effect selected polymers had on both cell types as a measure of 
emulating thymic functions in vitro.  
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In Chapter Five, I tested the hypothesis that miniaturising the RTOC process could be 
conducive to creating a culture system for thymus biology that is amenable to high 
throughput screening applications. Chapter Five establishes a novel method that aims to 
reduce tissue and improve consistency between conditions and beings to evaluate the 
compatibility of the novel system with ex vivo TEC and iTEC.  
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Mice were housed at the animal unit within the Medical Research Councils’ Centre for 
Regenerative Medicine, University of Edinburgh. Wild type mice refer to C57BL/6 originally 
acquired from the Jackson Laboratory and maintained at the MCR Centre for Regenerative 
Medicine (Jax SCRM). Three transgenic strains were used in this thesis: Foxn1G (O’Neill et 
al., 2016) (Transgene outlined in Figure C4.12); iFoxn1 (Bredenkamp et al., 2014) and 
Rosa26:CreERt2 (Hameyer et al., 2007) (Transgene outlined in Figure C3.1) . All colonies 
were maintained by crossing a transgenic mouse, heterozygous with the relevant transgene, 
with a wild type (WT) C57BL/6 Jax SCMR mouse. Animal husbandry and treatments were 
carried out in accordance with Animal (Scientific Procedures) Act 1986 and performed in 
accordance with the institution and ethical guidelines of the University of Edinburgh.   
2.1.B.  Timed Mating 
Embryos were produced by pairing mice overnight. The following morning, females with a 
vaginal plug were classified as E0.5. WT tissues were the result of 
 crosses; Foxn1G tissues were produced using 
and iFoxn1 tissues were generated by pairing 
.  
2.1.C. Isolation of Genomic Deoxyribonucleic Acid  
Mice were weaned at fourteen days of age. At this point, ear clips marked each mouse with 
a unique identification number. The surplus tissue was collected to isolate genomic 
Deoxyribonucleic Acid (DNA). To isolate genomic DNA from embryos, the head of each 
embryo was collected. Tissue was digested overnight using tissue lysis buffer and 400 μg / 
ml Proteinase K (Promega), heated to 55°C in an agitated water bath. After a minimum of 
eight hour and a maximum 16 hours, the reaction was heat inactivated at 95°C for ten 
minutes and centrifugated for ten minutes at  rfc to pellet contaminating material, 
purifying the DNA in the supernatant. Genomic DNA was stored at 4°C. 
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2.1.D. Tissue Lysis Buffer  
 10mM Tris-HCL, pH 8.3 (Roche) 
 2.5mM Magnesium Chloride (MgCl2) 
 50mM Potassium Chloride (KCl) 
 0.1mg / ml Gelatin 
 0.45% NP40 
 0.45% Tween20 
2.2. Genotyping 
All genotyping protocols used Taq polymerase and associated buffers (Quigen).  
2.2.A. Rosa26:CreERt2 
2.2.A.I. Master Mix 
 3 μl 10x buffer 
 0.5 μl Deoxyribonucleotide Triphosphate (dNTPs) 
 0.5 μl Taq 
 1 μl Forward CreERt2 primer  
 1 μl Reverse CreERt2 primer 
 19 μl DEPC-treated water 
5 μl DNA
2.2.A.II. Thermocycling 
 Five minutes at 94°C 
 30 cycles of: 
o 30 seconds at 94°C
o 30 seconds at 58°C
o 1 minutes at 72°C
 Seven minutes at 72°C 
 Infinite hold at 4°C. 
2.2.A.III. Product Size 
269 base pairs 
2.2.B. iFoxn1 
2.2.B.I. Master Mix 
 3 μl 10x buffer 
 0.5 μl dNTPs 
 0.5 μl Taq 
 1 μl Forward iFoxn1 primer  
 1 μl Reverse iFoxn1 primer 
 6 μl Q buffer 
 19 μl DEPC-treated water 
 5 μl DNA. 
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2.2.B.II. Thermocycling 
 Five minutes at 94°C 
 35 cycles of: 
o 30 seconds at 94°C
o 30 seconds at 60°C
o 1 minutes at 72°C
 10 minutes at 72°C 
 Infinite hold at 4°C. 
2.2.B.III. Product Size 
750 base pairs 
2.2.C. Foxn1G 
2.2.C.I. Master Mix 
 3 μl 10x buffer 
 0.5 μl dNTPs 
 0.5 μl Taq 
 1 μl Forward GFP primer  
 1 μl Reverse GFP primer 
 6 μl Q buffer 
 19 μl DEPC-treated water 
5 μl DNA 
2.2.C.II. Thermocycling 
 Five minutes at 94°C 
 30 cycles of: 
o 30 seconds at 94°C
o 45 seconds at 57°C1 minutes at 72°C
 10 minutes at 72°C 
 Infinite hold at 4°C. 
2.2.C.III. Product Size 
220 base pairs 
2.3. Tissue Processing 
2.3.A. Dissection of Embryos 
Once gestation had reached the desired length, the female mouse was sacrificed by cervical 
dislocation. Embryos were removed from the uterus and collected in Phosphate-Buffered 
Saline (PBS) at 4°C. Using a dissection microscope (Zeiss), embryos were removed from 
the embryonic sack and beheaded.  
2.3.B. Disassociation of Embryonic Thymus 
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To harvest embryonic thymus from beheaded embryos, incisions were created to remove the 
rib cage and expose the upper thorax. Embryonic thymic lobes of all ages were located by 
tracing the common carotid vessels leading to the pharyngeal arches. Early tissues have 
thymic lobes located closer to the third pharyngeal arch, while in later tissues the thymic 
lobes have coalesced above the heart. Thymic lobes were harvested, and care was taken to 
removed surrounding, supportive tissues. Thymic lobes were incubated in TrypLE Express 
Enzyme (life technologies #12604013) for five minutes in a thermomixer set to 1400 rpm and 
37°C. To complete disassociation, the suspension was triturated with a P1000 for a further 
60 seconds to apply mechanical force to the lobes. To inactivate the reaction, the 
suspension was chilled to 4°C and washed twice using centrifugation and resuspension in 
2% Fluorescence Activated Cell Sorting (FACS) buffer. All cellular centrifugation steps used 
500 relative centrifugal force (rcf) for five minutes. Embryonic tissues are processed in 2% 
FACS buffer. 
2.3.C. Establishment of Murine Embryonic Fibroblasts 
Murine Embryonic Fibroblasts (MEFs) were routinely established from E13.5 beheaded 
embryos, the head being used for genomic DNA collection. All internal organs were stripped 
away from the embryo and the arms, legs and tail removed. The remaining tissue was 
homogenised by compression with a 18G syringe and enzymatically disassociated in 0.25% 
trypsin EDTA (Invitrogen) for 10 minutes at 37°C. Finally, tissue was further triturated with a 
23G syringe before seeding into a gelatinised T75 (Corning #CLS430641U).  
2.3.D. Isolation of Adult Thymocytes 
To isolate thymocytes from the postnatal thymus, a four-week female mouse was sacrificed 
using cervical dislocation. The thymus was harvested by removing the rib cage to expose the 
upper thorax. Once collected, the thymus was compressed to mechanically remove the 
thymocytes. Adult thymocytes were processed in 0.2% FCS containing FACS buffer at 4°C. 
2.3.E. Isolation of Adult LSK Haematopoietic Stem Cells 
To isolate Lineage-SCA-1+c-KIT+ haematopoietic stem cells (LSKs) from the postnatal bone 
marrow, a six-week male mouse was sacrificed using cervical dislocation. The tibia and 
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femur were harvested and crushed to release the bone marrow. Bone marrow was 
processes in 0.2% FACS buffer at 4°C. 
2.3.F. Magnetic Enrichment of C-KIT Expressing Thymocytes 
Given the scarcity of early thymocyte progenitors (ETPs) within the four-week postnatal 
murine thymus and LSKs within the six-week postnatal bone marrow, magnetically 
conjugated beads were used to enrich the population before FACS sorting. Cells were 
stained with antiCD117-magentic bead conjugates concurrently to the rest of the panel and 
stained at 4°C for 15 minutes. This process was optimised as this results in competition 
between the antiCD117-magnetic bead conjugate and the antiCD117-Pe/Cy7 conjugate for 
available epitopes. Note that optimisation between batches of beads was required to 
maintain consistency. To remove excess and unbound antibody, cells were washed twice by 
centrifugation and resuspension in FACS buffer. The magnetically labelled cells were 
separated from the rest of the sample using the QuadroMACs Separator and LS columns 
(Miltenyi Biotechnologies). LS columns were washed with three ml FACS wash before 
application of cells and unlabelled cells were washed out of the column with nine ml of FACS 
wash after application of cells. To collect the CD117 expressing fraction, the LS columns 
were removed from the magnetic field allowing labelled cells to be washed out. This 
preparation was resuspended at cells / ml and FACS sorted.  
2.4. Flowcytometry 
2.4.A. Antibody staining protocol 
Antibodies directly conjugated to fluorophores were used for flow cytometry. To stain surface 
markers, cells were resuspended in FACS buffer with pre-defined concentrations of 
antibody. All concentrations of antibodies were rigorously optimised when designing panels. 
Antibody – antigen interactions were incubated for 15 minutes at 4°C. To remove excess and 
unbound antibody, cells were washed twice by centrifugation and resuspension in FACS 
buffer. A membrane impermeable nuclear dye was used to discriminate between dead and 
alive cells and was added just before initiation of analysis or FACS sorting. This was 4′,6-
diamidino-2-phenylindole (DAPI) or 7-Aminoactinomycin D (7AAD) depending on the panel 
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design. Flow cytometry panels were compensated using Ultracomp beads (Invitrogen) for all 
fluorophores except for the nuclear dye, which used a small proportion of unstained cells. 
Compensation matrices were always manually checked post-acquisition. When necessary, 
fluorescence minus one (FMO) samples were used to set gates.  
2.4.B. Acquisition 
All FACS sorting was performed by the Centre for Regenerative Medicine’s FACS facility 
using BD FACS Arria II or Fusion running FACS Diva 4.1 (BD Biosciences). All 
flowcytometry was completed on a Novocyte running NovoExpress 1.3.0 (ACEA). All post-
acquisition analysis was performed with FCSexpress 6 (De Novo Software). 
2.4.C. Fluorescence Activated Cell Sorting Buffers 
 2% or 0.2% FCS (Life Technologies #10270106) for embryonic and adult tissue, 
respectively 
 PBS without calcium and magnesium (Sigma) 
  0.05 mg / ml DNase1 (Lorne Laboratory). 
2.5. Immunohistochemistry 
2.5.A. Tissue Fixation and Sectioning 
Tissues for whole mount staining were fixed in 4% paraformaldehyde (PFA) overnight at 4°C 
on an agitator. This includes monolayers, microarrays and miniaturised-reaggregate thymic 
organ culture (MTOC) in addition to whole thymic lobes. Tissue for sectioning was 
embedded in OCT (VWR) and snap frozen on dry ice. OCT blocks were stored at -80°C 
until cryo-sectioning (Leica CM3050 S or CM1950) into 7 μm sections, which were 
transferred on to 1.5 mm polystyrene glass microscopy slides (VWR). Slides were stored 
-80°C until fixation and staining. Immediately prior to staining, a hypophonic pen was used 
to draw a ring around sections. Once dry, 4% PFA (Sigma) was applied to the ring for 15 
minutes at room temperature to fix tissue. Note that the total volume of PFA, and 
subsequent staining buffers, required is proportional to diameter of hydrophobic ring.  
2.5.B. Types of Immunohistochemistry Samples 
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There were three types of sample that were taken for staining based on what the samples 
were stored in. The protocol remained the same. However, application of solutions had to be 
performed differently based on format: 
1. The microarray and sections were on glass microscopy slides. Staining solutions
were pipetted onto samples that were encapsulated in a hydrophobic ring
2. MTOC and monolayers of cells, such as the focused polymer arrays were in tissue
culture plates. Staining solutions were pipetted directly into each well.
3. Whole, fixed thymic lobes were in a trans-well with 8 μm pores that was transferred
between wells containing the various staining solutions in a 48-well plate.
2.5.C. Staining Protocol 
Samples were blocked in Permeabilization and Block Buffer overnight at 4°C inside a 
humidity chamber. Primary antibodies were suspended in PtwH and centrifuged at  
rcf for 10 minutes to remove antibody aggregates or contamination. The Permeabilization 
and Block Buffer was removed from the samples and the primary antibodies applied 
overnight at 4°C inside a humidity chamber with gentle agitation. The appropriate secondary 
antibodies and DAPI were suspended in PtwH and centrifuged at  rcf for 10 minutes 
to remove antibody aggregates or contamination. The sections were washed twice in PtwH 
to remove excess and unbound primary antibody. The secondary antibodies and DAPI were 
incubated with the samples overnight at 4°C inside a humidity chamber and gentle agitation. 
Samples were washed twice with PtwH to remove excess and unbound secondary antibody 
and airdried. Samples were stored in PBS 0.1% sodium azide until imaging except for the 
microarrays and sectioned samples, which were compatible with mounting agents. These 
samples were treated with Vectorshield hard set mounting medium (Vector Laboratories) 
and was mounted with a coverslip. Once dry, samples were stored at 4°C until imaging. 
2.5.D. Staining Buffers 
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All staining buffers are taken from the iDisco+ protocol (Renier et al., 2016). All solutions 
contained 0.1 % sodium azide (Sigma) to prevent bacterial growth and were strained through 
a 0.22 μm filter before application to samples.  
2.5.D.I. Permeabilization and Block Buffer 
 400 ml PBS (Sigma) 
 8 ml TritonX-100 (Sigma) 
 11.5g of Glycine (Sigma) 
 100 ml of Dimethyl Sulfoxide (DMSO) (VWR) 
 10% goat serum (Sigma) – added immediately prior to application  
2.5.D.II. PtwH 
 1 L PBS  
 2 ml Tween-20 (Sigma) 
 1 mg Heparin (Sigma) 
 1 % goat serum - added immediately prior to application 
2.6. Gene Expression Analysis 
2.6.A. mRNA Acquisition and Preparation 
2.6.A.I. Small Population Samples  
2.6.A.I.a. mRNA Isolation 
The CellsDirect (Invitrogen) protocol was employed to collect rare cell types for mRNA 
isolation. Populations of 50 cells were FACS sorted into PCR tubes containing 10 μl of 
CellsDirect 2X Reaction Mix and 0.2 μl SUPERase-in (Applied Biosystems). Once samples 
were collected, tubes were centrifuged briefly and stored at -80°C.  
2.6.A.I.b. Reverse Transcription of mRNA into cDNA 
Gene-specific reverse transcription was used to create cDNA for both small and large 
population mRNA isolation methods. For the small populations, the samples were mixed with 
10 μl pre-amplification mix and then subjected to the thermocycling procedure. 
2.6.A.I.c. Pre-Amplification Mix 
 5 μl primer pair mix. Forward and reverse primer pairs for each target gene were 
suspended in 5 μl DEPC-treated water (Life Technologies) at 0.2 μM. 
 4 μl DEPC-treated water 
 1 μl SuperScript III RT/Platinum Taq mix from CellDirect kit. To create a no reverse 
transcription control this was replaced with 1μl Taq (Qiagen).  
60
2.6.A.I.d. Thermocycling Procedure for Reverse Transcription and Amplification of mRNA 
 15 minutes at 50°C 
 2 minutes at 95°C 
 18 cycles of:  
o 15 seconds at 95°C
o Four minutes at 60°C
 Infinite hold at 4°C. 
2.6.A.II. Large Population Samples 
2.6.A.II.a. mRNA Isolation 
RNEasy (Qiagen) was used to collect mRNA for large cell populations. Target cells were 
lysed with RLT lysis buffer before purification using affinity chromatography. A nanodrop 
(Thermo) was used to measure the concentration and purity of mRNA before storage at -80 
°C. 
2.6.A.II.b. Reverse Transcription of mRNA into cDNA 
Gene-specific reverse transcription was used to create cDNA for both small and large 
population mRNA isolation methods. The SuperScript III First-Strand Synthesis System for 
Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR) (Invitrogen) kit 
was used to reverse transcribe mRNA collected from large populations. First, a standardised 
quantity of mRNA between samples was incubated with 0.2 μM of primer pairs and 10 mM of 
dNTPs in 10 μl DEPC-treated water for five minutes at 65°C. After cooling to 4°C for one 
minute, 10 μl of cDNA Synthesis Mix was added to each mRNA/primer sample. Reverse 
transcription was conducted at 50°C for 50 minutes before being terminated at 85°C for five 
minutes. After cooling to 4°C for one-minute, excess mRNA was removed by incubating 1 μl 
of RNase H to the cDNA samples at 37°C for 20 minutes. Manufactured cDNA was stored at 
-20°C.
2.6.A.II.c.  cDNA Synthesis Mix 
 2 μl 10x RT buffer 
 4 μl 25 mM MgCl2 
 2 μl 0.1 M DTT 
 1 μl RHaseOUT (40 Units / μl) 
 1 μl SuperScript III RT (200 Units / μl). 
2.6.B. Reverse Transcription-Quantitative Polymerase Chain Reaction 
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2.6.B.I. Plate Loading 
A white, 384-well plate (Roche) was loaded with 7.5 μl RT Gene Specific Master Mix and 2.5 
μl cDNA in triplicate. The cDNA samples were diluted in DEPC-treated water to ensure 
enough for each plate. Note the quantity of cDNA in each well was specific to each plate and 
is comparable to other plates only as relative expression of target genes compared to house 
keepers.  
2.6.B.II. RT Gene Specific Master Mix 
 5 μl 2x master mix (Roche) 
 0.1 μl UPL probe (Roche) 
 0.225 μl 20 μM forward and reverse primer pair (Sigma) 
 2.175 μl DEPC-treated water. 
2.6.B.III. Real Time Fluorescence Detection 
Completed 384-well plates were sealed (Applied Biosystems) and centrifuged at 1000 rcf for 
1 minute at 4°C. A Lightcycler 480-II (Roche) was used to perform the PCR with real time 
detection of fluorescence.  
2.6.B.IV. Thermocycling procedure for Reverse Transcription-Quantitative 
Quantitative PCR 
 Five minutes at 95°C 
 45 cycles of:  
o 10 seconds at 95°C
o 20 seconds at 60°C
o Capture Fluorescent Signal
 40°C – 10s. 
2.6.B.V. Calculation of Relative Gene Expression 
Triplicates were checked to ensure all replicates were with 1 Cq value of each other and 
outlies were removed. The numerical average for each triplicate was calculated. Each gene 
was then reported as a product of the housekeepers Ywhaz, Hprt and Tbp. It was assumed 
that each round of amplification doubled fluorescence output of unquenched probes. The 
following equation was used to calculate the expression of target express relative to the 




2.7. Tissue Culture 
2.7.A. Medium Formulation 
2.7.A.I. Induced Thymic Epithelial Cell Medium 
 Advanced DMEM/F12 (Life Technologies #12634010) 
 10% performance FCS, US origin (Life Technologies) 
 1% penicillin (10,000 Units / ml) and streptomycin (10,000 μg / ml) (Invitrogen 
#15140-122) 
 1% L-glutamine (200 mM) and sodium pyruvate (100 mM) (Invitrogen #25030-024 
and #11360-039)  
 1% MEM non-essential amino acids (Invitrogen #11140-036) 
2.7.A.II. 2% Medium 
 Advanced DMEM/F12 (Life Technologies) 
 2% performance FCS, US origin (Life Technologies) 
 1% GlutaMAX (Life Technologies) 
2.7.A.III. N2B27 Medium 
 10 ml DMEM/F12 (Life Technologies #31330-038) 
 10 ml Neurobasal medium (Life Technologies #21103-049) 
 200 μl N2 Supplement (Life Technologies #17502-048) 
 100 μl B27 Supplement (Life Technologies #17504044) 
 45.5 μl 2-Mercaptoethanol (Life Technologies #31350010) 
 440 μl L-glutamine (200 mM) and sodium pyruvate (100 mM) (Invitrogen) 
 100 μl penicillin (10,000 Units / ml) and streptomycin (10,000 μg / ml) (Invitrogen) 
 50 ng / ml BMP4 (Peprotech #315-27) 
 50 ng / ml FGF7 (Peprotech #100-19) 
 10 ng / ml EGF (Peprotech #315-09) 
2.7.B. Expansion of MEFs 
Once E13.5 tissues have been processed and seeded, each 10 ml induced Thymic Epithelial 
Cell (iTEC) medium was added to each T75. MEFs reached confluency within 24 hours. 
MEFs were washed twice in 10 ml of room temperature PBS, without magnesium and 
calcium, before incubation with 1 ml chilled 0.25% trypsin EDTA for one minute at 37°C. The 
reaction was quenched with MEF expansion medium. To begin P1, all T75s were seeded 
into a T150 (Corning #CLS430825) and 15 ml of iTEC medium was added to each. At 
confluency, MEFs were washed twice in 15 ml of room temperature PBS, without 
magnesium and calcium, before incubation with 3 ml chilled 0.25% trypsin EDTA for one 
minute at 37°C. Each T150 flask was seeded into three T150 flasks. Once at confluency, 
MEFs were passaged using the above protocol and each T150 was split into three cryovials 
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suspended in iTEC medium with 5% DMSO. The temperature of each cryovial was gently 
reduced to -80°C using the Mr Frosty propan-2-ol containers (Nalgene ThermoFischer). After 
24 hours, cryovials were transferred to liquid nitrogen. 
2.7.C. iTEC Reprogramming 
Cryovials were thawed for three minutes at 37°C in a water bath. The DMSO was washed 
out and MEFs were seeded directly into a T150. After 48 hours, the flask was passaged and 
split into three T150s. After four hours, 0.1 μM 4OHT was administered to each flask. Fresh 
medium was added to the iTEC every two to three days for 18 days. iTEC were liberated 
from T150s using the above defined protocol. However, the trypsin incubation length was 
increased from one minute to five. For all experiments this process utilised iTEC medium, 
except the functionality assay detailed in chapter three and all MTOC experiments, which 
used 2% medium. 
2.7.D. Coating Tissue Culture Flasks with Polymer 
Glass-bottomed tissue culture plates were used to prevent the solvent from damaging the 
plates. To coat the plates, polymers were dissolved in acetone at 0.2 mg / mL and pipetted 
into wells in the appropriate layout. 15 μl was used to coat 384-well plates and 500 μl was 
used to coat 24-well plates, which was completed on an orbital shaker. The plates were 
airdried at room temperature to remove the acetone and then washed with water and PBS to 
remove any residual contaminates.  
2.7.E. Microarray, Focused Arrays and Ex Vivo TEC Functionality Array 
iTEC and TEC were cultured in iTEC medium, except for the N2B27 ex vivo TEC 
functionality array that used N2B27 medium. On all experiments, medium was changed 
every two to three days. Microarrays were cultured in 5 ml of medium using rectangular 
tissue culture flasks (ThermoFischer #167063). The focused polymer arrays and ex vivo 
TEC functionality arrays were performed in glass bottomed 384-well plates (ThermoFisher 
#164586). These smaller wells had the capacity for 100 μl of media.  
2.7.F. Co-Cultures Cytokine Supplements 
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2.7.F.I. High Co-culture Cytokines 
 50 ng / ml FGF-7 (Peprotech #100-19) 
 5 ng / ml FLT3L (Peprotech #250-31L) 
 10 ng / ml IL-7 (Peprotech #217-17) 
 25 ng / ml KITL (Peprotech #250-03) 
2.7.F.II. Low Co-culture Cytokines 
 50 ng / ml FGF-7  
 5 ng / ml FLt3L  
 1 ng / ml IL-7  
 5 ng / ml KITL  
2.7.G. Monolayer Co-Cultures / iTEC Polymer Functionality Assay  
FACS isolated iTEC and adult ETPs were seeded simultaneously in glass bottomed 24-well 
plates (CellVis #P24-1.5H-N). For the first four days, cells were cultured in 500 μl iTEC 
medium with high co-culture cytokines. For the final 10 days, cells were cultured in 500 μl 
iTEC medium with low co-culture cytokines. Medium was replaced every two to three days 
using a 50% change so the thymocytes would not be drawn off the monolayer.  
2.7.H. Reaggregates Thymic Organ Culture 
Reaggregates thymic organ culture (RTOC) were created using compact reaggregation 
(Sheridan et al., 2009). Briefly, target cell populations were suspended in 2% medium within 
a parafilm-sealed pipette tip. Centrifugation at 500 rcf, for five minutes, at room temperature 
created a cell pellet within the tip. The parafilm was removed and the cell pellet excised upon 
a porous membrane (Merck Millipore Corporation #ATTP01300) in a 24-well plate (Corning 
CLS3527). The membrane was floated on 1 ml of iTEC medium with low co-culture 
cytokines media. A 50% medium exchange was performed every two to three days. 
2.7.I. Miniaturised-Reaggregates Thymic Organ Culture 
Miniaturised-reaggregates thymic organ culture (MTOC) were created using the GRID3D 
system (Sun Biosciences). Target cell populations were suspended in 25 μl 2% medium and 
applied directly onto hydrogel. After one hour, 200 μl of 2% medium with low co-culture 
cytokines was added to the medium port of each well. This was replaced every two to three 
days using a 50% medium change. 
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2.7.J. Seeding Densities of Culture Methods 
Table C2.1 :The Seeding Densities of Culture Methods. 
This table shows seeding densities of cellular components used in a given experiment 





WT MEF Adult ETP Embryonic 
DN 
Thymocytes 
sevRTOC 600,000 100,000 100,000 
iRTOC 
Chapter 3 
600,000 100,000 100,000 
Cre only 
RTOC 

























600,000 100,000 7,000 
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2.8. Panels 
The following panels describe the combination of antibodies used in either the flow cytometry 
or FACS procedures of in immunohistochemistry. 
2.8.A. Flow Cytometry  
2.8.A.I. Adult ETPs 
Table C2.2: The Antibody Panel to Isolate ETPs for the Four-Week-Old Thymus. 
This table shows the name, associated fluorophore, supplier, clone and concentration of 
antibodies used to isolate ETPs in adult mice. 
Antigen Clone Fluorophore Supplier Catalogue Number Dilution 
CD45 30-F11 APC/eflour780  Life 
Technologies 
47-0451-80 1/1000 
CD25 PC61 PE  BioLegend 102007 1/2000 
CD44 IM7 APC  BioLegend 103011 1/2000 





















































DAPI - - Life 
Technologies 




2.8.A.II. Embryonic DN Thymocytes and TEC 
Table C2.3: The Antibody Panel to Isolate DN Thymocytes and TEC in E15.5 Mice. 
This table shows the name, associated fluorophore, supplier, clone and concentration of 
antibodies used to isolate DN thymocytes and TEC from E15.5 Embryos. 
Antigen Clone Fluorophore Supplier Catalogue Number Dilution 




















































CD45 30-F11 APC/eflour780  eBioscience 47-0451-80 1/1000 
DAPI - - Life 
Technologies 





Table C2.4: The Antibody Panel to Analyse Thymocyte Subsets in Co-culture Assay. 
This table shows the name, associated fluorophore, supplier, clone and concentration of 
antibodies used to analysis the thymocyte subsets found in co-culture assays. Note that 
the iTEC Polymer Functional Array omitted the CD25, CD44, CD62 and CD69 because 
they were not relevant to the readout. 









































CD4 RM4-5 Pe BioLegend 100512 1/800 
CD8 53-6.7 APC BioLegend 100711 1/800 
CD3e 145-2C11 BV786 BioLegend 100355 1/100 
TCR-β H57-597 Pe/Cy7 BioLegend 109222 1/100 
CD62L MEL-14 APC/FIRE BioLegend 104450 1/800  
CD25 PC61 BV650 BioLegend 102038 1/1000 
CD44 IM7 BV510 BioLegend 103043  1/1000 
CD69 H1.2F3 BV421 BioLegend 104528 1/100 
7-AAD - - BioLegend 420404 1/200 
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2.8.A.IV. Isolation of LKS Haematopoietic Stem Cells 
Table C2.5: The Antibody Panel to Isolate Lineage-SCA-1+c-KIT+ HSCs. 
This table shows the name, associated fluorophore, supplier, clone and concentration of 
antibodies used to isolate Lineage-SCA-1+c-KIT+ haematopoietic stem cells (LSKs) from 
murine bone marrow. 












































SCA-1 D7 Pe BioLegend 108107 1/1600 
c-KIT 2B8 APC/Cy7  BioLegend 105826 1/1600 
DAPI - - Life 
Technologies 





2.8.B.I. Microarray and Focused Array 
Table C2.6: The Antibody Panel to Count iTEC/TEC in the Microarray and Focused 
Arrays. 
This table shows the name, associated fluorophore, supplier, clone and concentration of 
antibody and DAPI used to count iTEC/TEC in the microarray and focused arrays. 
Antigen Clone Supplier Catalogue 
Number 
Dilution Host 
Pan-Cytokeratin - Dako Z0622 1/250 Rabbit 
DAPI - - Life 
Technologies 
D1306 5 μg / ml 
71
2.8.B.II. Selective Binding Assay 
Table C2.7: The Antibody Panel to Count the Number of β5t+ iTEC and to Quantify 
MHC2 Expression. 
This table shows the name, associated fluorophore, supplier, clone and concentration 
of antibodies and Cell Mask Blue used to count the number of β5t+ iTEC and to quantify 
MHC2 expression.  
Antigen Clone Supplier Catalogue 
Number 
Dilution Host 
Β5t PD021 MBL PD021 1 / 1000 Rabbit 
MHC2 ER-TR3 Abcam ab15630 1/250 Rat 
Cell Mask Blue - Molecular 
Probes 
H32720 1/1000 - 
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2.8.B.III. TEC Proliferation and mTEC Maintenance Assay 
Table C2.8: The Antibody Panel to Observe Proliferation and mTEC within MTOC. 
This table shows the name, associated fluorophore, supplier, clone and concentration of 
antibodies and DAPI used observe proliferation and mTEC within MTOC. 
Antigen Clone Supplier Catalogue 
Number 
Dilution Host 
EpCAM G8.8 BioLegend 118201 1/1000 Rat 








B-1065 1/500 - 
DAPI - - Life 
Technologies 




2.8.B.IV. Secondary Antibodies 
Table C2.9: The Secondary Antibodies used in all Experiments. 
This table shows the name, associated fluorophore, supplier, clone and concentration 
of antibodies and cell mask blue used observe proliferation and mTEC within MTOC. 
Specificity Fluorophore Host Supplier Catalogue 
Number 
Dilution 
Rabbit Alexa Fluor 
(AF)-488 
Goat Thermo A-11001 1/500 
Rat AF-568 Goat Thermo A-11031 1/500 
Streptavidin AF-647 Goat Thermo S21374 1/500 
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2.9. Primers 
2.9.A. Designing Primers 
The Universal Probe Library (Roche) primer design software was used to create all primer 
pairs. When possible, intron spanning primers were used. Primers were judged based on the 
internal sore assigned by the software and the primers with the highest score were selected 
for use. All primers were ordered from Sigma as standard DNA oligonucleotides.  
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2.9.B. Genotyping Primers 
Table C2.10: The Oligonucleotide Sequences used to Genotype Mice. 
This table shows the name, orientation and sequences of primers for genotyping mice. 
Transgene Orientation Sequence 
Rosa26:CreERt2 Forward  GCA TAA CCA GTG AAA CAG CAT TGC TG 
 Reverse GGA CAT CAG GGA TCG CCA GGC G 
iFoxn1 Forward  GGG AGC AGC TGA AGG ATG AC 
 Reverse CGC TTG AGG AGA GCC ATT TG 
Foxn1G Forward  TAT ATC ATG GCC GAC AAG CA 
 Reverse GAA CTC CAG CAG GAC CAT GT 
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2.9.C. Reverse Transcription-Quantitative-PCR Primers 
Table C2.11: The Oligonucleotide Sequences used to Genotype Mice. 
This table shows the name, orientation and sequences of primers for RT-qPCR 
experiments and the associated UPL probe number (Roche). 
Gene Orientation Sequence UPL 
Probe 
Endogenous Foxn1 Forward  CTTAAAGGTCAAAGAAGGAAAACACT 68 
 Reverse GGCTAACAAATAAGTTGGCTGA  
Total Foxn1 Forward  TGACGGAGCACTTCCCTTAC 94 
 Reverse GACAGGTTATGGCGAACAGAA  
Dll4 Forward  AGGTGCCACTTCGGTTACAC 106 
 Reverse GGGAGAGCAAATGGCTGATA  
Dll1 Forward  ACAGAGGGGAGAAGATGTGC 20 
 Reverse CCCTGGCAGACAGATTGG  
Aire1 Forward  GGTTCCTCCCCTTCCATC 45 
 Reverse GGCACACTCATCCTCGTTCT  
Psmb11 (β5t) Forward  CAGGGTTAGTTCTGGGAGCA 21 
 Reverse CAAAGCAGGAAACCCAAAAG  
CTSL1 (Cathepsin-L) Forward  CAAATAAGAATAAATATTGGCTTGTCA 60 
 Reverse TGTAGCCTTCCATACCCCATT  
Il-7 Forward  CGCAGACCATGTTCCATGT 27 
 Reverse TCTTTAATGTGGCACTCAGATGAT  
KitL Forward  TCAACATTAGGTCCCGAGAAA 71 
 Reverse ACTGCTACTGCTGTCATTCCTAAG  
Flt3L Forward  CCTAGGATGCGAGCCTTGT 102 
 Reverse TGTTTTGGTTCCCAACTCG  
Ccl25 Forward  GAGTGCCACCCTAGGTCATC 9 
 Reverse CCAGCTGGTGCTTACTCTGA  
Cxcl12 Forward  GGTTCTTCGAGAGCCACATC 21 
 Reverse TGTTCTTCAGCCGTGCCAA  
MHCIIEβ Forward  CCTCCAGTGGCTTTGGTC 109 
 Reverse CCGTTGTAGAAATGACACTCAGA  
Ywhax Forward  CTTCCTGCAGCCAGAAGC 74 
 Reverse GGTTTCCTCCAATCACTAG  
Hprt Forward  TCCTCCTCAGACCGCTTTT 95 
 Reverse CCTGGTTCATCATCGCTAATC  
Tbp Forward  GGGGAGCTGTGATGTGAAGT 97 
 Reverse CCTGGTTCATCATCGCTAATC  
Wnt4 Forward  TCATGAATCTTCACAACAACGA 4 
 Reverse CCCCGTGACACTTGCACT  
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3. Chapter Three: Optimisation of the Induced 
Thymic Epithelial Cell Reprogramming 




3.1. Introduction and Aims 
In 2014, this laboratory published a method of direct reprogramming of murine embryonic 
fibroblasts (MEFs) into induced thymic epithelial cells (iTEC). Reprogramming into iTEC 
uses a genetic method to enforce transgenic Foxn1 expression once the system has been 
exposed to 4-hydroxy tamoxifen (4OHT). Two transgenes are required to elicit this effect 
which are both knocked into the Rosa26 locus. The transgene in the maternal allele, 
contains Foxn1 and GFP, with are produced as discrete proteins using an internal ribosome 
binding site. In the absence of CRE recombinase, this transgene is functionally inactive due 
to a floxed element, which when present, produces a transcriptional pause. This transgene is 
referred to as the induced FOXN1 (iFoxn1) transgene and is depicted in Figure C3.1A. The 
CreERt2 fusion protein is knocked into the paternal Rosa26 allele. The CreERt2 protein 
mediates activation of the iFoxn1 transgene by excising the transcriptional pause in the 
presence of 4OHT. In the absence of 4OHT, CreERt2 is localised to the cytoplasm, where it 
is functionally inactive, while in the presence of 4OHT, CreERt2 translocates to the nucleus 
where it can mediate excision of the transcriptional pause and hence activation of the iFoxn1 
transgene. 
The CreERt2 transgene is also represented in Figure C3.1A. Strikingly, iTEC were able to 
support T-cell differentiation in vitro, including production of βTCR+CD4+ and CD8+ single 
positive (SP) T cells and Foxp3+ Tregs, and upon transplantation were able to generate an 
organised and functional thymus (Bredenkamp et al., 2014). Whilst this was a significant 
step toward generating a source of transplantable TEC for clinical application, the original 
protocol did not meet the scale up requirements necessary for larger experiments. 
Therefore, optimisation of the protocol into a scalable and standardised process was 
required. 
This chapter details a series of experiments through which I optimised the expansion and 
reprogramming of iFoxn1 MEFs into iTEC (Figure C3.1A), such that a single embryo can 
produce in excess of  iTEC for experimentation, with a cryopreservation step. The 
experiments described include medium selection, titration of 4OHT and altering the duration 
79
of the reprogramming protocol. This chapter also demonstrates that iTEC generated using 
the improved protocol upregulate key genes associated with thymic epithelial cell (TEC) 
function and compares the functionality of these optimised iTEC to ex vivo TEC and the 


















































































































































































































































































3.2. Creating a Bank of Cryopreserved MEFS 
At the starting point of my thesis, it was routine to establish fresh iFoxn1 MEFs to generate 
each batch of iTEC for each individual experiment and induce reprogramming in MEFs after 
one passage (P). This practice limited the number of MEFs that could be feasibly expanded 
from each embryo and prevented each batch of MEFs from being used in more than one 
experiment. The timeline of the original protocol in detailed in Table C3.1. 
To standardise the input population of MEFs for reprogramming and remove dependence on 
timed matings, I therefore set out to investigate whether iTEC could be generated from 
expanded and cryopreserved MEFs, since cells stored in liquid nitrogen can be reliably 
prepared for reprogramming within a short timeframe. There is evidence that extended 
passaging of cells in culture perturbs cellular growth, metabolism and introduces genetic 
abnormalities in a range of primary cell types, including MEFs (Hayflick, 1965). Given the 
sensitivity of reprogramming strategies to variation, it is reasonable to assume that 
populations of MEF established concurrently and using a standardised protocol should 
reduce batch-to-batch variability in generation of the target reprogrammed cell population. 
MEFs are a commonly used cell type in reprogramming assays, so the literature details 
common limitations of expansion (Amand et al., 2016). As it was reported that MEFs display 
the characteristic abnormalities associated with culture after P5 – 7, I decided to avoid this 
upper limit by initiating reprogramming at P4 (Amand et al., 2016; Hayflick, 1965). The 
passage at which expanded MEF display abnormalities is dependent upon environmental 
factors, most notably the severity of the passaging process. In setting out to test whether 
cryopreserved MEFs could be used to generate iTEC, I therefore employed a gentle 
passaging process: minimising exposure of the MEFs to trypsin and seeding tissue culture 
flasks with one third of the flask’s maximum potential.  
After each passage, bright field imaging was used to evaluate changes to cellular 
morphology, size and time taken to reach confluency. MEFs were cultured to P4, with a 
cryopreservation step between P2 and P3, without overt changes in size or morphology 
(Figure C3.1B). To prepare the MEFs for cryopreservation, each vial was seeded with one 
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third of the cells harvested from a confluent T150 tissue culture flask, which was 
approximately cells. MEFs were frozen in 5% Dimethyl Sulfoxide (DMSO), with an 
overnight equilibration to -80°C using a Mr Frosty® container to surround cells in propan-2-ol. 
At all passages MEFs become confluent by 24 hours after seeding at a one-in-three dilution, 
at a confluent concentration of  MEFs per cm2.  
Therefore, I was able to produce large quantities of MEFs for reprogramming. Before 
progressing, I needed to ensure increasing the passage number of MEFs did not 
compromise their ability to undergo reprogramming into iTEC. 
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Table C3.1: Comparison Between the Timelines of the Original and Optimised 
Protocols to Generate iTEC. 
A table comparing the original protocol to reprogram iFoxn1 MEFs into iTEC to the one 
detailed in this chapter. Note X denotes the day iFoxn1 MEFs were removed from storage.  
Day Original Optimised 
0 Establish P0 MEFs Establish P0 MEFs 
1 Change Medium, Genotype - 
2 - Passage P1 MEFs 1/3 
3 Passage P1 MEFs 1/9 Passage P2 MEFs 1/3 For cryopreservation 
4 Change Medium on P1 MEFs - 
6 Add 1 μM 4OHT - 
8 Wash off 4OHT and change medium - 
10 FACS to isolate GFP+ MEFs - 
X0 - Thaw P3 MEFs 
X1 - Passage P3 MEFs and add 0.1 μM 4OHT  
X3 - Wash off 4OHT and change medium 
X19 - FACs to isolate GFP+ MEFs 
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3.3. Expanded iFoxn1 MEFs Successfully Initiate Programming  
iFoxn1 MEFs expanded in the above fashion and exposed to 4OHT displayed evidence of 
reprogramming into iTEC. MEFs were exposed to 3 μM 4OHT for 48 hours and left to 
reprogramme for a total of eight days (Bredenkamp et al., 2014). Fluorescence activated cell 
sorting (FACS) was used to observe whether CreERt2-mediated excision of the floxed 
transcriptional pause had activated GFP expression, and to collect GFP+ and GFP- fractions 
for mRNA preparation. Collection of both fractions controlled for expression of transgenic 
Foxn1 as GPF- MEFs contained the inactive iFoxn1 transgene and could not express 
transgenic Foxn1. The expression of key genes was then quantified using E13.5 thymic 
epithelial progenitor cells (TEPC) as positive controls, and GFP- MEFs as negative controls. 
TEPC were defined as EpCAM+PLET1+. Furthermore, both the GFP+ and GFP- MEFs were 
cultured in the same tissue culture flask, so the environment was consistant, and both arose 
from the same starting MEF population, so any genetic abnormalities introduced during the 
expansion process were shared. 
A panel of genes was selected to encompass a range characteristic of TEC identity (Figure 
C3.2). Total Foxn1 quantified the amount of mRNA contributed from both transgenic and 
endogenous loci and expression of endogenous Foxn1 was also quantified. This is important 
to understand whether reprogramming promotes transcription of the endogenous locus but 
to also calculate the amount of transgenic mRNA. Wnt4 was included as there is evidence 
that it is important for thymic organogenesis, it is both regulated by FOXN1and also acts as a 
negative regulator of Foxn1 expression (Bredenkamp et al., 2014; Swann et al., 2017b). Dll4 
and Psmb11 were included as they represent functional targets that are directly regulated by 
FOXN1 (Hozumi et al., 2008; Takada et al., 2017; Žuklys et al., 2016). Finally, Il-7 was 
included as it represents an important factor for thymopoiesis and thymus organogenesis, 
but is not a direct target of FOXN1 (Zamisch et al., 2005).  
Unpaired t-tests were used to compare the relative level of expression in GFP- and GFP+ 
iFoxn1 MEFs eight days after administration of 4OHT. Data were evaluated for 
homogeneous variance using Levene's test and normality using the Shapiro-Wilks tests. 
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Data that failed assumptions were analysed using Welch corrected t-test or Mann-Whitney 
tests, respectively. This reverse transcription-quantitative polymerase chain reaction (RT-
qPCR) provided evidence that GFP+ MEFs had initiated reprogramming with significantly 
greater expression of transgenic Foxn1. This led to increased Wnt4 and Dll4 but GFP+ MEFs 
had not completed reprogramming as indicated by similar expression of Psmb11 and Il-7, 
compared to GFP- MEFs (Figure C3.2).  
There were two caveats to this readout. Firstly, it could be argued a one-way Analysis of 
Variance (ANOVA) was better suited to analyse the data as it would allow comparison of 
both MEF groups to the positive control, E13.5 TEPC. This was decided against as the 
TEPC introduced a large amount of variation to the ANOVA. Given that TEPC are a rare cell 
type, a small cell population method was used to collect mRNA for the positive controls. 
Whilst this overcomes tissue limitation, it also promotes sampling bias. This is most evident 
in the total Foxn1 data set. One biological replicate reported ~500% greater expression than 
the remaining two replicates. Ultimately the ANOVA was associated with an R2 value of 0.5 
and as result the ANOVA was a poor comparison between groups. Therefore, it was decided 
to test the more specific hypothesis that GFP+ MEF expressed greater amounts of TEPC 
associated genes than GFP- MEFs as this could be queried more robustly. It is possible to 
test the hypothesis that GFP+ MEFs have a similar gene expression profile to TEPCs by 
increasing the number of cells analysed in each condition to remove the sampling bias. Over 
a larger sample the average gene expression profile of TEPC would be more similar. 
However, this hypothesis ultimately aims to make indirect assertions regarding the behaviour 
of GFP+ MEFs compared to TEPC, which can be, and was, explored directly. Secondly, it 
could be argued that it is important to investigate the effect the expansion process had upon 
reprogramming by using a repeated measure design and collecting mRNA from the same 
batch of MEFs at P1 and P4.  
Therefore, I established that increasing the passage number did not prevent MEFs from 
instigating the reprogramming. The next step was to optimise the reprogramming stage.  
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Figure C3.2: iTEC Display Upregulation of Key TEC Genes
RT-qPCR data showing initiation of reprogramming in GFP+ MEFs into iTEC eight days after 
treatment with 4OHT. Expression of GFP marks those MEFs that have activated expression of 
the iFoxn1 transgene. Both the GFP+ and GFP- fractions were isolated from the same iFoxn1 
MEF preparations using FACS. 
The endogenous Foxn1 and total Foxn1 gene expression measurements utilised two sets of 
primers that distinguished between transcripts that originated from the transgenic allele and the 
endogenous Foxn1 locus. The primer pair responsible for measuring total Foxn1 expression 
bind to both transgenic and endogenous Foxn1 transcripts. However, the primer pair that 
measured just endogenous Foxn1 was unable to bind to the Foxn1 transcripts originating from 
the transgenic allele due to the presence of the IRES system found at the 3' end. 
Gene expression is shown relative to three housekeeping genes, Hprt, Ywhaz and Tbp.* 
denotes significance. The Y-axis for the genes Endogenous Foxn1, Il-7 and Psmb11 use a 
logarithmic scale. This experiment was performed three times using iFoxn1 MEFs established 
from unique embryos. Note that due to the low expression of Il-7, one biological replicate was 
unable to provide a measurement. Each biological replicate produced one sample of mRNA 
that was quantified in three technical replicates by RT-qPCR.
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3.4. Optimisation of 4OHT concentration 
3.4.A. 0.1μM 4OHT Applied to Proliferating MEFs in Advanced DMEM/F12 is 
Optimal for Reprogramming 
Once a method was optimised to establish a bank of cryopreserved iFoxn1 MEFS, with the 
potential to initiate reprogramming into iTEC, using a standardised strategy, it was necessary 
to optimise the reprogramming protocol. Three key variables were identified for this process: 
confluency, cell culture medium and concentration of 4OHT (Figure C3.3).  
It was assumed that a significant environmental variable within a single tissue culture flask is 
confluency. Once cells reach a certain density, they dramatically inhibit their proliferative 
behaviour via Yes-associated protein (YAP) inactivation and the Hippo signalling pathway 
(Eagle and Levine, 1967; Zhao et al., 2007). Therefore, I tested the effect of initiating 
reprogramming in proliferating or confluent MEFs. Additionally, since different cells require 
different cell culture medium to reflect their native environment (McKee and Komarova, 
2017) and thus to maintain their identity, two media conditions were tested. These were 
DMEM (Gibco #42430025), which was used in the original publication and is commonly cited 
as the preferred medium for MEF expansion; and Advanced DMEM/F12 (Gibco #12634-
028), which this lab reported to be beneficial in RTOC (Sheridan Thesis, 2007; Bredenkamp 
et al., 2014; Amand, Hanover and Shiloach, 2016). It was hypothesised that reprogramming 
MEFs in medium associated with improving ex vivo TEC culture, would be conducive to 
producing more TEC-like iTEC. Finally, the concentration of 4OHT was optimised to avoid 
adverse reactions, as it has established toxic properties (Hodges et al., 2003).  
To examine the influence of these variables,  CreERt2+iFoxn1+ (“iFoxn1”) MEFs and 
CreERt2+iFoxn1- (“CreERt2 only”) control MEFs were seeded into 24-well plates and were 
assigned to conditions in triplicates. 4OHT was administered to the wells after 2 hours in the 
proliferating group and after 48 hours for those in the confluent group (Figure C3.3). After 
four days, MEFs were liberated from the wells with trypsin and the percentage of GFP+ 
MEFs determined using flow cytometry. An unbiased gating strategy was developed that 
treated the 0 (vehicle only) 4OHT group as a GFP Fluorescence-Minus-One (FMO) control 
(Figure C3.3). To ensure the iFoxn1 transgenes was responsible for producing GFP+ MEFs, 
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CreERt2 only MEFs were treated alongside iFoxn1 MEFs, and GFP was not observed at any 
concentration of 4OHT in these CreERt2 only controls (data not shown). 
A three-way ANOVA was used to compare effects between mean proportion of MEFs 
expressing GFP. The three independent variables compared were 4OHT concentration, 
medium condition and confluency (Table C3.2). The greatest and only statically significant 
contributor of variation within the experiment arose between the vehicle only control and 
other concentrations of 4OHT (Table C3.3). As no significant difference in reprogramming 
efficiency between 4OHT concentrations was found, the 0.1 μM concentration was used in 
subsequent experiments based on the assumption that reducing the concentration of 4OHT 
would reduce the probability of side effects causing adverse consequences (Figure C3.4). 
Application of 0.1 μM 4OHT to proliferating MEFs produced less variance, reported as the 
Coefficient of Variation (CoV), than application to confluent MEFs (Table C3.4). Given the 
aim of reducing variance within the reprogramming protocol, this was taken as enough 
evidence to apply 4OHT to proliferating cells in all subsequent experiments.  
The basal DMEM medium preparation did not have a significant effect on the reprogramming 
efficiency, so both, DMEM and advanced DMEM/F12 were taken forward for further 
experimentation to evaluate their effects on the proliferation of iFoxn1 MEFs undergoing 
reprogramming. MEFs were seeded into four 150 cm2 tissue culture flasks and two were 
assigned to the DMEM group and two to the Advanced DMEM/F12 group. After two hours, 
0.1 μM 4OHT was applied. On day four and day 18, the total MEFS from one of the flasks 
from each group were counted. A one-way ANOVA found there were significantly more cells 
in the Day 18, Advanced DMEM/F12 than at day 4, whilst there was no difference in the 
DMEM group. MEFs in Advanced DMEM/F12 proliferated during the reprogramming phase 
whilst those in DMEM did not. This analysis returned a satisfactory R2 of 0.8653 and 
Advanced DMEM/F12 was therefore judged superior, given the objective of the experiment 
to create a scalable protocol to generate iTEC, and was used in all subsequent experiments 
(Figure C3.5). 
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Therefore, I was able to improve the reprogramming conditions to produce a larger number 
of iTEC than previously achievable. Now I need to ensure that the changes I made to the 
protocol did not comprise iTEC ability to function. The main function of the thymus is to 














Figure C3.3: Method to Determine Optimal 4OHT Concentration
A. Bright field images of MEFs before reprogramming. 4OHT was applied to proliferating MEFs 
two hours (left) and confluent MEFs 48 hours after seeding (right). B. The gating strategy used 
to measure effect of 4OHT concentration on the proportion of MEFs expressing GFP. 
Representative plots shown from a single experiment using Advanced DMEM/F12 media. The 
experiment was performed in triplicate using MEFs established from unique embryos and for 
each condition three technical replicates were used. Gate was set to a maximum of 0.1% error 
across all three technical replicates on untreated control MEFs, which was treated as an FMO.  
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Figure C3.4: Results of Optimising 4OHT Concentration for iFoxn1 MEF 
Reprogramming
Graphs depicting the percentage of GFP expressing MEFs when exposed to a range of 4OHT 
concentrations when cultured in DMEM (red) and Advanced DMEM/F12 (blue). 4OHT was 
added to MEFs when during proliferation (left) and at confluency (right). The experiment was 
perfromed in triplicate using MEFs established from three unique embryos. Each biological 
replicate, represented as a data point above, represents the mean of the three technical 

























































































































































































































Table C3.2: Optimising the Application of 4OHT, Raw Data.  
Table shows the portion of GFP+ MEFs found in a 24well. Each condition was produced in 
triplicate across confluence, 4OHT concentration and medium condition. The results are 
shown as the mean and CoV of the triplicate wells. 





DMEM Confluent 0 0.07 4.761 
  0.1 34.9 62.24 
  1 37.17 72.09 
  3 37.76 70.62 
  10 37.91 73.31 
DMEM Proliferating 0 0.7556 14.18 
  0.1 28.85 25.22 
  1 36.13 26.01 
  3 33.73 30.77 
  10 39.8 28.38 
Advanced 
DMEM/F12 
Confluent 0 0.09 7.408 
  0.1 39.33 58.47 
  1 41.45 46.5 
  3 40.05 47.35 
  10 48.52 57.83 
Advanced 
DMEM/F12 
Proliferating 0 0.28 123.7 
  0.1 53.29 18.67 
  1 65.59 13.12 
  3 58.31 16.42 
  10 63.43 36.51 
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Table C3.3: Optimising Application of 4OHT, Results of Three-Way ANOVA.  
Table shows the proportion of contribution of each variable to the total variation. The 
ANOVA also includes the variation produced through the interaction of these variables. 
The technical variation is termed “Technical Replicates” as this represents variation 
between replicates. 
Source of Variation Percentage of Total Variation 
(%) 
P value 
4OHT Concentration 52.47 <0.0001 
Medium 1.646 0.4850 
Confluency 6.524 0.1831 
4OHT Concentration x Medium 0.6505 0.6731 
4OHT Concentration x Confluency 1.686 0.2181 
Medium x Confluency 2.765 0.3705 
4OHT Concentration x Medium x 
Confluency 
0.8469 0.5548 
Technical Replicates 24.57 N/A 
  
95
Table C3.4: The CoV within the 0.1 μM 4OHT Condition. 
This table shows the variation in the proportion of GFP+ MEFs in the proliferating group 
compared to the confluent group. The proliferating group was associated with less 
variation, which made it the preferable condition.  
Condition DMEM CoV (%) Advanced DMEM/F12 CoV 
(%) 
Proliferating 25.22 18.67 
Confluent 62.24 58.47 
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Table C3.5: iTEC Proliferation during Reprogramming, Raw Data. 
Table shows the number of MEFs liberated from a T150. This study compared the number 
of MEFs produced after four and 18 days after activation of the iFoxn1 transgene in both 
DMEM and Advanced DMEM/F12. Advanced DMEM/F12 medium mediated an increase 
in the number of MEFs from day four to 18 and was the preferred condition. 
Condition Day 4 Mean 
Cell Number 
Day 4 CoV Day 18 Mean 
Cell Number 
Day 18 CoV 
DMEM 5373667 62.51% 4676667 31.87% 
Advanced DMEM/F12 11891667 44.75% 28700000 23.54% 
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3.5. Assessment of iTEC Functionality  
3.5.A. Method  
The ability to mediate T-cell differentiation was used to evaluate whether iTEC manufactured 
in the optimised protocol detailed above were successfully reprogrammed and competent to 
recapitulate TEC functionality. Reaggregate thymic organ culture (RTOC) was used to 
compare the functionality of iTEC to ex vivo TEC as it is currently the best available method 
for culturing functional ex vivo TEC (Anderson et al., 1993). RTOC generation was 
performed as outlined by Sheridan and colleagues, using the ‘compaction reaggregation’ 
technique (Sheridan et al., 2009). 
Thus, defined numbers of iTEC or ex vivo TEC were reaggregated into RTOC, along with 
defined numbers of CD4-CD8- double negative (DN) thymocytes and wild type (WT) MEFs to 
form RTOC, which were then cultured for two weeks (Figure C3.6). WT MEFs were C57BL/6 
background and were expanded and cryopreserved using the above defined process. Both 
DN thymocytes and TEC were isolated simultaneously from the embryonic day (E) 15.5 
thymus. DN thymocytes were defined as: CD45+EpCAM-CD3ε-CD4-CD8-CD11b-CD11c-
TCRβ-TCRγδ-B220-GR-1-NK1.1-TER-119-. TEC were defined: as EpCAM+CD45- (Figure 
C3.7). Each RTOC contained  iTEC, TEC or CreERt2-only MEFs, reaggregated with 
 DN thymocytes and WT MEFs.  
RTOC were cultured for 14 days at the gas/liquid interface, on a porous membrane, after 
which thymocytes were recovered from the RTOC for analysis by squashing the structure 
with a syringe. RTOC were mechanically disassociated to prevent disruption of target 
antigens with enzymatic treatment. However, while this increased the probability of losing 
cells during the preparation, this loss was assumed to be constant and proportional. 
Advanced DMEM/F12 was used as the culture medium and was supplemented with FGF7, 
FLT3L, KITL and IL-7. A positive staining control was produced for each experiment using 
thymocytes harvested from a four-week postnatal mouse as a reference to determine 
thymocyte developmental progression in the RTOC (Figure C3.8). Finally, comparison to 
RTOC in which CreERt2 only MEFs replaced the iTEC or TEC component, was included to 
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control for the effect of the iFoxn1 transgene and contaminating, differentiated thymocytes 
within the DN thymocytes pool proliferating in the RTOC. 
The RTOC were then analysed using flow cytometry designed to interrogate thymocyte 
development. This panel was inspired by Xing and colleagues (2016) with the notable 
omission of C-C motif receptor (CCR) 7 and major histocompatibility class I (MHC1) due to 
the physical limitations of the selected flow cytometer. The Novocyte (ACEA) was used for 
the experiment as capturing information regarding cell numbers was considered more 
important than quantifying expression of more than ten markers. The addition of anti-CD117 
(cKIT) would have allowed identification of DN thymocytes within the DN1 subpopulation 
(Figure C3.4); the addition of CCR7 would have allowed gating on to positively selected 
thymocytes that are moving from the cortex into the medulla and observations on the 
expression of MHC1 would have provided further understanding of the single positive (SP) 
phase (Xing et al., 2016).  
In this analysis, CD4 and CD8 provide information on thymocyte differentiation. CD25 and 
CD44 define the DN phase (Godfrey et al., 1993). CD3ε marks the completion of β-selection, 
and then is upregulated both after completion of the αβTCR and lineage commitment (Wang 
et al., 1999). TCRβ was intended to mirror CD3ε but in practice marked expression of the 
αβTCR. CD69 is a marker of T-cell activation and during thymopoiesis, marks positive 
selection. CD62L is upregulated prior to thymic egression and was used as a loose marker 
(given the omission of CCR7 and MCH1) of the completion of thymopoiesis. In practice, 
CD62L was also upregulated during transition from the DN to double positive (DP) phases. 
The lineage cocktail removed non-T-cell, blood cell lineages, iTEC and TEC.  
To make valid inferences regarding the capacity of iTEC to mimic native TEC function, a 
two-step comparison was used: firstly, between native thymopoiesis and sorted ex vivo TEC 
based RTOC (sevRTOC) to observe the effects of the culture method; secondly, by 
comparing iTEC and ex vivo TEC in RTOC to identify the differences between the cell types. 
In this regard, over the 14 day co-culture, the absence of thymic immigration was not 
predicted to be a problem given that early thymic precursors (ETPs), presence within the 
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input DN thymocyte pool, can maintain the thymus for extended periods when trafficking of 
thymus seeding precursors (TSPs) to the thymus is perturbed (Zlotoff et al., 2010). However, 
it must be stated that RTOC lack regulated egression of thymocytes and therefore it was 
assumed there would be a build-up of mature SP thymocytes. All data were acquired 
concurrently as it was important to compare RTOC within a repeat measures experimental 





































































































































































































Figure C3.7: Sorting Strategy for E15.5 TEC and DN Thymocytes
Images depict the sorting strategy for E15.5 thymus to isolate TEC and ETPs. Lineage cocktail 
included: CD3 , CD4, CD8, CD11b, CD11c, TCR , TCR , B220, Gr1, Nk1.1, Ter119. DN 




Figure C3.8: Profile of Thymopoiesis in The Native Thymus
The flow cytometry profile used to characterise thymopoiesis in this chapter. Here it is 
demonstrated using thymocytes isolated from a four-week old thymus. The warmer the colours 
the greater the expression of the stated marker. The title of each plot describes where the cells 
are gated from. To gain temporal resolution of specified markers, its expression was overlaid on 





3.5.B. Native Thymopoiesis  
3.5.B.I. Overview of Native T-cell Differentiation 
Native thymopoiesis was described in detail in Chapter One and is presented here with 
respect to the markers used for flow cytometry in Figure C3.8. Here is a brief description 
using the selected markers: the early thymocytes are DN, referring to CD4-CD8- thymocytes. 
This population is then segmented using CD44 and CD25 (Godfrey et al., 1993). 
CD44+CD25- cells represent the earliest thymocyte population and is termed DN1. This 
subpopulation is heterogeneous and contains the ETP (defined as Lin-CD25-c-Kit+), which 
amongst DN1 cells is the canonical T cell progenitor (Prockop and Petrie, 2004). 
Thymocytes then progress into DN2 by upregulating CD25 and to DN3 by downregulating 
CD44. TCR variable (diversity) joining (V(D)J) recombination begins during DN2. Focusing 
solely on αβ T-cells, only thymocytes that are able to produce a T-cell receptor (TCR)β chain 
are allowed to continue through thymopoiesis, this process is called β-selection (Petrie et al., 
1995). Thymocytes downregulate CD25 to enter the DN4 stage, here thymocytes undergo a 
second round of V(D)J recombination to generate a unique TCRα chain that heterodimerises 
with the previously created TCRβ chain to form the αβTCR. During this process, thymocytes 
upregulate both CD4 and CD8 and initiate the DP phase (Koch and Radtke, 2011).  
Note the CD25 stain in this experiment was taken to be a technical failure as the proportion 
of CD25+ were much lower than expected and not representative of previous experiments 
(Figure C3.8). This means that analysis of DN thymocytes within any experimental condition 
are likely to be confounded and this analysis was not performed. Analysis was only 
performed using CD4 and CD8 with markers CD69, CD62L, TCRβ and CD3ε. DP 
thymocytes enter positive selection, in which thymocytes communicate with TEC through 
cognate TCR-peptide:MHC interactions. Within the thymocytes, TCR activation is marked 
with expression CD69 and downregulation of either CD4 or CD8 to become SP thymocytes 
and enter the thymic medulla for negative selection. During negative selection, thymocytes 
downregulate CD69 and upregulate CD62L for thymic egression.  
3.5.B.II. Initiation of Positive Selection 
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The expression of the above markers was plotted onto the CD4 and CD8 profile to provide a 
temporal map of their expression (Figure C3.8). Focusing on the αβ T-cells, it is interesting 
to note that TCRβ (clone #H57-597) was only detectable in the DP phase, which was 
unexpected (Petrie et al., 1995). Whether this reflects the true expression pattern on the 
cellular membrane, or the antibody is specific to an epitope of the C region of the TCRβ 
chain that only becomes available once the αβTCR becomes available or recognises the 
TCRα chain is unclear. Instead of mirroring CD3ε, TCRβ expression was observed to mirror 
CD69 expression, which likely represents that at this stage thymocytes receive active TCR 
signalling for positive selection and lineage fate decision (Brugnera et al., 2000). This 
process occurred alongside a small downregulation in CD4 and CD8, flagging the start of 
positive selection. CD69 expression itself adhered to the kinetic signalling model with 
expression shifting over to CD4medCD8low thymocytes, which do not yet express CD62L 
(Brugnera et al., 2000). CD62L was dynamically expressed through thymopoiesis. It was 
expressed during DN to DP and represents the migration of thymocytes from the CMJ to the 
subcapsular region. CD62L is also expressed in thymocytes that have finished the lineage 
specification begin to downregulate CD69, in which CD62L mediates thymic egression (Xing 
et al., 2016).  
3.5.C. sevRTOC Recapitulated T-cell Differentiation 
As expected, the sevRTOC effectively mediated T-cell differentiation with all CD4 an CD8 
subpopulations being present (Figure C3.9). However, expression of CD69, CD62L and 
TCRβ were largely dissimilar in DP thymocytes compared to those in the native thymus, in 
which thymocytes entering positive selection downregulated both CD4 and CD8 a small 
degree and upregulated TCRβ and CD69. Within the RTOC, this slight downregulation of 
CD4 and CD8 and the accompanying upregulation of TCRβ and CD69 was not evident and 
may represent that the majority of thymocytes capable of positive selection had already 
passed through or that positive selection was disrupted. However, it is likely that thymocytes 
effectively transitioned into the SP phases as there is the incremental increase in CD3ε and 
TCRβ between the DN, DP and SP thymocytes that was observed in the native thymus. 
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Finally, there was a build-up of SP thymocytes in the sevRTOC but this was attributed to an 
inability of thymocytes to egress from the structure. 
Therefore, by analysing the ability of ex vivo TEC to mediate T-cell differentiation, we can 
infer what can maximally be expected of the iTEC system. SevRTOC mediated generation of 
all CD4 and CD8 thymocyte subsets with evidence of correct transition from the DP into the 
SP phase. However, there were some differences between sevRTOC and the native thymus: 
there was a relative increase in γδ T-cells and an accumulation of SP thymocytes. 
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Figure C3.9: Profile of Thymocyte Subsets in sevRTOC
Thymopoiesis profile of a sevRTOC from experiment A. When specified, expression of a marker 
is overlaid upon the CD4 and CD8 plot as a flame UTI to provide temporal resolution. The 
warmer the colours the greater the expression of the stated marker. The title of each plot 
describes where the cells are gated from. Lineage cocktail = CD11b, CD11c, B220, Gr-1, 
Nk1.1, EpCAM, Ter119.   
Expression
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3.5.D. iTEC Mediate T-cell differentiation but with Perturbed Positive 
Selection 
Analysis of the thymocyte subsets in iTEC-based RTOC (iRTOC) cultured concurrently to 
the above described sevRTOC demonstrated that iRTOC supported T cell differentiation 
from the DN input population, but that the outcome exhibited variability. Three examples are 
shown herein. Figure C3.10 presents an iRTOC with a bias towards SP8 thymocytes; Figure 
C3.11 represents iRTOC with a bias toward the SP4 lineage and Figure C3.12 shows data 
from an iRTOC that performed weakly as judged by the absolute cell counts of each 
thymocyte subset (Table C3.6 and C3.7). All three experiments were performed concurrently 
using the same pool of iTEC, MEFs, DNs.  
Flow cytometric analysis confirmed that iTEC were able to mediate T-cell differentiation 
because all CD4 and CD8thymocyte subsets were present in the iRTOC. This suggests that 
the iTEC could activate Notch signalling effectively in thymocytes and mediate upregulation 
of CD4, CD8, CD3ε and TCRβ. However, the overall kinetics of thymopoiesis were slower in 
iRTOC as the build-up of SP thymocytes, caused by the absence of thymic egression, was 
not as pronounced as in sevRTOC. Comparatively, there was a greater proportion of DP 
thymocytes, so it is likely that the transition from DP to SP phases was slower in the iRTOC.  
Once T-cell lineage has been enforced, thymocytes undergo positive selection and the 
lineage fate decision. These processes were dramatically different between iRTOC and 
sevRTOC. Notably, expression of CD3ε and TCRβ in the sevRTOC and native thymus 
increased incrementally from DN to DP and then SP stages. This pattern was not shown in 
the iRTOC, in which expression of these markers decreased between DP and SP 
thymocytes, suggesting a perturbation in positive selection. iTEC appeared to be selecting 
for SP thymocytes with lower TCR expression. Furthermore, in the native thymus and 
sevRTOC, CD69 expression increased between the DP and SP thymocytes. In the iRTOC 
this did not occur and expression of CD69 decreased between DP and SP thymocytes, 
which may reflect weaker TCR activation, or a failure of thymocytes to produce a TCR. 
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This may represent the absence of a medulla within the iRTOC. In effect, thymocytes 
completing positive selection become stuck at the transitional phase when thymocytes 
become licenced to migrate to the medulla because there are no mTEC to establish the 
necessary chemokine gradient for migration. The CD62L stain provides evidence for 
mechanism. In the native thymus and sevRTOC, CD62L is upregulated in DP to SP 
transition, while in iRTOC this is absent. Providing more detail on this mechanism is outside 
the limits of the flow cytometry panel that was designed to focused on cortical thymopoiesis. 
It would be interesting to compare CCR4 and CCR7 expression, and whether thymocytes 
undergo the VCAM-1 to ICAM-1 switch that characterises this section of thymopoiesis. 
Furthermore, interesting future experiments could determine whether ex vivo mTEC 
supplemented into iRTOC can rescue this phenotype, making it more like the sevRTOC. 
Overall, iRTOC was able to mediate T-cell differentiation and produce all subsets of 
thymocyte based upon CD4, CD8 TCRβ and CD3ε and this was taken as evidence of iTEC 
functionality. However, the kinetics of this mechanism were slower in iRTOC that sevRTOC. 
In addition, once T-cell lineage was enforced on thymocytes, the transition between DP to 
SP phases did not reflect that in sevRTOC or the native thymus 
Finally, CreERT2 only MEF-based RTOC were unable to support T-cell differentiation (Fig 
3.13). Therefore, the above effects result from expression of the iFoxn1 transgene in MEFs 
and the pool of DNs were not contaminated with any pre-specified thymocytes able to 
proliferate within the system. 
Therefore, we can conclude that within this single experiment iTEC produced using the 
above described protocol were functional, in which they were able to mediate T-cell 
differentiation. The total absolute counts of each thymocyte subset are shown for every 
iRTOC in Figure C3.14. However, further evidence was required from multiple experiments 
before this conclusion could be generalised to all future produced iTEC.  
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Figure C3.10: Profile of Thymocyte Subsets in iRTOC with CD8 Bias
Thymopoiesis profile of iRTOC with CD8 bias. When specified, expression of a marker is 
overlaid upon the CD4 and CD8 plot as a flame UTI to provide temporal resolution. The warmer 
the colours the greater the expression of the stated marker. The title of each plot describes 
where the cells are gated from. Lineage cocktail = CD11b, CD11c, B220, Gr-1, Nk1.1, EpCAM, 
Ter119. See table C3.6 and C3.7 for information on relative cell abundances and proportions.   
Expression
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Figure C3.11: Profile of Thymocyte Subsets in iRTOC with CD4 Bias
Thymopoiesis profile of iRTOC with CD8 bias. When specified, expression of a marker is 
overlaid upon the CD8 and CD4 plot as a flame UTI to provide temporal resolution. The warmer 
the colours the greater the expression of the stated marker. The title of each plot describes 
where the cells are gated from. Lineage cocktail = CD11b, CD11c, B220, Gr-1, Nk1.1, EpCAM, 
Ter119. See table C3.6 and C3.7 for information on relative cell abundances and proportions.     
Expression
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Figure C3.12: Profile of Thymocyte Subsets in Weakly Performing iRTOC 
Thymopoiesis profile of weakly performing iRTOC. When specified, expression of a marker is 
overlaid upon the CD4 and CD8 plot as a flame UTI to provide temporal resolution. The warmer 
the colours the greater the expression of the stated marker. The title of each plot describes 
where the cells are gated from. Lineage cocktail = CD11b, CD11c, B220, Gr-1, Nk1.1, EpCAM, 
Ter119. See table C3.6 and C3.7 for information on relative cell abundances and proportions.      
Expression
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Figure C3.13: Profile of Thymocyte Subsets in Cre Only MEF Control RTOC
Thymopoiesis profile of the control RTOC that replaced iTEC/TEC component with Cre Only 
MEFs. When specified, expression of a marker is overlaid upon the CD4 and CD8 plot as a 
flame UTI. The warmer the colours the greater the expression of the stated marker. The title of 
each plot describes where the cells are gated from. Lineage cocktail = CD11b, CD11c, B220, 














































































































































































































































Table C3.6: Percentages of each iRTOC from the Live, Lineage Negative Gate. 
The table shows the relative proportions (%) of each thymocyte subset from the total cells 
gated as Live and Lineage Negative 
Replicate 
% Live, 





A 43.45 8.35 9.74 12.53 69.37 1.86 9.05 
A* 48.59 3.26 45.42 18.87 32.44 5.06 2.17 
A 62.89 5 56.72 10.18 28.1 2.27 1.37 
A 47.53 3.37 47.14 24.22 25.28 5.74 2.84 
A*** 38.06 2.48 49.11 5.14 43.26 1.77 4.43 
A 58.83 3.57 66.65 11.8 17.98 2.23 1.76 
A 41.93 3.04 16.32 2.47 78.18 1.71 0.19 
A** 54.84 17.12 52.62 6.51 23.75 3 3.53 
B 45.68 2 1.64 10.23 86.13 8.91 23.78 
B 57.62 4.91 8.62 13.32 73.15 13.17 33.46 
B 57.02 6.9 3.44 11.82 77.84 10.49 30.59 
C 28.69 0.35 1.18 3.73 94.74 1.77 2.42 
C 40.07 0.37 3.26 3.73 92.65 2.1 2.39 
* iRTOC represented in Figure C3.10 
*** iRTOC represented in Figure C3.11 
** iRTOC represented in Figure C3.12 
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Table C3.7: Absolute Cell Counts from each iRTOC from the Live, Lineage Negative 
Gate. 
The table shows the absolute cell counts of each thymocyte subpopulation in all iRTOC in 
all three experiments 
Replicate 
Live, 
Lineage  SP4 DP SP8 DN Αβ T-cells γδ T-cells 
A 431 36 42 54 299 8 39 
A* 13035 425 5921 2460 4229 659 283 
A 3438 172 1950 350 966 78 47 
A 4720 159 2225 1143 1193 271 134 
A*** 564 14 277 29 244 10 25 
A 18711 668 12470 2208 3365 417 330 
A 527 16 86 13 412 9 1 
A** 15943 2729 8389 1038 3787 478 563 
B 11896.5 238.5 195 10246.5 1216.5 1060.5 2829 
B 27370.5 1344 2358 20022 3646.5 3604.5 9159 
B 15684 1081.5 540 12208.5 1854 1645.5 4798.5 
C 7636.5 27 90 7234.5 285 135 184.5 
C 10666.5 39 348 9882 397.5 223.5 255 
* iRTOC represented in Figure C3.10 
*** iRTOC represented in Figure C3.11 
** iRTOC represented in Figure C3.12 
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3.5.E. Variation Between Independent Experiments 
Whilst it was pertinent to perform the above analysis within one experiment to standardise 
stochastic variation produced from differences between input populations and environmental 
factors, it was also important to observe gross changes over multiple independent 
experiments, given the aspiration of standardising iTEC. Table C3.6 and C3.6 and Fig 3.14 
present data collected from iRTOC in three biological replicate experiments. Although the 
above discussion comparing iRTOC and sevRTOC used evidence provided exclusively from 
replicate A, the patterns highlighted were observed in all experiments. Note that different 
numbers of iRTOC were created in each experiment for technical reasons (FACS sorting 
availability). A minimum of three iRTOC was set up in each experiment but, in experiment C, 
one of these resulted in a technical failure so no data were collected. Comparison between 
iRTOC from these independent experiments simultaneously emphasises biological 
differences in iTEC, but also thymocytes and WT MEFs, and environmental factors such as 
cytokine batch and variation in manufacturing RTOC, with little ability to differentiate the 
contributions of these sources of variation from each other. However, on the assumption that 
ex vivo TEC are less variable than iTEC, a comparison between sevRTOC from each 
experiment isolates the iTEC/TEC variation to provides information on differences in 
thymocytes, WT MEFs and environment. Note, due to the scarcity of E15.5 TEC, only one 
sevRTOC was produced in each experiment (Figures C3.9, C3.15 and C3.16). 
iRTOC manufactured for experiment B produced more γδ T-cells than in the other replicates. 
This is likely to be a related to the iTEC as this phenotype was not shown in the sevRTOC 
control. The mechanics underscoring the αβ vs γδ lineage decision are not completely 
understood. There is some evidence of IL-7 involvement (Huang et al., 2001; Ye et al., 
2001). However, it should be noted that in this experiment IL-7 was supplemented at 
consistant levels. Therefore, this observation provides evidence against the fate decision 
being completely independent of environment, the effect was likely to have arisen from the 
iTEC, or the same bias would have been present in the sevRTOC. Strikingly, regardless of 
γδ T-cells, sevRTOC B performed weakly. SevRTOC A and C look very similar, with respect 
to cellular proportions and expression of CD69, CD62L, CD3ε and TCRβ, while in sevRTOC 
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B these were more reminiscent of iRTOC. It maybe that either the DN thymocyte or WT MEF 
population, or an environmental factor, rather than the iTEC, reduced the efficacy of 
experiment B, which in turn may explain why the iRTOC were unable to generate many DPs 
thymocytes. A notable difference between iRTOC and sevRTOC in experiment B is that the 
sevRTOC did not generate aberrant SP thymocytes, with respect to the relative expression 
levels of TCRβ and CD3ε, which is further evidence that this abnormality is likely to be 
associated with iTEC. The same cannot be said for iRTOC generated in experiment C, which 
demonstrated very poor ability to mediate thymopoiesis while the concurrent sevRTOC 
performed well. 
Therefore, despite efforts to create a standardised process to reprogram iTEC, there was 
dramatic variablity between preparations of iTEC that appears not to be due to other the 
cellular compartments or environmental factors. This variation existed within batches, as 
demonstrated between iRTOC within experiments and between batches as shown by 
comparing the above three independent experiments. Future work is necessary to further 
reduce the variability in the iTEC system.  
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Figure C3.15: Profile of Thymocyte Subsets in sevRTOC from Experiment B 
Thymopoiesis profile of sevRTOC from experiment B. When specified, expression of a marker 
is overlaid upon the CD4 and CD8 plot as a flame UTI to provide temporal resolution. The 
warmer the colours the greater the expression of the stated marker. The title of each plot 
describes where the cells are gated from. Lineage cocktail = CD11b, CD11c, B220, Gr-1, 
Nk1.1, EpCAM, Ter119.   
Expression
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Figure C3.16: Profile of Thymocyte Subsets in sevRTOC from Experiment C
 
Thymopoiesis profile of sevRTOC from experiment C. When specified, expression of a marker 
is overlaid upon the CD4 and CD8 plot as a flame UTI to provide temporal resolution. The 
warmer the colours the greater the expression of the stated marker. The title of each plot 
describes where the cells are gated from. Lineage cocktail = CD11b, CD11c, B220, Gr-1, 
Nk1.1, EpCAM, Ter119.   
Expression
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3.5.F. Comparison between sevRTOC and Unsorted RTOC 
iTEC are intended to recapitulate only the epithelial component of thymic stroma. It is 
pertinent to compare the sevRTOC to an RTOC created using the entire range of thymic 
stroma to set realistic, evidence-driven goals for iTEC. A comparison between the successful 
sevRTOC from experiment C and a control created by dissociating and reaggregating six 
whole E15.5 thymic lobes, with appropriate proportions of WT MEFs, allowed resolution of 
the effect of the non-epithelial thymic stroma on RTOC functionality (Figure C3.17). Note the 
caveat of this control is that the input thymocyte population was not DNs but already 
contained differentiating thymocytes (Klug et al., 2002; Petrie and Zúñiga-Pflücker, 2007). 
Interestingly, the unsorted RTOC did not display the abnormal expression pattern of CD69 
observed in sevRTOC but an expression pattern much more in keeping with the kinetic 
signalling model (Brugnera et al., 2000). Thymocytes within the unsorted RTOC, 
downregulated CD69 appropriately after an initial and, with respect to SP8 thymocytes, 
transient SP4 phase. This lends evidence to the hypothesis that non-epithelial stromal cells 
supported TEC to mediate positive selection. The other striking difference is that the 
unsorted RTOC did not accumulate SP thymocytes to the extent that the sevRTOC did, 
particularly for SP8 thymocytes. Whether this reflects SP thymocytes leaving the structure, 
or a better regulation of thymocyte proliferation, is unclear. Whilst understanding these 
differences is not relevant to the main aims of this thesis, it remains an interesting future 
experiment to test how the non-epithelial thymic stromal cells effect RTOC organisation. A 
notable experiment would be to compare sevRTOC to 2′-Deoxyguanosine treated unsorted 
RTOC and fetal thymic organ culture that had been seeded from a common pool of DN 
thymocytes. Therefore, it may be unrealistic to expect iTEC to mediate positive selection 
without support from key non-epithelial thymic stromal cells.  
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Thymopoiesis profile of an RTOC created by dissociating six thymic lobes and reaggregating 
the cells without sorting with WT MEFs into RTOC. When specified, expression of a marker is 
overlaid upon the CD4 and CD8 plot as a flame UTI. Note that the greater than expected 
expression of CD3  and CD69 within the CD4-CD8- population is due to the increased  T-cell 
population. The title of each plot describes where the cells are gated from. Lineage cocktail =
CD11b, CD11c, B220, Gr-1, Nk1.1, EpCAM, Ter119.   
Figure C3.17: Profile of Thymocyte Subsets in Unsorted RTOC Experiment C
Expression
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3.6. Conclusion  
From these data, I concluded that iTEC generated using the protocol optimised in this 
chapter were able to mediate T-cell differentiation, but that additional work was required 
standardise results between batches. Additionally, by probing thymocyte differentiation in 
iRTOC in more detail than previously reported, I identified differences in the capacity of iTEC 
to support thymocyte development compared to ex vivo TEC, particularly at the CD4+ / CD8+ 
lineage commitment and/or positive selection stages. However, evidence was presented that 
these processes may be perturbed in sevRTOC, with iTEC further confounding these 
problems. These effects are likely due to differences in TCR activation between the systems; 
iTEC instigating weaker activation than their native counterparts. Overall, these data 
validated iTEC as an alternative source of TEC to generate the in vitro thymus. However, 
improvements are required, particularly when enforcing positive and negative selection. 
Whether this phenotype can be rescued by including additional populations in the RTOC, 




4. Chapter Four: Screening Synthetic 
Polymers for Capacity to Bind and Support 
Thymic Epithelial Cells 
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4.1. Introduction and Aims 
It is well established that thymic epithelial cells (TEC) rapidly downregulate Foxn1 when 
culture in vitro, which ultimately leads to an inability to mediate thymopoiesis (Anderson et 
al., 1998). A study in 2006 found that loss of Foxn1 led to downregulation of the Notch 
ligands DLL1 and DLL4, which are essential for T-cell lineage commitment and some 
subsequent stages of T cell differentiation (Mohtashami and Zúñiga-Pflücker, 2006). The 
authors showed that TEC cultured in reaggregate thymic organ culture (RTOC) maintained 
Foxn1 expression, while those cultured in monolayers did not. It was therefore concluded 
that the three-dimensional (3D) structure of RTOC may have contributed in maintaining 
FOXN1 expression and thus TEC function in vitro (Mohtashami and Zúñiga-Pflücker, 2006).  
An essential component of any 3D structure is the extracellular matrix (ECM), which is the 
macromolecular network that creates the structure between cells. ECM is composed of a 
wide range of proteins and polysaccharides that form hydrophilic gels (Lam et al., 2019). 
Cells are both supported by and contribute to these structures, which become an essential 
part of cell-to-cell interactions by potentiating soluble factors and mediating 
mechanotransduction (Lam et al., 2019). ECM components, when added to in vitro culture 
systems, can affect cellular proliferation and function. In a recent example, Lam and 
colleagues show that supplementing neural networks with ECMs accelerated the formation 
of the networks, without affecting the functional properties compared to culture on Poly-D-
Lysine alone (Lam et al., 2019). Furthermore, fabricating synthetic 3D hydrogels with select 
ECM elements have been shown to affect the balance of self-renewal and differentiation in 
stem cells (Ranga et al., 2014). However, addition of currently available ECMs to in vitro 
monolayer cultures is associated with limitations including efficacy and reproducibility and 
can also be expensive (Tourniaire et al., 2006).  
These concerns have led to the development of the synthetic polymers that can be used to 
mimic the physicochemical properties of the ECM, for applications in cell culture systems 
(Sakiyama-Elbert and Hubbell, 2002). In turn, the ability to manipulate polymers to produce a 
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wide range of chemical and physical properties led to the development of polymer 
microarrays. These microarrays provide a means of screening cells against libraries of 
different polymers containing many different functional properties, in order to find those most 
compatible with a given cell type (Anderson et al., 2004; Tourniaire et al., 2006). This 
technique was developed by the Langer and Bradley groups and, since publication, has 
been applied to both the isolation and culture of tissue-specific cell types, including 
hepatocytes, mesenchymal stromal cells and osteoblasts, and for creating completely 
defined conditions for embryonic stem cell culture (Duffy et al., 2014a; Hay et al., 2011; Mei 
et al., 2010a, 2010b; Melkoumian et al., 2010; Tare et al., 2009). The rationale was that such 
polymers could form a component of a defined culture system suitable for propagating TEC 
or induced TEC (iTEC) monolayers and could potentially be further developed as 
components of engineered RTOC. 
Therefore, in this chapter I aimed to employ a two-step approach to first identify polymers 
that facilitate the adhesion of TEC and then to evaluate whether TEC cultured upon the 
selected polymers can more closely emulate native behaviours. To created testable 
outcomes that assay of the effect of polymers on TEC behaviour, I chose to address a set of 
objectives that analysed three discrete thymic functions: 
A. Determine whether candidate polymers can improve maintenance of Foxn1 
expression in cultured TEC. 
B. Determine whether candidate polymers improve the ability of ex vivo TEC and iTEC 
to mediate T-cell differentiation compared to standard culture methods, such that 
thymocyte development in monolayer cultures more closely resembles that observed 
in the native thymus. 
C. Determine whether candidate polymers promote differentiation of iTEC into mTEC-
like TEC, with evidence of promiscuous gene expression.  
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These objectives were selected because a culture system that met all the above criteria 
would be superior to currently available technology. Moreover, they were each technically 
feasible and created a non-redundant and sequential structure.  
Objective A was evaluated using transgenic embryonic TEC from a Foxn1 reporter mouse 
line in which expression of Foxn1 can faithfully tracked based on GFP fluorescence intensity 
(Foxn1G mice: O’Neill et al., 2016). Of note is that this criterion was assumed not to be 
relevant to iTEC as the iFoxn1 transgene enforces continuous Foxn1 expression. Testing of 
murine TEC was prioritised for this experiment as a suitable reporter line was already 
available.  
Objective B was inspired by the systems OP9-DLL1 and MS5-hDLL1 systems, in which 
enforced expression of the Notch signalling ligands delta-like-ligand (DLL)1 or DLL4 in the 
bone marrow-derived OP9 or MS5 cell line confers the capacity to partially support T cell 
development (Schmitt and Zúñiga-Pflücker, 2002; Seet et al., 2017; Montel-Hagen et al., 
2019). Both systems support commitment of haematopoietic progenitors to the T-cell 
lineage, and efficiently mediate the progression of ETPs and other haematopoietic 
progenitors into TCRβ+CD3+CD4+CD8+ thymocytes (Schmitt and Zúñiga-Pflücker, 2002; 
Schmitt et al., 2004). However, these systems cannot currently support physiological positive 
selection or production of TCRβ+CD3+CD4+ thymocytes given they cannot present peptides 
in the context of major histocompatibility class 2 (MHC2) (Takada, Kondo and Takahama, 
2017). 
Objective C asks whether the candidate polymers can support a monolayer system in which 
some cells adopt mTEC fates and exhibit promiscuous gene expression. This represents a 
reductionist readout for the ability to support negative selection. Given that OP9-DLL1 and 
MS5-hDLL1 cells are not able to do this, Objective C represents a novel aspiration for in vitro 
thymopoiesis. 
4.2. Identifying Polymers that the Facilitated TEC Adhesion 
4.2.A. Primary iTEC-based Screen of 367 Polymers 
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4.2.A.I. Experimental Design  
To identify TEC-specific polymers, I employed a similar method to that originally described 
by Bradley and colleagues (Tourniaire et al., 2006). The polymers used in this chapter were 
synthesised by to Dr C. Duffy and Dr S. Venkateswaran in the Bradley laboratory, who also 
helped me manufacture and image the initial microarrays. To produce the microarrays, a 
microscope slide was coated in 2% agarose to prevent cellular adhesion to the glass. On top 
of this, polymers were contact printed in quadruplicate to create a matrix of polymer spots 
(Figure C4.1A).  
Microarrays of 367 different polymers were fabricated using polymers selected to 
encompass a range of physical properties, and including polymers already identified as 
supporting other cell types via previous library screening experiments (Pernagallo et al., 
2009). The result was a microarray that presented a range of functional groups, wettability, 
charge, nano-topography, integrin contact point density and lipophilicity in polymer 
compositions with a proven history of success on other cell types (Duffy et al., 2014a).  
In the primary microarray screen, I elected to use iTEC as a surrogate for TEC, based on the 
validation of this reprogrammed cell-type documented in Chapter Three, and due to the 
scarcity of the native tissue. The screen was designed such that, once initial candidate 
polymers were identified, these were subject to a focussed secondary screen in which both 
cell types were tested in parallel on a scale appropriate to the scarcity of ex vivo tissue. 
In the initial screen, microarrays of either iTEC or CreERt2+iFoxn1- (Cre Only) MEFs were 
performed in parallel. iTEC were defined as Green Fluorescent Protein (GFP)+ 
CreERt2+iFoxn1+ (iFoxn1) MEFs that were purified eight days after exposure to 4OHT. A 
hydrophobic pen was used to draw a ring around the array to concentrate cells onto the 
polymers.  
The microarrays were sterilized using ultraviolet light and placed inside rectangular tissue 
culture dishes.  of either cell type were seeded into the hydrophobic ring in 1 ml of 
iTEC medium and allowed to bind to polymers. After four hours, an additional 4 ml of iTEC 
medium (described in Chapter Three) was added to each microarray, fully submersing the 
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glass slide. A 50% medium change was performed every 2 days until the microarrays were 
fixed seven days after being seeded.  
The number of cells adhered to each polymer spot was then manually counted using the 
nuclear stain 4′,6-diamidino-2-phenylindole (DAPI). On the microarrays seeded with iTEC, 
two measures were taken to ensure only successfully reprogrammed MEFs were counted. 
Firstly, the iTEC seeded on to the microarrays were isolated using fluorescence activated 
cell sorting (FACS) for expression of GFP, which reported expression of the iFoxn1 
transgene, prior to seeding and secondly the slides were stained for the epithelial cell marker 
pan-cytokeratin and only nuclei surrounded by a positive cytokeratin stain were counted as 
iTEC (Figure C4.1B). On the microarrays that were seeded with Cre only MEFs, all nuclei 
were considered eligible for counting.  
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Figure C4.1: Screening a Microarray of 367 Polyacrylates and Polyurethanes 
for Polymers able to Bind iTEC
A. Representation of microarray manufacturing process. Glass microscope slides were coated
in 2% agarose before 367 different polyacrylates and polyurethanes were contact printed on the
surface. Each polymer was represented in quadruplicates at various positions on each slide. B.
Representative images of a successful polymer spots with iTEC (top) or Cre only MEFs
(bottom). Average area of iTEC nuclei was 241 m2 while the area of the spot was 66,676  m2.
A
Coat microscopy 





Culture iTEC and 






Spots are 350 m in 
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4.2.A.II. Results  
The microarrays were imaged on a Nikon 50i microscope using pathfinder software 
(IMSTAR). Images of each polymer spot were taken to capture DAPI and Alexa Fluor (AF) 
488 (Figure C4.1B). The number of cells was counted for each microarray (Figure C4.2). The 
area of one spot from each polymer quadruplicate was measured and the cell counts were 
normalised using: 
Equation C4.1: 
 (Figure C4.3). 
A high degree of variability was observed in the screen, and therefore polymers that met 
defined criteria, rather than statistical inference, were taken forward (Wasserstein et al., 
2019). In this primary screen, type 2 statistical errors would have worse consequences than 
type 1 errors, since a type 2 error could mean that a potentially useful polymer was missed, 
while a type 1 error would simply result in a ‘false-positive’ polymer being subjected to 
another round of experiments, where it would be excluded. Therefore, all polymers that 
bound iTEC, MEF or both cell types across all four technical replicates in all three 
independent experiments were judged successful and are represented in Figures C4.2 and 
C4.3. The data presented in Figures C4.2 and C4.3 show only the polymers that bound iTEC 
alone (29/367 polymers), MEF alone (24/267 polymers), or both cell types (6/367 polymers). 
Therefore, the primary screen identified polymers than bound either iTEC, MEFs or both cell 
types. However, given the variation found in the screen these needed to be re-tested using a 
in secondary screen.  
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Graphs depict the number of cells observed on each polymer spot A. Shows all polymers, of 
the 367, that could bind iTEC. B. Of all 367 polymers those that bound MEFs. C. Of all 367 
polymers those that bound to both iTEC and MEFs. Polymers that did not bind any cells across 
all three independent experiments were excluded. Data points show the mean of three 
technical replicates.  




Graphs depict the number of cells oberved on polymer spots divided by the total area of that 
polymer spot. A. Shows the polymers, of the 367 that could bind only iTEC. B. Of all 367 
polymers those that bound only MEFs. C. Of all 367 polymers those that bound both iTEC and 
MEFs. Polymers that did not bind any cells across all three independent experiments were 
excluded. Data points show the mean of three technical replicates.  




4.2.B. Secondary iTEC Screen on the Focused Array Format 
4.2.B.I. Experimental Design 
Given the high level of variance in the microarray experiments described above, all polymers 
that bound iTEC across all four technical replicates in all three independent 
experiments were taken forward for subsequent testing. This necessitated development of 
focused polymers arrays, which were designed to screen fewer polymer conditions but with 
greater precision.  
A 384-well plate was used as it allowed testing of many conditions, without demanding an 
unreasonable amount of input tissue. To coat the plate, all selected polymers from the 
primary screen were dissolved in acetone at 0.2 mg / ml and pipetted into wells in the 
appropriate layout. The plates were airdried at room temperature to remove the acetone and 
then washed with water and phosphate-buffered saline (PBS) to remove any residual 
contaminates (Figure C4.4A).  
Compatibility with this procedure was an essential criterion for identification of candidate 
polymers with work-up potential for routine laboratory use. Polymers that were unable to 
dissolve completely produced a thick and clumpy coating that impaired imaging. Acetone 
was considered a mandatory solvent as harsher solvents damage the silicon glue currently 
used to manufacture tissue culture plates. A potential alternative was to spin-coat glass 
cover slips with polymer and insert these into tissue culture flasks. This was decided against 
as it would impair future scale-up, an important component of clinical applicability, and 
makes the assay incompatible with high throughput imaging systems, which use refractive 
index to automatically focus objectives.  
Overall, a total of 12 polymers were excluded from the panel at this stage due to poor 
solubility in acetone and were not used in subsequent experimentation. These were 
polymers 117, 232, 235, 276, 296, 317, 329, 342, 422, 424, 461 and 488. Polymer 369, 
which featured on the primary microarray but was not a “hit” candidate, was included as a 
















































































































































































































































































































































The Focused Polymer Array aimed to test the same hypothesis as the microarray 
experiments, using a more precise methodology. iFoxn1 MEFs were treated with 4OHT to 
induce reprogramming and GFP+ cells were FACS sorted at 18 days post-induction for use 
in the screen. A total of  iTEC were seeded into each well in iTEC medium, over a 
14-day culture period, the medium was replaced every two to three days. Care was taken to 
wash off unbound cells before the plate was fixed and the iTEC were stained with DAPI and 
anti-cytokeratin to identify epithelial cells, as for the microarray above (Figure C4.4A).  
An automated pipeline to was optimised to calculate the number of cytokeratin expressing 
cells in each well using the ColumbusTM software (PerkinElmer) (Figure C4.4B). First, DAPI+ 
nuclei were segmented, on the assumption that one cell contained one nucleus, to form the 
basic cell count. To count the number of successfully reprogrammed iTEC, the area 
surrounding each nucleus, which was assumed to be the cytoplasm, was to be segmented 
into individual cells. Areas with variable brightness, with respect to the neighbouring region, 
were delineated and assumed to mark the boundary between cells, thereby pairing a 
nucleus with a surrounding delineated area, or cytoplasm, to create a whole cell. Note that 
by using a camera with a high bit depth, it was possible to use cellular autofluorescence to 
make this measurement. The mean fluorescence intensity (MFI) for each ‘cell’, which was 
simply a delineated area in the AF488 channel extending from a DAPI+ spot, was calculated 
and those over a given threshold, which was set using a negative control, were counted as 
cytokeratin+ iTEC. 
The number of iTEC bound to each polymer, calculated using this pipeline, is shown in 
Figure C4.5. A high degree of variation was observed between biological replicates within 
this study (Table C4.1).  
The two most probable sources of this variation were: biological variation within the iTEC, 
creating cells with heterogeneous adhesive properties; and inaccurate cell counting before 
seeding into wells. Given that all cell counts have associated precision errors, the later effect 
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was normalised against by reporting the cell counts with respect to the positive control, 0.1% 
gelatin (Figure C4.6). 
Equation C4.2: 
  
With this equation applied, the major source of variation was likely to be biological with the 
caveat of the normalisation being that binding to 0.1% gelatin is assumed to be consistent 
across biological replicates i.e. if the same cell type was repeatedly seeded into 0.1% gelatin 
the same number of cells should consistently bind.  
Once this normalisation was applied, the average coefficient of variation (CoV) for each 
condition was reduced from 95.7% to 79.95%, and polymers were evaluated using this 
metric (Figure C4.6). The normalised cell counts for each polymer were compared to the 
negative control 369. Logical criteria were used to judge successful candidates rather than 
statistical inference, because the experimental design was more forgiving of type 1 errors 
than type 2 errors as with interpretation of the primary screen (Wasserstein et al., 2019). The 
red line on Figure C4.6 indicates the mean plus + 1 standard deviation (SD) (0.08564) of the 
cell count for polymer 369. Any polymers with a mean ± 1 SD that intercepts this line were 
considered failures and removed from future tests. 
Based on these criteria, polymers 111, 287, 396, 427, 509, 519, 520 and 563 were identified 
as able to bind iTEC. Now I had identified polymers that could bind iTEC, I could apply ex 
vivo TEC to the same test to determine whether iTEC shares a similar adhesion profile to 







































































































































































































































































































Table C4.1: Biological Replicate Affected Cell Count in Focused Arrays. 
Table depicts the mean number of iTEC counted in three conditions across three technical 
replicates. Data from three experiments are shown. The cell counts of each condition were 
variable across experiments despite using the same methodology.  
Polymer Replicate A Count Replicate B Count Replicate C Count 
0.1% gelatin 5429 5155 11900 
519 5294 3898 14170 
287 5538 6670 14325 
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4.3. Primary Ex Vivo TEC Screen on the Focused Array Format  
The screening strategy described above assumed that iTEC effectively mimicked native TEC 
and shared the same adhesion profile. To test this hypothesis, ex vivo embryonic murine 
TEC were screened on the successful polymers from the primary iTEC microarray. The 
experimental set up described above in the iTEC focused array was applied to ex vivo 
material, with the exception that tissue availability allowed for only one technical replicate per 
condition (Figure C4.7A).  
Selecting the developmental age at which TEC were obtained for these experiments was a 
compromise between total TEC yield and TEC heterogeneity. TEC in the older embryonic 
thymus are more heterogeneous than TEC at younger developmental ages, as TEC 
differentiation actively progresses with age during thymic organogenesis. For example, from 
E13.5 to E15.5, PLET1 expression decreases in most fetal TEC, and patterning into K5+ or 
K8+ TEC, representing mTEC and cTEC respectively, also occurs during this time window 
(Bennett et al., 2002; Farley et al., 2013; Klug et al., 2002). I elected to use E13.5 and E14.5 
murine TEC to balance tissue scarcity with increasing heterogeneity within the samples. 
Embryonic thymi were collected and dissociated before depletion of the CD45 compartment 
using magnetically conjugated beads. The resulting stromal cell preparation was seeded 
onto polymer coated wells and fixed after 16 hours to mitigate downregulation of Foxn1 as a 
confounding variable (Figure C4.7A). Wells were stained with DAPI and anti-pan-cytokeratin 
and the automated pipeline described above was used to determine the number of 
cytokeratin expressing cells, assumed to be TEC, within each whole well (Figure C4.7B). 
The native murine TEC focused arrays were seeded with cells from 140 lobes per array, 
rather than a defined cell number because a cell count was assumed to be misleading given 
that whole thymic stroma was seeded into the arrays and only thymic epithelial cells would 
be counted in the readout (Figure C4.8). Since two developmental ages were used, the 
proportion of TEC within the total cellularity would not be consistant (Hirakawa et al., 2018). 
To remove this technical variation, the same strategy used in the iTEC focused array was 




This reduced the mean CoV from 60.53% to 49.14%. It is interesting to compare the mean 
CoV in the iTEC and ex vivo TEC focused array, which were 79.95% and 49.14%, 
respectively. Despite the iTEC using three technical replicates the system contained greater 
variation. The same criteria were set for polymers in the native TEC focused array as in the 
iTEC focused array: any polymer with a mean ± 1 SD that intercepted the mean plus + 1 SD 
(0.3362) of the cell count from polymer 369 was considered a failure (Figure C4.9).  
On these criteria, polymers 111, 287, 394, 396, 427, 461, 519, and 563 were identified as 
able to bind ex vivo TEC. This highly similar binding pattern of ex vivo TEC and iTEC to the 
individual polymers present in the Focused Polymer Array (Table C4.2) validated the initial 
iTEC-based screening approach.  
Additionally, I began to test whether ex vivo human fetal TEC would also bind these same 
polymers. Preliminary data were obtained using this approach, with human fetal TEC 
obtained from a fetus of week 11 of gestational age (Farley et al., 2013). However, the 
human screen was stopped after one experiment because of limitations in sourcing tissue. 
No normalisation was performed on these data as comparison between biological replicates 
was impossible. None-the-less, polymers with a higher TEC count than 0.1% gelatin are 
highlighted in Figure C4.10. These include polymers 111, 309, 396, 427, 461, 519, 520 and 
531. The monomers used to create each selected polymer are represented in Table C4.3 
















































































































































































































































































































































































































































































































































































































































































































































































































































Table C4.2: List of Successful Polymers in all Focused Arrays. 
Table shows all successful polymers with respect to the cell type.  
iTEC Candidates Murine TEC Candidates Human TEC Candidates 
111 111 111 
287 287 - 
- - 309 
- 394 - 
396 396 396 
427 427 427 
- 461 461 
509 - - 
519 519 519 
520 - 520 
- - 531 
563 563 - 
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Table C4.3: List of Monomeric Structures of Successful Polymers in all Focused 
Arrays. 
This table details the monomer composition of the selected polymers. Monomer structures 
are described in Figure C4.11. MEMA (methoxyethyl methacrylate); MMA (methyl 
methacrylate); EMA(ethly methacrylate); BAEMA (t-butly methacrylate); GMA(glycidyl 
methacrylate); DMAEMA (dimethylaminoethyl methacrylate); DEAEA (2-
(diethylamino)ethyl acrylate); MAN (methacrylonitrile); BMA (N-butyl methacrylate); 
THFFMA (tetrahydrofurfuryl Acrylate); DAA (dihydroxyaluminum aminoacetate); DEAEMA 
((diethylamino)ethyl methacrylate); St (styrene) 





(ratio) Group  
Molecular 
Weight 
111 MEMA (90%)  BAEMA (10%) 
Amine 
- 273000 
287 MEMA (50%) GMA (50%) Man (>1%) 
Amine 
>2,000,000 
309 MMA (90%) GMA (10%) DnHA (>1%) 
Amine 
1900000 
394 EMA (70%) DMAEMA 
(30%) Amine 
- 120000 
396 EMA (90%) DEAEA (10%) 
Amine 
- 123000 
427 MEMA (60%) DEAEA (10%) 
Amine 
BMA (30%) 111000 
461 MEMA (80%0 DEAEA (10%) 
Amine 
THFFMA (10%) 152000 





519 MEMA (60%) DEAEMA 
(10%) Amine 
St (30%) St 86600 
520 MEMA (60%) DEAEMA 
(30%) Amine 
St (10%) St 143000 
531 MEMA (55%) DEAEMA 
(45%) Amine 
- 141000 








Figure C4.11: Monomer Structures of Candidate Polymers 
Images depict the chemical structures of the monomer sub-units used to fabricate the polymers 













4.4. Characterising the Functional Effects of Culturing Ex Vivo 
TEC on Selected Polymers 
4.4.A. Experimental Design  
The data presented above identify a set of 12 polymers that bound TEC, iTEC and human 
TEC as well as or better than 0.1% gelatin that were screened from a library of 367 
candidates. These polymers therefore have potential for replacing gelatin and other animal 
derived ECMs, in TEC culture protocols. Next it was interesting to test whether these 
polymers identified above affected the behaviour of the cells bound as described into the 
introduction of this chapter. 
Glass bottom 384-well plates were coated with candidate polymers as previously described. 
Matrigel was included in the screen as an addition control, representing a heterogeneous 
native ECM matrix. Note that in this experiment, 0.1% gelatin represents the negative control 
as it is known that TEC downregulate Foxn1 in monolayer cultures in when plated on gelatin 
(Anderson and Jenkinson, 2007; Mohtashami and Zúñiga-Pflücker, 2006). 
E12.5 and E13.5 tissue was dissected and dissociated, to obtain sufficient numbers to seed 
each well with cells. The cell count was used to standardise conditions with the aim 
of minimising variability, since seeding density often affects cellular behaviour in culture. 
Given the relative high proportion of TEC to other cells within the thymic rudiment at these 
developmental ages, a cell count was assumed to reasonably capture information regarding 
total input TEC into each well (Hirakawa et al., 2018). However, it should be noted that the 
seeding population was a heterogenous mixture of TEC, mesenchymal cells and early 
haematopoietic colonising cells (Itoi et al., 2001). The decision not to sort the samples using 
FACS was justified because of the importance of the crosstalk during thymic organogenesis. 
It was assumed if all cell types within the thymus were seeded into the monolayer, crosstalk 
would make ex vivo TEC more likely to recapitulate native behaviour and maintain Foxn1 
expression. The mating strategy used to obtain embryos for microdissection was to 
backcross heterozygous Foxn1G/+ to C57BL/6 mice, since Foxn1G is a null allele. Therefore, 
only half of the cultured TEC had the capacity to express GFP (Figure C4.12A). However, 
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this was reasoned to not affect the readout based on the assumption that downregulation of 
Foxn1 was relatively consistent between all TEC within a well. Furthermore, a no staining 
control was not required for the experiment as the wild type TEC in each well fulfilled this 
control. 
After seeding, the plates were imaged in brightfield and for GFP after 2, 24 and 48 hours 
(Figure C4.12B). ImageJ was used to automatically threshold the GFP image set to ‘Rényi 
entropy’ mode, which segmented out objects brighter than the background using a single 
colour histogram (Kapur et al., 1985). The number of segmented objects were then filtered 
according to size and shape and this provided the number of GFP+ TEC at each time point. 
The inclusion of dividing cells produced inconsistencies and therefore these cells were 
excluded from the cell count (Figure C4.12C).  
Using only one colour for image segmentation was not ideal, as both selecting on the target 
population and quantifying fluorescence intensity had to be performed using one histogram. 
The total level of GFP could not accurately be measured down to zero, as GFP expression 
was used to select on cells and so cells without Foxn1 expression could not be measured. 
This bias toward reporting false positive cells was further aggravated by the premise of 
segmenting cells using ‘Rényi entropy’ (Kapur et al., 1985). The mode actively looks for 
outliers by taking the upper proportion of the histogram as positive i.e. this mode will always 
find positive pixels based upon deviation away from the mean. In turn, this complicated direct 
testing of the null hypothesis that the fluorescence intensity of GFP, and therefore Foxn1 
expression, did not decrease over time. To test this hypothesis more rigorously, a dual 
reporter mouse would be required, such that one colour could be used to identify TEC and 
one to quantify Foxn1 expression. This could have been achieved by using a triple 
transgenic mouse line in which a fluorescent reporter was expressed under the Foxn1 
promoter, Cre was knocked into the Foxn1 locus, and an inducible fluorescent reporter was 





























































































































































































































































































































































































The number of GFP+ TEC was recorded at each time point across three independent 
experiments (Figure C4.13). Given that there were two independent factors, which were 
polymer condition and time, associated Foxn1 maintenance, and that time is a continuous 
variable, a second order polynomial (quadratic) regression was employed to calculate a 
curve of best fit and confidence intervals for all three replicates, in all polymer conditions and 
at all three time points.  
The number of GFP+ TEC decreased over time in all polymer conditions and there was a 
degree of variation between the biological replicates in the experiment. The variation 
between biological replicates can be represented by the R2 of the quadratic regression and 
denotes how well the regression curve fits the three data sets simultaneously. Hypothetically, 
if the data from all three experimental replicates were the same, R2 would equal 1. Similarly, 
to the focused arrays, there were two probable sources of variation: biological differences 
between TEC within wells and differences in starting cell densities. The latter was 
normalised for by reporting the cell count as a percentage of the initial cell count, as this 




This normalisation also created the assumption that the two-hour point must equal one, so a 
parameter constraint was included in the regression to enforce that B0 = 1. This raised the 
mean R2 of the regression from 0.42852 to 0.74846. The null hypothesis that the quadratic 
regression was not statistically different from  was rejected (Figure C4.14). The 
number of TEC expressing detectable GFP decreased over time. This inference was used to 
conclude that Foxn1 was downregulated over time on all substrates.  
The other source of variation within this experiment was biological. This might result from 
using undefined culture medium containing fetal calf serum. The experiment was therefore 
repeated in serum-free N2B27 medium supplemented with BMP4, FGF7 and EGF (Figure 
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C4.15), since these conditions were previously shown to support growth of TEC in vitro (this 
laboratory, unpublished). BMP4 and FGF7 are implicated in thymic organogenesis and have 
also been used in a directed differentiation process to create TEC from human pluripotent 
stem cells (Farley, 2010; Jenkinson et al., 2007; Su et al., 2015; Swann et al., 2017a).  
After following the same normalisation strategy to remove variation in the initial seeding 
density, the defined medium increased the average R2 of the regression curves to 0.92662. 
The high value shows that the data points across all three independent experiments were 
regressed into similar curves of best fit for each polymer condition, as described above if all 
three curves of best fit were identical the hypothetical R2 would equal 1, this can be used to 
infer that there was little technical variation between experiments and differences found in 
the study were due to the changes measured independent variables (polymer condition and 
time). The increase between the R2 found in the experiment using serum compared to this 
serum free experiment shows that serum was introducing variation into the results. Again, 
the null hypothesis that number of detectable GFP+ TEC did not change over time (and that 
the regression curves were not different from  was rejected (Figure C3.16). 
Thus, culture on none of the eight candidate polymers tested met Objective A, as Foxn1 was 
not maintained in any of these culture conditions.  
Given that ex vivo TEC were unable to maintain Foxn1, it was assumed that they will not be 
able to meet the second objective of this chapter, which was to mediate T-cell differentiation 
(Mohtashami and Zúñiga-Pflücker, 2006). No further testing of the effect of the polymers on 
TEC functionality was performed, given the technical limitation of polymers currently only 
being compatible with monolayer culture conditions. Therefore, this chapter identified eight 
defined polyacrylate substrates that allowed culture of ex vivo TEC and maintained Foxn1 
expression to the same extent as currently existing technologies. Now I wanted to 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.5. Determination of Whether Select Polymers Improved the 
Ability of iTEC to Mediate T-cell Differentiation Compared to 
Standard Culture Methods  
4.5.A. Experimental Design 
To investigate the effects of culture with the selected polymers on iTEC behaviour, I tested 
the second objective: investigation of whether culture on any of the polymers selected for 
iTEC culture resulted in an improved ability to mediate T-cell differentiation compared to 
standard culture methods. The first objective, that polymers were able to maintain Foxn1 
during culture was redundant in the iTEC system because Foxn1 is genetically enforced 
through the reprogramming method.  
To allow collection of enough thymocytes for flow cytometric analysis, these experiments 
were conducted in 24-well plates. The larger surface area of these wells necessitated a 
different coating strategy. 500 μl of 0.2 g / ml polymer solution was applied to each well on 
an orbital shaker and left to airdry. Agitation ensured that the centre of each well did not dry 
before the outer edge of the well, which would create a nonuniform coating of polymer. 
Gelatin (0.1%) was used as a positive control substrate given that it was used in the original 
publication of iTEC (Bredenkamp et al., 2014). Matrigel was also included as a control as 
this is a heterogeneous ECM-based substrate. Note that unlike previous experiments, Cre 
only MEFs were not included as a negative control as all polymers except 287 did not bind 
MEFs in the microarray.  
In each well,  iTEC were co-cultured with ETPs in iTEC medium 
supplemented with 50 ng / ml FGF-7, 5 ng / ml FLT3L, 10 ng / ml IL-7, 25 ng / ml KITL. 50% 
of the medium was replaced on day two or three and then, for all subsequent media changes 
that occurred every other day, IL-7 was reduced to 1 ng/ ml and KITL to 5 ng / ml. Of note is 
that in these experiments, ETP were isolated from the thymus of a four-week old female 
mouse and before isolation using FACS were enriched for c-KIT using magnetic beads to 
reduce the length of the FACs sorting session. ETPs were defined as: CD45+CD44+c-
Kit+CD25-CD3-CD4-CD8-CD11b-CD11c-B220-Gr-1-Nk1.1-Ter119- (Figure C4.17). 
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Ckit Expression   
Figure C4.17: Sorting Strategy for c-KIT Enriched ETPs
Strategy for isolating ETPs after magnetic enrichment for c-Kit. The title of each plot shows 
which gate is active. c-Kit expression is shown on live, CD45 population as a flame UTI to justify 
the DN1 gate. The lineage cocktail was: CD3 , CD4, CD8, CD11b, CD11b, Gr-1, Nk1.1, Ter119.    
Expression
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4.5.B. Results of Thymocyte Subset Analysis 
After 14 days, the cells were separated using trituration, creating a single cell suspension of 
thymocytes and leaving the monolayer of iTEC in the well and the two cell types were 
subjected to different analyses. The changes to the iTEC were measured using reverse 
transcription-quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry, 
while progression of the thymocytes through thymopoiesis was quantified using flow 
cytometry. The absolute numbers of CD4+CD8+ (DP), CD4+CD8- (SP4), CD4-CD8+ (SP8) 
and TCRβ+CD3ε+ (T-cells) thymocytes from each well were counted using a standardised 
gating strategy (Figure C4.18). Note, that only 75% of each sample was collected so the 
absolute count had to be corrected for this. The data were collected and analysed without 
further normalisation; representative plots are shown in Figures C4.19-29; the mean cell 
counts are displayed in Table C4.4 and this is broken down into each experiment in Tables 
C4.5, C4.6 and C4.7. The mean proportions are presented in Tables C4.8 and the mean 
CoVs are shown in Table C4.9. The assumption used on previous normalisation methods, 
that the positive control was consistent, was not satisfactory. In this screen 0.1% gelatin had 
a higher co-efficient of variation than average for each thymocyte subset (Table C4.9).  
Whether culture on any individual polymer resulted in improved iTEC functionality compared 
to culture on 0.1% gelatin was determined using a one-way ANOVA. Data were tested for 
normality using the Shapiro-Wilk test. Note that the Total T-cell count data failed this test and 
were analysed with the non-parametric Kruskal-Wallis test. The null hypothesis was 
accepted. No polymer condition was found to produce a significantly different number of 
thymocytes compared to 0.1% gelatin (Figure C4.30). However, the ANOVA was associated 
with an average R2 of 0.338875. This is low and describes that most of the variance within 
the experiment was not captured within the analysis and arose from unmeasured sources of 
variation. This is probably due to technical variability in both the iTEC and co-culture 
methodologies and this ‘noise’ prevent resolution of the biological effect found between 
polymer conditions (Table C4.9). The variation between wells is shown in Figure C4.31. It is 
notable to highlight in this figure that there was no distinct pattern that could be used to 
normalise the data.  
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Overall, it was concluded that due to the large variation associated with the iTEC system in 
monolayer co-cultures it was impossible to find a significant effect between iTEC across 
polymer conditions. However, polymers 396 and 427 and, to a lesser extent, polymer 509 
warranted further investigation and provided evidence that the overarching hypothesis of this 
chapter (outlined in Chapter One) was true, defined polymers were able to reduce variation 
in iTEC. Next, I characterised the direct changes in the iTEC of the co-culture. 
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Figure C4.18: Method for iTEC Functionality Polymer Array
A. Representation of iTEC Functionality Array. B. Bright field image of iTEC and adult ETP co-
culture after 14 days on 0.1% Gelatin. C. Gating strategy, demonstrated using thymocytes 
isolated from a four-week old thymus, to count cell numbers of T-cells and subsequent













Figure C4.19: iTEC Functionality Polymer Array Representative Plots - Glass 
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.20: iTEC Functionality Polymer Array Representative Plots - 0.1% 
Gelatin
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.21: iTEC Functionality Polymer Array Representative Plots - Matrigel 
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.22: iTEC Functionality Polymer Array Representative Plots - 
Polymer 563
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.23: iTEC Functionality Polymer Array Representative Plots - 
Polymer 520
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.24: iTEC Functionality Polymer Array Representative Plots - 
Polymer 519
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.25: iTEC Functionality Polymer Array Representative Plots - 
Polymer 509
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.26: iTEC Functionality Polymer Array Representative Plots - 
Polymer 427
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.27: iTEC Functionality Polymer Array Representative Plots - 
Polymer 396
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.28: iTEC Functionality Polymer Array Representative Plots - 
Polymer 287
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 
Lineage cocktail included: CD11b, CD11c, Gr-1,Nk1.1, B220, EpCAM, Ter119.
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Figure C4.29: iTEC Functionality Polymer Array Representative Plots - 
Polymer 111
Flow cytometric profile of a representative replicate in the iTEC Functionality Polymer Array. 

























































































































































































































































































































Table C4.4: Mean Total Thymocyte Counts from iTEC Functionality Polymer Array. 
Table shows the mean counts of each thymocyte subset found in each polymer condition.  
Polymer T-cells SP4  DP SP8  DN  
Matrigel 168.7 42.56 89.56 132.7 4481 
Glass 432 176.9 241.7 359.1 11109 
0.1% gelatin 731.1 204.7 385.6 388.8 8306 
563 128.3 61.22 78 73.11 5345 
520 40.89 9.667 4.333 7.111 3800 
519 102.1 34.56 58.89 63.67 4160 
509 226.2 115.6 808.7 316 6783 
427 712.9 273.3 499.9 507.6 15749 
396 574.4 345.6 528 350.6 17107 
287 29.19 7.222 5.222 17.44 1917 
111 125.3 46.44 58.78 104.8 5114 
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Table C4.5: Thymocyte Counts from iTEC Functionality Polymer Array Experiment A. 
Table shows the mean counts of each thymocyte subset found in each polymer condition in 
Experiment A.  
Polymer T-cells SP4 DP SP8 DN  
Matrigel 69 56 16 389 18404 
Matrigel 202.6666666 62 99 203 3720 
Matrigel 408 48 63 53 4648 
0.1% gelatin 107 7 16 64 1061 
0.1% gelatin 103 67 247 242 3770 
0.1% gelatin 331 12 46 21 1435 
Glass 88 18 1 41 5913 
Glass 175 11 11 32 7187 
Glass 25 95 86 232 8816 
563 120 29 7 30 6452 
563 5 0 0 1 4131 
563 27 3 0 15 1791 
520 5 5 3 8 911 
520 27 14 24 23 24349 
520 139 6 0 0 4477 
519 32 84 253 313 8989 
519 468 117 115 185 16763 
519 408 4 5 10 6018 
509 36 12 2 7 4232 
509 167 35 14 46 15907 
509 33 6 2 0 2453 
427 36 41 45 31 5070 
427 671 168 172 363 37508 
427 3420 1039 2390 1966 46958 
396 1527 1171 2661 1118 37261 
396 120 48 38 53 13025 
396 1019 205 214 153 18314 
287 15 5 0 4 6279 
287 3 1 0 2 2780 
287 11 1 0 0 2255 
111 31 73 72 175 19143 
111 143 19 9 15 9276 
111 200 23 7 12 3508 
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Table C4.6: Thymocyte Counts from iTEC Functionality Polymer Array Experiment B. 
Table shows the mean counts of each thymocyte subset found in each polymer condition in 
Experiment B.  
Polymer T-cells SP4 DP SP8  DN  
Matrigel 104 45 80 74 4908 
Matrigel 192 127 542 395 5320 
Matrigel 11 17 2 6 2176 
0.1% gelatin 503 345 377 887 34209 
0.1% gelatin 757 736 1111 839 26096 
0.1% gelatin 313 288 572 1120 15363 
Glass 381 88 97 306 16179 
Glass 2419 1290 2789 2447 37691 
Glass 179 163 266 303 10284 
563 32 92 73 168 10078 
563 105 408 620 421 19869 
563 379 6 0 1 4292 
520 1 5 2 2 765 
520 17 22 2 2 762 
520 36 28 7 11 2326 
519 15 9 0 6 646 
519 1 77 148 47 3137 
519 19 14 9 3 1466 
509 9 157 273 332 10583 
509 139 38 14 51 8563 
509 32 779 6968 2391 17861 
427 789 651 1131 1720 19420 
427 1761 231 37 233 14869 
427 163 212 562 181 12279 
396 284 1018 1559 1313 39232 
396 860 236 126 329 26739 
396 135 412 151 150 17638 
287 168 4 1 8 555 
287 5 8 43 108 1186 
287 43 12 3 15 1968 
111 16 258 427 703 9997 
111 493 30 14 23 1621 
111 4 9 0 5 1526 
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Table C4.7: Thymocyte Counts from iTEC Functionality Polymer Array Experiment C. 
Table shows the mean counts of each thymocyte subset found in each polymer condition in 
Experiment C.  
Polymer T-cells SP4 DP SP8  DN  
Matrigel 91 45 80 74 4908 
Matrigel 78 127 542 395 5320 
Matrigel 55 17 2 6 2176 
0.1% gelatin 48 345 377 887 34209 
0.1% gelatin 47 736 1111 839 26096 
0.1% gelatin 81 288 572 1120 15363 
Glass 28 88 97 306 16179 
Glass 24 1290 2789 2447 37691 
Glass 63 163 266 303 10284 
563 53 92 73 168 10078 
563 25 408 620 421 19869 
563 8 6 0 1 4292 
520 79 5 2 2 765 
520 8 22 2 2 762 
520 51 28 7 11 2326 
519 12 9 0 6 646 
519 13 77 148 47 3137 
519 15 14 9 3 1466 
509 9 157 273 332 10583 
509 11 38 14 51 8563 
509 35 779 6968 2391 17861 
427 129 651 1131 1720 19420 
427 141 231 37 233 14869 
427 216 212 562 181 12279 
396 39 1018 1559 1313 39232 
396 35 236 126 329 26739 
396 144 412 151 150 17638 
287 13 4 1 8 555 
287 72 8 43 108 1186 
287 27 12 3 15 1968 
111 13 258 427 703 9997 
111 19 30 14 23 1621 
111 0 9 0 5 1526 
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Table C4.8: Mean Thymocyte Proportions (%) Gated from Live, Lineage-. 
Table shows the mean proportion of CD4 and CD8 thymocyte subsets gated from the total 
T-cells population
Polymer SP4 DP SP8  DN  
Matrigel 1.68 1.66 3.44 93.2 
Glass 1.92 1.2 2.69 94.19 
0.1% gelatin 2.12 2.20 3.28 92.38 
563 0.7 0.49 1.31 97.46 
520 1.066 0.16 1.51 97.25 
519 1.25 0.92 1.36 96.46 
509 0.89 3.1 1.80 94.12 
427 2.13 4.09 2.57 91.2 
396 1.37 1.51 2.10 95 
287 0.88 0.39 2.11 96.61 
111 0.89 0.58 1.47 97.06 
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Table C4.9: Coefficient of Variations (CoV) in the iTEC Functionality Array. 
Table shows the CoV associated with each mean calculated between the three 
independent experiments of the iTEC functionally array 
Polymer T-cells SP4 DP SP8 T-cells Average  
Matrigel 52.09% 68.21% 119.00% 73.66% 78.24% 
Glass 121.90% 136.80% 159.60% 142.60% 140.23% 
0.1% gelatin 158.70% 131.20% 150.00% 140.60% 145.13% 
563 110.80% 152.10% 169.90% 146.50% 144.83% 
520 21.41% 83.62% 100.90% 39.87% 61.45% 
519 133.20% 96.03% 106.00% 144.30% 119.88% 
509 126.60% 156.80% 172.40% 166.80% 155.65% 
427 72.45% 74.73% 82.60% 82.73% 78.13% 
396 74.65% 85.73% 92.88% 86.31% 84.89% 
287 66.49% 63.00% 173.20% 130.90% 108.40% 
111 92.09% 105.50% 132.40% 118.80% 112.20% 
Average 93.67% 104.88% 132.63% 115.73% 
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4.5.C. Results of RT-qPCR on the iTEC Monolayers 
4.5.C.I. Justification of Selection of Target Genes 
I next set out to observe what effects, if any, resulted from culturing iTEC on selected 
polymers compared to on gelatin, by measuring changes in expression of key functional 
genes. Once thymocytes were removed from the underlying iTEC monolayer, two technical 
replicates were fixed for immunohistochemistry and one was lysed for mRNA preparation 
(Figure C4.32A). This approach allowed me to gain greater understanding of the iTEC 
cultured on the polymers, at the cost of increasing the probability that the variation in iTEC 
across all three technical replicates was not represented in the mRNA analysis. Furthermore, 
by relying upon a simple, physical method of separating the two cellular components, there 
was a risk that some remaining thymocytes would contaminate the iTEC mRNA. 
 To observe whether culturing iTEC on polymers affected gene expression, mRNA collected 
from each polymer condition was compared to mRNA isolated from  iTEC directly 
after purification of GFP+ reprogrammed cells by FACS. This was termed time zero (t0), since 
these iTEC were from the same pool as the iTEC seeded onto the polymers.  
For a positive control, mRNA was isolated for 50 E13.5 ex vivo TEPC (Thymic Epithelial 
Progenitor Cells) defined as EpCAM+PLET1+. Note that given the scarcity of TEPC, a small 
cell population mRNA isolation and amplification method was used (CellsDirect Invitrogen). 
Whilst being a valid method of collecting mRNA, the increased amplification necessitated by 
this process is a confounding variable when comparing the gene expression of TEPC to the 
remaining conditions, which was isolated using methods suitable for larger populations 
(RNAEasy Invitrogen), so care was taken before making this comparison.  
mRNA from Cre only MEFs was isolated as a negative control for the iFoxn1 transgene 
independently to the iTEC Functionality Polymer Array. Whilst it could be argued that this 
represents a weak control, the hypothesis that the iFoxn1 transgene reprograms MEFs into 
iTEC was rigorously tested in Chapter Three and this control is reinforced by previous 
conclusions. Additionally, one Cre Only MEF mRNA preparation failed, so this condition is 
only represented with two data points.  
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For this analysis, the gene panel analysed in Chapter Three was extended to 13 genes, plus 
housekeepers. The genes were chosen based upon cortical thymic function, with the 
exception of Aire which is an mTEC marker (Lopes et al., 2015): Endogenous Foxn1, Total 
Foxn1, Dll4, Il-7 and Psmb11 were included for the reasons justified in Chapter Three. The 
genes encoding the chemokines Ccl25 and Cxcl12 were included given their role in thymic 
trafficking and thymocyte immigration (Calderón and Boehm, 2011; Liu et al., 2006; Misslitz 
et al., 2004; Schwarz et al., 2007; Sultana et al., 2012; Zlotoff et al., 2010); The genes 
encoding the cytokines Kitl and Flt3l were also analysed given the role they play promoting 
thymocyte proliferation at various stages of thymopoiesis (Kenins et al., 2010; Rodewald et 
al., 1995); the Notch ligand Dll1 was included given its ability to mediate in vitro T-cell 
commitment in the OP9-DLL1 and MS5-hDLL1 systems despite its redundancy in the native 
thymus (Koch et al., 2008; Schmitt and Zúñiga-Pflücker, 2002; Seet et al., 2017); Finally, 
Ctsl1 and MHC2Eβ2 (was taken as representative for the expression of the entire MHC2) 
were measured given their role in peptide processing and presentation for SP4 thymocytes 
(Takada et al., 2017). This analysis was conducted concurrently with the screen described 
above, which tested the capacity of iTEC to support T cell development when cultured on the 
polymers in serum-containing medium. 
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Figure C4.32: Gene Expression Profiles of iTEC Cultured on Polymers
A. Schematic of post-co-culture analysis. Haematopoietic cells were removed using tituration 
leaving the iTEC adhered to the well. In each biological replicate, one well was used for RT-qPCR 
and two were taken for immunohistochemistry. B. Gene expression profile of iTEC after 14 day co-
culture. Ct values between 25 and 36 were accepted for iTEC mRNA while Ct values between 16 
and 24 were observed for TEPC and MEF . Some conditions failed so Endogenous Foxn1: 
Matrigel and Polymer 396 have two data points and Cxcl12: CreERt2 MEF only has one. Each 
gene was analysed for significant difference between means. * denotes significance.
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4.5.C.II. Results  
The expression levels for each of the genes tested are shown in Figure C4.32B and were 
compared using one-way ANOVA. Normality was tested for using the Shapiro-Wilk test and 
all data sets were found to be normally distributed, except for Dll4, Dll1, Endogenous Foxn1, 
Aire, Il7, MHC2Eβ2. The Brown-Forsythe test found all data had homogeneous variances 
except for Cxcl12 and these data were analysed using a Kruskal-Wallis test and Brown-
Forsythe corrected ANOVAs, respectively. 
In most conditions there was no significant difference between the gene expression profiles 
of iTEC cultured on the various polymers. The null hypothesis that polymers did not affect 
gene expression over time, which was tested by comparison with all post-co-culture 
conditions with t0 iTEC, and across polymer groups was accepted. However, it is worth 
highlighting the exceptions. Firstly, comparison between t0 and iTEC cultured on polymer 
396, 520 and 563 showed a significant reduction in total Foxn1 expression over time. 
Whether this is a biological effect and iTEC are epigenetically downregulating transgenic 
Foxn1 or this is a result of incomplete separation of iTEC from thymocytes and dilution of 
iTEC mRNA is unclear. However, this is evidence that an initial assumption of this chapter, 
that culture conditions will not affect iTEC expression of Foxn1 because it is genetically 
enforced, may be untrue.  
Secondly, iTEC cultured on Matrigel had significantly greater expression of Ccl25 than on 
polymer 396 and at t0. Given the role of CCL25 in thymic homing, a redundant process in 
this system, the biological link between Matrigel, iTEC and CCL25 is not obvious. However, 
the fact that this was significant and others not, does highlight that other conditions and 
genes contain much greater variation and this lack of precision maybe responsible for 
insignificance.  
MHC2Eβ2 was greatly upregulated in iTEC cultured on polymers 427 and 396 compared to 
other conditions. Although this effect did not reach statistical significance, as these data were 
variable and did not follow a normal distribution, the result warrants further investigation. 
Several conclusions can be drawn from the non-significant differences between data. All 
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polymers maintained a TEC-like profile retaining expression of most key genes through the 
co-culture, except for expression of Il-7 that remained poorly expressed compared to E13.5 
TEPC. There was no detectable Aire expression in any iTEC condition, providing substantial 
evidence against Objective C. However, this warranted further investigation in case Aire 
expressing iTEC were too uncommon to be identified using analysis of bulk mRNA. 
4.5.D. Culture on the Selected Polymers Did Not Induce a Medullary 
Phenotype in iTEC  
4.5.D.I. Results 
The remaining two, fixed wells of iTEC stained for markers of mTEC. This was to test 
Objective C. iTEC were stained for expression of AIRE, the major regulator of promiscuous 
gene expression in mTEC; cytokeratin 14 (K14), which marks mTEC from early 
organogenesis onwards and ulex europaeus agglutinin I (UEA1), which binds glycoproteins 
and/or glycolipids on the surface of mTEC but not cTEC (Klug et al., 2002; Kyewski and 
Peterson, 2010). Each polymer condition had a pair of wells, one was used for the 
experimental stain and the other an isotype control (Figure C4.33A). Both were imaged and 
the true staining was calculated by subtracting the isotype control staining profile from the 
biological staining sample (Figure C4.33B). The staining pattern of AIRE is very specific, so 
a qualitative assay was used, since designing an automatic pipeline to segment such 
staining would be challenging and prone to error (Figure C4.33C).  
Only a few iTEC displayed the K14 and UEA1 double staining pattern indicative of mTEC, 
and there was no evidence of AIRE expression, in agreement with previous mRNA analysis 
(Figures C4.32 and C4.33B). Despite the qualitative nature of the readout, it was concluded 
that polymers did not efficiently stimulate iTEC differentiation into mTEC. 
Therefore, with respect to the aims of this chapter, there was evidence that iTEC 
downregulated transgenic Foxn1 expression during culture on the polymers. This may be 
significant, given the clinical aim of iTEC to be used as a source of tissue for transplantation, 
if iTEC were to downregulate expression of key FOXN1 targets it would likely compromise 
the function of transplanted material after extended periods. We also cannot conclude that 
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polymers had a significant effect on the ability of iTEC to mediate T-cell differentiation but 
427, 396 and 509 had promise and warrant further investigation in a more precise 
experimental design. However, it is not inconsequential to have identified synthetic, defined 
conditions that supports iTEC functionality and reduced variation (Table C4.9), particularly 
given the main objective to reduce variation in the system. Finally, there was no evidence 
that polymers stimulated iTEC to adopt a functional mTEC phenotype with evidence of 
promiscuous gene expression. I next wanted to design an experiment that would support the 
mRNA analysis suggesting that culture on polymers 427 and 396 either stimulated iTEC to 
upregulate MHC2Eβ2 or selected cells with greater expression.  
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Figure C4.33: Polymers Did Not Promote iTEC Medullary Differentiation
A. After the co-culture hematopoietic cells were removed using tituration and iTEC were stained for 
key markers of medullary TEC: K14, UEA1 and Aire. In each independent experiment a control, 
isotype well (right) was performed concurrently to the experimental well (left). The image of 
polymer 427 was representative of all conditions. B. ROI showing stained iTEC in greater detail. C. 




















4.6. iTEC cultured on Polymer 427 Did not Upregulate MHC2 
4.6.A. Method  
To further investigate the result that iTEC showed greater expression of MHC2 when 
cultured on polymers 396 and 427 (Figure C4.32B) than on gelatin, albeit not at statistical 
significance, a 24-well plate was coated with polymer 427, 0.1% gelatin or Matrigel in 
triplicate. This was designed to be smaller in scale as using a more limited selection of 
conditions allowed more intensive analysis of each. Polymer 427 was selected over polymer 
396 because both conditions produced the described upregulation of MHC2 but polymer 427 
performed more robustly during the iTEC functionality polymer array. iTEC were seeded with 
adult ETPs, in the same co-culture procedure described in the iTEC Functionality Polymer 
Array. After 14-days the thymocytes were removed by trituration and the underlying iTEC 
monolayer fixed and stained for β5t, MHC2 and with cell mask blue (Molecular Probes) 
(Figure C4.34). Without β5t and MHC2, iTEC cannot process and present peptides for 
positive selection in a physiologically relevant fashion (Takada et al., 2017). 
Given that there was no evidence that iTEC were able to differentiate into K14+UEA1+AIRE+ 
mTEC-like cells, β5t was used in the segmentation strategy to focus on cTEC-like cells. Note 
that, as depicted in the segmentation strategy, the iTEC monolayer was contaminated with 
much smaller cells expressing MHC2. Many of these cells were removed by selecting on 
β5t+ iTEC. However, this strategy was not completely effective. If polymers 427 and 396 
were more conducive to the binding of these cells in the monolayer this effect probably 
contributed to the upregulation found by RT-qPCR. The nature of these cells was not defined 
and remains speculative, but they could represent either dendritic cells or iTEC that are 
differentiating into mTEC-like cells with the characteristic smaller morphology (Hirakawa et 
al., 2018).  
Multiple micrographs, 70 per well, were images and segmented to establish the total number 
of cells, based on the assumption that each cell contained one nucleus. Cell mask blue, 
which binds brightly to the nucleus of cells and dimly to the cytoplasm, was employed to 
assist with the automated segmentation. This was found to be effective at segmenting most 
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cells but performed poorly on unusually large iTEC, which were incorrectly split into 
segments. This is because large nuclei contained a heterogenous spread of chromatin for 
the dye to bind too and consequently the varying brightness prevented correct segmentation. 
To count the number of iTEC from the number of cells, those that expressed β5t to a greater 
extent than the background were selected on and then the MFI of MHC2 within these cells 













































































































































































































The data were analysed using a one-way ANOVA after normality and homogeneity of 
variance was confirmed. There was a large amount of variation found between biological 
replicates (Figures C4.35A and B). Following the same syllogism as previous experiments 
this was probably due to two factors. The first is the biologically differences between iTEC 
and the second is technical noise from inaccurate cell counting. Again, the latter was 
normalised by reporting the cell counts in proportion to a control. In this case, the Matrigel 
condition was used. It could be argued that given the heterogenous nature of Matrigel, this 
was a poor choice. However, the normalisation was satisfactory. Matrigel was associated 
with lower CoV than 0.1% gelatin. In the total cells data, Matrigel was associated with a CoV 
of 30.75% compared to 46.65% in 0.1% Gelatin (Figure C4.35C and D). The normalisation 
was performed as: 
Equation C4.5: 
 .  
Ultimately this reduced the total mean CoV in the total cell count from 44.38% to 15.91% and 
increased the R2 associated with the statistical inferences quantifying total cell number from 
0.1615 to 0.6045 and total iTEC number from 0.3498 to 0.8644. There was no significant 
difference in the total number of cells, the total number of iTEC, the percentage of cells that 
expressed β5t or the MFI of β5t or MHC2 between polymer 427 and 0.1% gelatin. The null 
hypothesis was accepted: iTEC co-cultured with adult ETPs on polymer 427 had similar 
levels of MHC2 as those on and 0.1% gelatin. The CoV in the percentage of β5t expressing 
cells was dramatically larger in the polymer 427 (30.9%) condition, than 0.1% gelatin 
(6.562%) and Matrigel (4.516%) but this difference was found to be statistically insignificant 

































































































































































































































































4.7.A. Summary of Experimental Results 
Strikingly, this chapter observed that iTEC and ex vivo TEC share a similar adhesion profile, 
which was shown by the similar preferences the cell types shared for the polymers. I then 
characterised the effect culturing both cell types on the polymers and showed that ex vivo 
TEC were unable to maintain Foxn1 in this system, despite using a serum-free medium that 
was supplemented with relevant cytokines. When I examined how culturing iTEC on the 
polymers effected its ability to facilitate T-cell differentiation, I found that polymer 427 and 
396 were strong candidates to reduce the variation of the co-cultures but also to improve the 
numbers of thymocytes produced by iTEC, although this did not produce significance. The 
reasons why this did not produce significance will frame an evaluation of the experimental 
design, before elucidating the likely mechanism of action the polymers effect and finally how 
to use this insight to design future experiments.   
4.7.B. Variation in Monolayer Co-Culture Conditions 
4.7.B.I. Potential Sources of Variation  
There was a large amount of variation in the iTEC functionality array that arose from 
unmeasured independent variables. The ANOVA analysis that aimed to compare how the 
polymer affected the ability of iTEC to mediate thymopoiesis returned an R2 of 0.338875, 
which is low and implies most of the variation did not originate from polymer condition. There 
are two main sources of variation that were not measured in this study. First, the biological 
variation within the input cell populations; and secondly, the variation in co-culture 
mechanics between wells.  
4.7.B.II. Variable input populations 
There were two cell types in the co-culture: iTEC and ETPs. iTEC must be considered a 
heterogeneous population. Evidence for this was presented in Chapter Three, iTEC-based 
Reaggregate Thymic Culture produced large variations in the number of thymocytes 
generated both inside and between batches of iTEC. If polymer condition only contributed a 
small difference in the ability of iTEC to mediate T-cell differentiation, it may be difficult to 
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detect. Furthermore, ETPs will also contain variation, although this was assumed to be much 
milder than the iTEC population, it is plausible that using 500 cells was insufficient to capture 
this total variance with a normal distribution. As a result, some wells may have had different 
starting thymocyte populations. The small initial starting population was justified by the 
relative rarity of the ETP population in the adult mouse, routinely only  ETPs were 
recoverable from a four-week old, female BL6/J mouse. It may be that the total variation in 
this study could be decreased by using a greater number of ETP and or a less mature cell 
population i.e. e.g. the Flk1+ subpopulation of ETP, or haematopoietic stem cells.  
4.7.B.III. Sampling Bias Across Time  
In the native thymus, thymocytes interact with many TEC as they migrate through the 
thymus, this process thought to be an essential part of thymopoiesis (Petrie and Zúñiga-
Pflücker, 2007). The density of cells is much greater in 3D structures, such a RTOC and the 
native thymus, than monolayers and this will reduce the number of thymocyte – iTEC 
interactions that can occur over time. Given the heterogeneity of the iTEC, it is likely that 
thymocytes in monolayers will not ‘sample’ the entire range of iTEC and as a result will 
behave differently. Comparison between the 3D culture methods used in Chapter Three and 
the monolayer co-culture employed here show a dramatically reduced efficiency of iTEC 
mediating the DN to DP transition, this could also be explained in the lower cell and Notch 
ligand density. It is notable to highlight here that the MS5-hDLL1 system was ineffective in a 
2D system and necessitated the Artificial Thymic Organoid system (Seet et al., 2017). 
Therefore, it is likely that monolayers are inherently more variable than their 3D equivalents. 
Increasing the number of cell-to-cell interactions that occur within a co-culture would mitigate 
ETP sampling bias and could be achieved by implementing a 3D environment.  
4.7.B.IV. Justification Not to Increase Power 
The probability of statistical inference producing a type 2 error, i.e. failing to reject the null 
hypothesis when the hypothesis is false, is dictated by the power (β) of a study. It is scientific 
convention to use α=0.05 and β=0.8. G*Power was used to perform the power calculations 
(Faul et al., 2007). Focusing on the number of TCRβ+CD3ε+ thymocytes: the weighted 
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average of SD was 311.62 and the total effect size of the readout was 0.816. There were 11 
groups with 33 total observations. The power of this experiment was 0.764, which was 
considered acceptable. A notable feature of this experiment was that most conditions had at 
least one technical replicate that produced no thymocytes. These were not excluded on 
technical grounds because the cells for all conditions were seeded from a shared pool. If at 
least one replicate was successful, then the experiment cannot be considered a technical 
failure. As a result, all conditions have at least one replicate with very low numbers of 
thymocytes causing the data to overlap. Further increasing β was likely to only find 
differences between very poorly performing polymers, such as polymer 520 and 287. Note, 
that completing one more biological replicate would increase the power to 0.93, which might 
be considered overpowered. Therefore, the inability to resolve differences was either due to 
the imprecision of the system or because polymers did not affect iTEC. 
4.7.C. Polymer Structure 
Each of the polymers was synthesised from two or three monomers, that each form a 
proportion of the total polymer (Table C4.3). Each monomer alters the physical and chemical 
properties of the polymer and affects its interaction with cells (Figure C4.11). Notable 
patterns emerged. Methoxyethyl methacrylate (MEMA) was the backbone in all polymers 
except for 394 and 396, which used EMA. All polymers had the presence of a monomer with 
an amine group, except for 509 that contained an amide. Interestingly, polymers with the 
same monomer but in different proportions scored differently. For example, polymer 394 
(70% EMA, 30% DMAEMA) was a hit on the focused array while polymer 395 (50% EMA, 
50% DMAEMA) was not successful on the initial microarray. Furthermore, a comparison 
between 394 and 396 (90% EMA, 10% DMEAEA) is interesting as the structure of the 
secondary monomers is similar yet 396 was successful across all tissues while 394 was 
specific to murine TEC. Whether this is due to human / mouse differences, inability of iTEC 
to recapitulate all elements of the TEC adhesion profile, differences in the relative embryonic 
maturity of the TEC, or a type 1 error is unanswerable. Ultimately, the properties required of 
a polymer to mediate cellular adhesion is a multifaceted process that required not only the 
presence of certain elements but also the presentation of these elements to the cell. An 
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interesting mechanism is that the charged polymers associate with specific proteins in the 
tissue culture medium, which acts as an intermediary between cells and the polymer. If this 
were proven correct, the synthetic polymers represent a unique method to establishing 
defined protein conditions for cell culture, this warrants further investigation. 
4.7.D. Mechanisms of Action 
There are two potential mechanisms that describe how polymers assert effects on cells. The 
first is that polymers selectively bind cells with a complementary adhesion profile. The 
second is that the polymers instruct the behaviours of bound cells (Duffy et al., 2014a, 
2014b; Hay et al., 2011). It can be assumed that the iTEC population is composed of a 
heterogenous population of cells with a spread of biological variance between two extremes: 
a TEC-like phenotype and a MEF-like phenotype, although this excludes the possibility of the 
reprogramming strategy inducing the phenotype of another cell lineage that expresses 
Foxn1. If it is assumed that a cell’s adhesion profile represents its phenotype, it can be 
postulated that culturing iTEC on polymers that bind the target TEC-like end of the range 
and, not the unwanted MEF-like end, will enrich the population towards more TEC-like iTEC. 
This is the selective binding mechanism. An alternative hypothesis is that synthetic polymers 
are instructive and can directly affect cellular behaviour. This notion is supported by previous 
research on synthetic polymers and is envisaged to work in a similar manner to ECM (Duffy 
et al., 2014a; Tourniaire et al., 2006). The ex vivo TEC bind to selected polymers because 
these recapitulated the signalling environment in the thymus. iTEC that bind to these 
polymers are receiving signals important to the behaviour of TEC, which will promote a TEC-
like phenotype. This is an instructive mechanism. 
4.7.D.I. Polymers Do Not Instruct TEC-Like Behaviour  
The data collected in this thesis show that the polymers did not instruct TEC-like behaviours. 
One of the hallmarks of thymic organogenesis is initiation of Foxn1; without Foxn1, mice 
develop the nude phenotype and loss of Foxn1 in TEC is a hallmark of thymic involution 
(O’Neill et al., 2016; Vaidya et al., 2016). Therefore, a potential minimum requirement of 
TEC-like behaviour is maintenance of Foxn1 expression. There can be one of two outcomes 
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when ex vivo TEC are cultured on the polymers: either TEC maintain expression of Foxn1 
and, therefore, polymers instruct behaviour that promotes a native TEC phenotype; or TEC 
do not maintain expression of Foxn1 and, therefore, polymers do not instruct such 
behaviour.  
Culture on the polymers did not maintain Foxn1 over time and therefore polymers did not 
instruct a TEC-like phenotype in the cells (Figure C4.13 and C4.15). There is also no 
evidence in the literature to suggest that ECM can maintain Foxn1 in culture, the prevailing 
hypothesis is that using a 3D architecture is the most important factor to maintain native TEC 
behaviour ex vivo. However, the exact mechanism linking 3D structure to Foxn1 is unclear 
but may reflect the presence of non-epithelial stromal cells, availability of growth factors or 
3D environmental interactions (Mohtashami and Zuniga-Pflucker, 2006). 
4.7.D.II. Polymers Selectively Bind iTEC with a TEC Adhesion Profile  
4.7.D.II.a. The Three Assumptions  
It was possible to test the selective binding mechanism because of the observation that iTEC 
interacted with the same synthetic polymers as ex vivo TEC (Table C4.2), and not with 
polymers successful for binding Cre only MEFs (Figure C4.2 and C4.3). A comparison 
between iTEC cultured on 0.1% gelatin and on polymers effectively equates to a comparison 
between the range of iTEC extremes, and iTEC selected to have a more TEC-like adhesion 
profile. The selective binding mechanism holds two assumptions:  
A. Isolation GFP+ MEFs does not completely remove all cells that have yet to adopt a 
TEC-like adhesion profile.  
B. The adhesion profile of iTEC is representative of its function.  
iTEC cultured on 0.1% gelatin and polymer 287 represent the conditions containing the full 
variation of iTEC, as these matrices bind both MEFs and iTEC (Figure C4.2 and C4.3). The 
remaining polymers were incapable to binding MEFs and may therefore selectively binding 
iTEC with a more TEC-like adhesion profile. iTEC cultured on polymers 111, 396, 427, 519 
bound to both human and murine TEC; 520 bound to human TEC only and 563 bound to 
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murine TEC only (Table C4.2). Therefore, compared to gelatin most polymers will also 
prevent iTEC with a MEF-like adhesion profile from entering the co-culture. This is a variable 
and can have potential effects:  
Ci. If fewer MEF-like iTEC in the co-culture positively impacts T-cell differentiation, then 
synthetic polymers will improve iTEC ability to mediate T-cell differentiation as an 
inhibitory factor, MEFs, is being removed. 
Cii. If fewer MEF-like iTEC in the co-culture does not affect T-cell differentiation, then 
synthetic polymers will not affect iTEC ability to mediate T-cell differentiation as 
MEFs are to the co-culture. 
Ciii. If fewer MEF-like iTEC in the co-culture negatively impacts T-cell differentiation, then 
synthetic polymers will reduce the ability of iTEC to mediate T-cell differentiation as 
MEFs contribute to the co-culture to a greater extent than iTEC. 
4.7.D.II.b. Selective Binding Did Not Affect iTEC Function  
Culturing iTEC upon polymers did not significantly affect ability to facilitate thymopoiesis 
(Figure C3.6). With respect to the prior assumptions we can now infer either:  
A. GFP isolation removed all cells that still had a MEF-like adhesion profile and this 
rendered the selective binding of polymers obsolete 
B. The adhesion profile of iTEC was not representative of its function so selectively 
binding those with a more TEC-like adhesion prolife did not affect the co-culture. 
C. Having MEF-like iTEC in the co-culture does not affect T-cell differentiation, as these 
cells are irrelevant to the co-culture. 
4.7.D.II.c. Is it Beneficial to Select Against MEFs? 
If assumption C is true and assumptions A and B are false, given that the polymers screened 
here are known to select against iTEC with a MEF-like adhesion profile, it is important to 
understand the potential effects MEFs would have in the co-culture system. It is well-
documented that MEFs are essential in RTOC experiments and using thymus-specific 
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mesenchyme provides further benefits (Anderson et al., 1998; Anderson and Jenkinson, 
2007). The mechanism by which mesenchymal cells create this effect is undefined but 
hypothesised to be via secreted factors (Jenkinson et al., 2007). Therefore, a potential 
confounding variable in the iTEC functionality polymer array is that removing more MEF-like 
iTEC, removes beneficial secreted factors from the co-culture and this effect acts against the 
benefits of selecting for more TEC-like iTEC. Including MEFs in co-cultures but separating 
them from the iTEC and ETPs with a trans-well would help to investigate this confounding 
variable. There is evidence against this theory, polymer 287 was unique in that it was a hit 
polymer on the microarray for both iTEC and MEFs and like gelatin, bound all iTEC. 
However, it represents one of the worst performing polymers in the experiment, although this 
effect was not significant and so no firm conclusions were drawn.  
4.7.D.II.d. Does Selective Binding Affect iTEC? 
If assumption C was false, then the selective binding properties of polymers may be obsolete 
because isolating GFP+ cells already removed all those cells with a more MEF-like adhesion 
profile or iTEC adhesion profile was irrelevant to function.  
4.7.E. Future Experiments 
4.7.E.I. Confirmation that Polymers Selectively Bind iTEC 
Future experimentation will aim to resolve these differences. Unsorted iFoxn1 MEFs, 4-days 
after exposure to 4OHT, will be seeded onto polymers to create the three following groups: 
substrates that select the entire range of variation in iTEC (0.1% gelatin and polymer 287), 
polymers that bind more TEC-like cells (polymers, 396, 427, and 563) and polymer 509, 
which binds iTEC but not ex vivo TEC. FACS isolated GFP+ iFoxn1 MEFs act as a positive 
control GFP+ iFoxn1 MEFs and as a negative control Cre only MEFs will be seeded onto 
0.1% gelatin.  
To test assumption A, after several hours, unbound cells will be collected, and bound cells 
fixed. If there are no differences within the groups, assumption A is true: the GFP isolation 
has rendered the selective binding of polymers obsolete. To test assumption B, a co-culture 
assay could be performed on the above groups. If there are no differences within the groups, 
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assumption B is true: the adhesion profile of iTEC is not representative of its function. To test 
assumption C, the same experiment will be repeated with MEFs contributing secreted factors 
to the experiment but physical isolated in a trans-well. If there are no differences between 
the groups, MEFs are not a contributing cofounding variable in the assay. 
If polymers are found to mediate selective binding, they can be an alternative to FACS, 
which is a costly and slow process that exposes cells to harsh conditions. Given that it is 
extremely probable that GFP- iFoxn1 MEFs will present a more MEF-like adhesion profile, 
the polymers represent a novel sorting strategy. It is plausible and testable that polymers can 
sort in place of FACS: seeding iFoxn1 MEFs on polymers will remove unsuccessfully 
reprogrammed MEFs. This method would dramatically increase the scale-up potential of the 
iTEC system. 
4.7.E.II. Observing Whether Polymers Affect Ex Vivo TEC Functionality  
Unfortunately, the fact that polymers did not maintain Foxn1 in ex vivo TEC made a direct 
comparison between TEC and iTEC impossible. TEC only maintain their phenotype in 3D 
techniques, such as RTOC, which is not compatible with the addition of the synthetic 
polymers tested herein (Anderson and Jenkinson, 2007). In order to make polymers 
compatible 3D techniques, they must be water-soluble. Designing shorter, hydrophilic 
polymers containing the monomer compositions observed to be preferable to TEC 
represents an interesting method to target cells. Whether the binding of water-soluble 
polymers will produce any functional changes in a TEC is challenging to predict, given the 
results of this chapter but represents a potentially novel pharmaceutical option targeting the 
cell – ECM interaction. Another alternative is to cross-link the polymers into a three-
dimensional structure (Duffy et al., 2014b; Zhang et al., 2013). However, given that non-
epithelial thymic stromal cells are beneficial for ex vivo thymic function, building such 
structures from polymers that actively select for TEC and potentially against the other 
stromal elements will share the disadvantages as highlighted by the exclusion of MEFs in 
iTEC Polymer Functionality Array. Note, that in the future the contribution of mesenchyme to 
these assays aims to be replaced, as previously discussed mesenchyme is hypothesised to 
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contribute to thymopiesis by secreting beneficial factors and once identified, these can be 
supplemented exogenously (Auerbach, 1960; Jenkinson et al., 2007).   
4.8. Conclusion 
In summary, this chapter identified 12 synthetic polymers that allowed the binding of TEC. 
These can be segmented into eight that allowed the binding of iTEC, eight for the binding of 
murine embryonic TEC and eight for human embryonic TEC. There was remarkable overlap 
in the polymers preferred by each cell type. These polymers were then tested against three 
objectives designed to parse thymic function into testable sections. Objective A investigated 
maintenance of Foxn1 expression; Objective B measured the ability to mediate T-cell 
differentiation and Objective C looked for evidence of promiscuous gene expression. These 
objectives were designed to be sequential. i.e. promiscuous gene expression is irrelevant if a 
system cannot mediate T-cell differentiation, which in turn is unlikely if a system cannot 
maintain Foxn1 expression.  
The polymers identified to bind ex vivo murine embryonic TEC were unable to maintain 
Foxn1. Arguably this was an unlikely objective for the polymers to meet, given the emphasis 
the literature has on the importance of 3D cell culture and on growth factor inputs to Foxn1 
expression (Mohtashami and Zúñiga-Pflücker, 2006). Given that polymers are currently only 
compatible with monolayer culture, this was the technical extent to which the polymers could 
be tested using ex vivo TEC; it would have been a waste of resources to continue testing 
Objective B. However, the polymers will be beneficial for screens that seek to identify factors 
that are able to maintain Foxn1 given that they performed as well-as 0.1% gelatin but will 
contribute less variation. 
The eight polymers selected by ability to bind iTEC were first tested for Objective B, because 
it was assumed that Foxn1 expression would not be affected by the polymers given that it is 
genetically enforced in iTEC, and were found to be able to mediate T-cell differentiation 
albeit inefficiently compared to the 3D culture methods discussed in Chapter Three. 
Ultimately, this chapter identified defined culture substrates that replicate the behaviour of 
iTEC on undefined matrices such as 0.1% gelatin and Matrigel. Whilst these results did not 
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generate significance, polymers were at least as effective as undefined matrix such as 
Matrigel and 0.1 % gelatin but had the benefit of being associated with less variation. The 
results of this were difficult to resolve from technical noise and this chapter discussed short 
comings of using 2D culture techniques for these screening experiments, which ultimately 
contributed to the high variation found in the co-culture assays. Therefore, it opens an 
interesting technical niche of developing a 3D culture system that, unlike RTOC, can be 
performed in higher throughputs with lower variation.  
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5. Chapter Five: Designing a Miniaturised 
Reaggregate Thymic Organ Culture System 
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5.1. Introduction and Aims 
The preferred technique for culturing thymic epithelial cells (TEC) is called reaggregate 
thymic organ culture (RTOC) (Auerbach, 1960; Jenkinson et al., 1992). The most common 
approach involves manual reaggregation of cells that are then cultured at the air-liquid 
interface upon a porous membrane, although many variations exist (Anderson et al., 1998; 
Anderson and Jenkinson, 2007; Jenkinson and Anderson, 1994; Sheridan et al., 2009). 
RTOC maintains Foxn1 expression in ex vivo TEC, which allows them to recapitulate native 
functions (Mohtashami and Zúñiga-Pflücker, 2006). However, RTOC is not without 
limitations. The process of generating RTOC is technically difficult, leading to technical 
variation between experiments. Furthermore, creating a cell pellet that is large enough to be 
manually manipulated requires a substantial number of input cells. Given that the target 
tissue is embryonic murine thymus, this limits the number of conditions that can be 
compared concurrently in any RTOC experiment. It is also difficult to use RTOC when 
investigating rare tissues such as the human embryonic thymus. Finally, visualisation of live 
cells during the RTOC is impossible as light cannot pass through the porous membrane. As 
a result, the community has focused on end-point point read outs, typically flow cytometry or 
immunohistochemistry. These short comings prompted development of the leading in vitro T-
cell generation systems, the OP9-DLL1, OP9-DLL4 and MS5-hDLL1 cell lines (Schmitt and 
Zúñiga-Pflücker, 2002; Seet et al., 2017). Whist overcoming the technical limitations 
associated with RTOC, these do not faithfully emulate positive selection or central tolerance, 
as the parental cells lines lack the TEC-specific functions required to mediate these 
processes. Furthermore, they are not patient-specific and thus have limited clinical value. 
I set out to test whether use of the GRID3D system (SUN Biosciences; now commercially 
available), might allow scale-up and miniaturisation of the RTOC process. The GRID3D 
system is essentially a cellular mould, in which micro-wells of defined dimensions are printed 
into a hydrogel matrix specifically designed for insertion into wells of a 24- and 96-well plates 
(Figure C5.1). A single cell suspension is then applied to each well of for example the 96-
well plate, and gravity pulls the cells into the micro-wells of the mould (Figure C5.1A). As the 
mould is created from polyethylene glycol (PEG), cells cannot bind to the mould itself and 
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instead bind to each other (Figure C5.1B). The cells autonomously reaggregate into a 
miniaturised organoid, which in the case of thymic cells, would be a miniaturised-
reaggregate thymic organ culture (MTOC). MTOC, if they could be produced, would address 
the limitations of the current RTOC system: they would be compatible with low cellular 
inputs, would be technically unchallenging and would be scalable. As the GRID3D is 
compatible with live fluorescent live imaging, MTOC would allow interrogation of events with 
spatiotemporal resolution. The major drawback of the miniaturisation is that it is reductionist. 
Reducing the complexity of the culture system should provide the capacity for more precise 
observations, but such small clusters of cells are unlikely to recapitulate thymic function to 
the same extent as larger structured organoids or RTOC/FTOC. Nonetheless, lessons learnt 
from MTOC should provide valuable insights for generation of larger thymic organoids. 
This chapter describes preliminary work in which I have optimised cellular inputs into the 
GRID3D system, created a pipeline to characterise the individual properties of reaggregates 
and evaluated the capacity of the system to support MTOC generation based on the key 
criteria proposed for the polymers in Chapter Four: determine whether MTOC can enforce 
maintenance of Foxn1 in cultured ex vivo TEC and whether iTEC can mediate T-cell 
differentiation when cultured in MTOC.  
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Figure C5.1: Description of the GRID3D Technology
A. Representation of MTOC system. Over time a single cell suspension coalesce, guided by the 
PEG hydrogel mould. B. The GRID3D system is completely flexible to experimental design. In this 
chapter, a mould was created that produced 70 micro-wells, with a diameter of 500 m, in each 
well of a 96-well plate. The images shows a bright field image of this design without input cells 
(left) and 24-hours after seeding with 100 WT MEFs in each well (right). Note that the yellow box 











5.2. The GRID3D System Produced Many Independently 
Observable Reaggregates  
5.2.A. Formatting the GRID3D System 
To test whether the GRID3D system could support development of MTOC, I performed a 
series of pilot experiments in which I first aimed to see if the system could provide the 
readouts, discussed above, to address current limitations in culture technologies. Afterwards, 
I needed to observe evidence that dissociated thymus cells and iTEC could reaggregate 
themselves and whether this had a minimal cell input requirement. The GRID3D system is 
highly tuneable. The depth, number and diameter of the micro-wells can be altered 
depending on the application. For this thesis, shallow micro-wells were used, which should 
promote a more rapid reaggregation. The total tissue requirement is dependent on two 
factors, firstly the number of micro-wells and secondly the number of cells seeded per micro-
well. The number of micro-wells printed into a well is dependent on the diameter of each 
micro-well. Initial observations found that using micro-wells with a diameter of both 200 μm 
and 500 μm was successful in creating reaggregates and both formats are exemplified in this 
chapter when relevant. However, most assays used the 500 μm format as this created fewer 
micro-wells and consequently the total tissue requirement was reduced. Printing micro-wells, 
with a diameter of 500 μm into an insert suitable for on well of a 96-well plate (called a 96well 
hereafter) produced 70 micro-wells (Figure C5.1B). To demonstrate that a small number of 
cells could reaggregate in this format,  wild type (WT) murine embryonic fibroblasts 
(MEFs) were seeded into one 96well. On average 100 MEFs were distributed randomly into 
each of the 70 micro-wells and over 24 hours the MEFs reaggregated (Figure C5.1B). Note 
that this produced an array of similar, but not identical, reaggregates.  
5.2.B. Automatic Segmentation to Characterise Individual Reaggregates. 
Given the large amount of technical noise reported in the iTEC polymer functionality array, I 
wished to test whether MTOC were able to provide more consistant readouts than other 
culture methods. There is no reason to assume that the miniaturised reaggregates created in 
MTOC are less variable than their larger scale counterparts in RTOC. In fact, it is more 
probable that there is less variation between RTOC as they contain many more cells, which 
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is more likely to encapsulate the total range of biological variance. In the MTOC system, it is 
improbable that each reaggregate will be created from the same number of similar cells and 
display identical behaviours as neighbouring reaggregates, given that each reaggregate 
comprises of such a small number of cells. Unless, each micro-well is seeded with a 
homogeneous stem cell population to derive clonally expanded organoids, which is not the 
case for this thesis and not be further discussed. However, the main advantage MTOC is 
that it produces many technical observations. It is more probable that the mean behaviour of 
70 reaggregates within one well will be similar of the mean behaviour of 70 other 
reaggregates in another well subjected to the same experimental conditions. Given the small 
cell number input requirements of MTOC, the number of technical replicates can be 
dramatically increased compared to RTOC. Hypothetically, if we assume that each 96well of 
MTOC requires 20% of the tissue input for every individual RTOC for a given experiment, 
MTOC can produce 350 reaggregates for each RTOC. The mean behaviour of 350 
reaggregates is more likely to reflect the true biological mean than a single RTOC. 
To quantify properties of individual reaggregates in a high throughput imaging system, I 
created an automatic pipeline to segment each reaggregate into an independent object using 
the ColumbusTM Image Storage and Analysis system (Perkin Elmer) (Figure C5.2A). This 
process employed a machine learning algorithm to differentiate between the texture of the 
PEG mould, noise and or artefacts, and the reaggregates. Notably, this negated the 
requirement of a counter stain to select on cells. The manufacturing process created small 
differences in the depth of each micro-well, which gave each reaggregate a different optimal, 
in focus, Z-plane, making automated image acquisition troublesome. To overcome this issue, 
each reaggregates was abstracted into its side, edges and ridges (SER) traits. These traits 
were observed to peak when each reaggregate was optimally in focus and SER Bright was 
used to identify the optimal Z-plane for each reaggregate (Figure C5.2B; I wish to thank Mr 
D. Rouse for kindly providing the script to organise and select reaggregates from the most in 
focus Z-plane). This GRID3D format and pipeline allows for automation characterisation of 
 reaggregates over one 96 well plate.  
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Figure C5.2: Creating a Pipeline to Segment Individual Reaggregates
A. WT MEFs were seeded into the GRID3D system to create an automatic pipeline to segment 
reaggregates into individual objects. i. A texture analysis employed machine learning to isolate 
reaggregates from background in bright field images. ii. Any cropped objects were removed to 
ensure data was collected only from whole reaggregates. iii. The size and shape of reaggregates 
were quantified to select only clusters of cells that were target reaggregates. iv. The properties of 
each reaggregate was quantified as individuals, which are represented in different colours. B. The 
reaggregates within each micro-well were on a different Z-plane due to variations in the PEG 
mould. The optimal Z-plane was identified by using the Z-plane in which reaggregates had the 
greatest SER Bright value. Blue line represents most in focus Z-plane by eye.
A
i. Find Reaggregate Texture ii. Removed Cropped Reaggregates




5.3. Identifying the Minimal Cellular Input of Ex Vivo Thymic 
Dissociate. 
Tissue scarcity remains the largest factor with the potential to limit the size of MTOC 
experiments. Given that the strength of the system is dependent on creating large numbers 
of technical observations, it was pertinent to define the minimal input requirements to 
successfully reaggregate cells. For ex vivo tissue the decision was made to optimise the 
system in terms of thymic lobes rather than cell number. This was justifiable for many 
reasons. Firstly, Chapter Four provided evidence that seeding experiments in terms of 
thymic lobes was more accurate than using cell counts. Also, it was assumed that if the 
whole range of thymic stroma was present, cells would be more likely to recapitulate 
behaviours of the native tissue. Finally, the proportion of different cell types within the 
thymus changes dramatically during development. For example: the number of T-cells 
quickly dwarfs the number of TEC (Hirakawa et al., 2018). As a result, using 1000 cells per 
micro-well of E13.5 tissues and E17.5 tissues would not be a fair comparison as the thymic 
stromal cells must be assumed to be responsible for reaggregating into a structure.  
Both E14.5 and E15.5 thymic lobes were used in this experiment. Thymi were dissociated 
into a single cell suspension and suspended in 25 μl of advanced DMEM/F12 supplemented 
with 2% fetal calf serum (2% medium) at the following concentrations: 100%, 50%, 25% and 
10% of a thymic lobe. The 25 μl cellular suspension was applied to each 96well and 
incubated to allow the cell suspension to distribute between micro-wells. After thirty minutes, 
each 96well was topped up to 200 μl of medium and cultured for 14 days with a 50% 
medium change every two to three days. On day 14, the central thirty micro-wells of each 
condition were imaged, and the automatic pipeline quantified the number and area of the 
reaggregates (Figures C5.3A and C5.4A). The number of successful reaggregates was used 
to infer the minimal cellular input and this was reported as a percentage of potential possible 
reaggregates. The proportion of micro-wells in which a successful reaggregate formed 
decreased when less than 50% of- and 100% of- a whole thymic lobe was used for E15.5 
and E14.5 tissue, respectively. For E15.5 tissues, using 25% of a thymic lobe resulted in 
65.4% of micro-wells containing a successful reaggregate, while for E14.5 tissues, using 
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50% of a thymic lobe resulted in 29% of micro-wells producing successful reaggregates. The 
mean area of successful reaggregates was also calculated. Notably, using 50% of an E15.5 
thymic lobe and one E14.5 generated reaggregates with a similar mean area (7332 μm2 and 
5500 μm2, respectively), suggesting that this is the smallest size that yield successful 
reaggregates. These data are also consistent with the number of TEC doubling each day 
during thymic organogenesis (Hirakawa et al., 2018). It was decided that future experiments 
would be seeded with one E15.5 thymic lobe as this was sufficient to ensure formation of 




Figure C5.3: Optimising Input of E15.5 Thymic Dissociate into GRID3D System
A. Images show MTOC created by dissociating one E15.5 thymic lobe and seeding the suspension 
into a 96well, which contained 70 micro-wells. Therefore, each micro-well contained 1/70 of an 
E15.5 thymic lobe. MTOC were cultured for 14 days.  B. Graph depicts that seeding less tissue, 
measured as a fraction of an E15.5 thymic lobe, into each 96-well reduced the amount of 
successful reaggregates. Thus, cell density is a limiting factor when creating MTOC. C. Reducing 








Figure C5.4: Optimising Input of E14.5 Thymic Dissociate into GRID3D System
A. Images show MTOC created by dissociating one E14.5 thymic lobe and seeding the cell 
suspension into a 96well which contained 70 micro-wells. Therefore, each microwell contains 1/70 
of a E14.5 thymic lobe. MTOC were cultured for 14 days. B. Graph depicts that seeding less 
tissue, measured as a fraction of a thymic lobe, into each 96-well reduced the number of 
successful reagregates. Therefore, cell density is a limiting factor when creating MTOC. C. 






5.4. Foxn1 Expression in Ex Vivo TEC is Maintained in MTOC. 
Chapter Four highlighted that current monolayer culture techniques are inadequate to 
maintain Foxn1 expression in TEC. Given that downregulation of Foxn1 has large effects on 
TEC behaviour, and this will confound any subsequent comparison between ex vivo and 
native TEC, MTOC were evaluated for the ability to maintain Foxn1 in TEC (Vaidya et al., 
2016). Mohtashami and Zúñiga-Pflücker (2006), provide reverse transcription-quantitative 
polymerase chain reaction (RT-qPCR) evidence that TEC maintain Foxn1 in RTOC and fetal 
thymic organ culture (FTOC) for at least five days in culture. However, given the accessibility 
of MTOC to microscopy, the Foxn1G transgene was employed to infer Foxn1 expression 
from GFP mean fluorescence intensity (MFI) (Figure C4.12) (O’Neill et al., 2016). This was 
described, and justified, in Chapter Four. Briefly, Foxn1G thymi were produced using a 
Foxn1G x C57BL/6 cross as the transgene knocked a GFP into exon1 of the Foxn1 locus, 
rendering it a null allele (Figure C4.12). A cell suspension, created from a mix of Foxn1G/+ 
and WT thymic lobes, was created for each experiment so only 50% of all TEC will contain 
the Foxn1G transgene but it was assumed that maintenance of Foxn1 expression was 
uniform through all TEC within a reaggregate.  
Four wells of a 96-well plate, which contained the GRID3D system were seeded at a 
concentration of one E15.5 thymic lobe per well, or 1/70 thymic lobes per micro-well. Every 
two to three days a 50% medium change of fresh 2% medium was performed. At 24 hours, 
seven and 14 days the central 30 micro-wells were imaged at a range of Z-planes to capture 
both the bright field and GFP channels (Figure C5.5A). The individual reaggregates were 
automatically segmented using the ColumbusTM software (Perkin Elmer) in the bright field 
channel and the GFP MFI for each reaggregate was taken from the Z-plane with the highest 
SER bright value. The mean value was found at each time point in each 96well. A nonlinear 
regression analysis of these data was used to generate a quadratic curve and 95% 
confidence intervals for the data (Figure C5.5B). This line was significantly different from the 
line , which represents the null hypothesis that GFP MFI was not affected by 
time, and the null hypothesis was therefore rejected. Over the 14-day culture period, the 
GFP MFI of all the reaggregates increased significantly over time. Interestingly, variation 
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also increased over time, as described by the increasing coefficient of variation over time 
(Day1 = 3.551%, Day 7 = 10.75% and Day 14 = 17.89%). However, the quadratic equation 
was still associated with a reasonable R2 value of 0.7417, indicating that time was the largest 
contributor of variation.  
This variation is exemplified in the representative images of the experiment (Figure C5.5A). 
The central reaggregate in the image shown did not maintain high level Foxn1 expression 
despite being exposed to the same external conditions as the neighbouring micro-wells. At 
day one there is nothing visually distinguishing this reaggregate from neighbouring 
reaggregates. By day seven, the reaggregate had expanded but the GFP was both lower 
and distributed thinly throughout the reaggregate. On day 14, this reaggregate had failed and 
both GFP expression and size of the reaggregate were reduced compared to day seven.  
These data posed two interesting questions: Did the reaggregates increase GFP expression 
over time because TEC upregulated Foxn1 or did the number of Foxn1 expressing TEC 
increase in each reaggregate? And, why did only some reaggregates fail to maintain Foxn1? 
Did this represent a dichotomy or did some reaggregates confer a lower steady-stead level 
of Foxn1 expression than others?  
To test whether the increase in GFP MFI was a result of increased Foxn1 in individual TEC 
or a collective increase of total TEC. The above experiment was repeated with the aim of 
collecting data at the single cell resolution. The ideal method to provide single cell resolution 
data using MTOC is confocal microscopy. This would be able to image live cells without 
substantial manipulation of the system. However, this process is still suboptimal, for reasons 
that will be discuss later in this chapter, and a flow cytometric readout was employed 
instead. This was not the ideal readout as MTOC as many cells are lost during processing 
for flow cytometry, which incorporates technical variation into assays (Hirakawa et al., 2018). 
These concerns are confounded when processing MTOC as the number of reaggregates is 
very small. Furthermore, by pooling together all reaggregates of a well, information on 
independent reaggregates is lost. Three different dissociation strategies were tested: 
mechanical force, enzymatic disassociation of extracellular matrix components and TrypLE 
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Express (Gibco), which targets cellular membrane-bound proteins. Only the latter, harsher 
dissociation provided enough cells for analysis, so the data presented is of only one 96well. 
Furthermore, the number of recoverable cells was low as indicated by the Z-axis of the 
histogram (Figure C5.6A). TEC were defined as EpCAM+ cells.  
Comparison with native E15.5 Foxn1G thymic disassociate at time zero (t0) indicated that 
some TEC in the MTOC were able to maintain the native steady-state level of Foxn1 
expression, with the GFP MFI remaining similar within the GFPhigh TEC fractions. However, 
the proportion of TEC that maintained GFP expression at this level diminished markedly, 
from approximately 50% (actual value was 40.4% due to chance) to 12.05% in the recovered 
TEC. Focusing on the similarities, this provides evidence against the total GFP MFI increase 
in reaggregates, over time, being attributed to upregulation of Foxn1 in TEC and supports 
that there are more TEC, contributing a similar amount of GFP over time (Figure C5.5B). The 
percentage reduction in GFPhigh TEC is also informative. Unlike the t0, E15.5 Foxn1G thymic 
dissociate, the recovered cells have multiple GFPlow peaks. This can be interpreted in two 
ways. Firstly, that the peaks captured a temporal transition of TEC between the GFPhigh and 
GFPlow groups. Alternatively, the peaks captured spatial information and each peak reflects a 
different environment within reaggregates that were conducive to a different steady-state 
level of Foxn1 expression. Which mechanism is true is currently difficult to answer without 
being able to calculate gross properties of each reaggregate and then, using confocal 
analysis to calculating properties of individual TEC. However, the first part was calculated 
and shown in Figure C5.6B using the data displayed previously in Figure C5.5B. Technical 
replicate A stands out as not being able to produce reaggregates with very high GFP MFI 
and technical replicate D has a much greater deviation away from normal distribution with a 
shift over to producing reaggregates with lower GFP MFI. Whether this data spread reflects 
that some reaggregates maintain a lower steady state of Foxn1 expression or this reflects 
that some reaggregates contain more TEC is impossible to distinguish. However, 
reaggregate size was not associated with GFP MFI (linear regression R2 = 0.2168) 
Furthermore, given that this experiment was not designed to test this hypothesis, the 
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absence of a control group comprised of entirely WT TEC, which do not express GFP, 
prevents being able to distinguish which reaggregates are truly GFP negative.  
Therefore, when cultured in MTOC, some TEC maintain Foxn1 expression at a similar level 
to native tissue, while others downregulate Foxn1 via a currently unknown mechanism. It is 
pertinent to draw comparison to the native thymus, in which TEC downregulate Foxn1 at the 
onset of involution, although more data is required to contrast the mechanisms, involution 
highlights particular areas to explore (O’Neill et al., 2016). Of note, it seems unlikely that 
reaggregates failed because of the increased proliferative action of Foxn1- TEC, given the 
representative images in Figure C5.5A demonstrated a reduction in size as TEC 
downregulated Foxn1. Although these data must be repeated to confirm this finding, the high 
number of technical replicates performed give confidence in these data. Therefore, based on 
the criteria of maintenance of Foxn1 expression, the MTOC system developed herein 
appeared superior to monolayer culture as an in vitro system that can mimic native thymus 
functions and was taken forward for further development 
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Figure C5.5: MTOC Created with Dissociate from One E15.5 Thymic Lobe 
Maintained Foxn1 Over Time
A. Images show MTOC created using dissociate from one E15.5 thymic lobe, so each micro-well 
contained 1/70 of a thymic lobe. Embryos of Foxn1G/+ x WT mating were used to produce a mix of 
thymic lobes, in which half of all TEC contain the Foxn1G transgene. Note, the reaggregate in the 
central micro-well failed to maintain Foxn1G. GFP is represented as a flame UTI. The histogram 
was consistent across time points so visual changes in GFP are biologically informative. B. The 
central 30 MTOC in each 96well, were automatically segmented into independent reaggregates at 
each time point and the MFI of each reaggregate in the GFP channel was quantified. The total 
mean of this value was calculated for four technical replicates. A quadratic regression analysis 
showed that the total mean MFI of GFP across all reaggregates in each 96-well increased over the 
14 day culture period. N=1.
A
Foxn1G - Flame UTI





A. Graphs show Foxn1G TEC, which are defined as EpCAM+, isolated from MTOC after 14
days in culture (right) compared to Foxn1G TEC freshly isolated from a litter of E15.5 embryos
(left). MTOC were created using dissociate from one Foxn1G E15.5 thymic lobe. Events
represent one 96-well of MTOC that was enzymatically disassociated. Note, that the MFI of the
GFPhigh fraction remained consistent throughout culture. However, not all TEC maintained GFP
expression and TEC lost GFP expression at different rates as indicated by the multiple peaks.
B. Graph depicts the GFP MFI of all reaggregates in four technical replicates after 14 days in
culture. Each replicate was seeded with dissociate from one Foxn1G E15.5 thymic lobe. To
calculate GFP MFI, each reaggregate was automatically segmented. Note, the GFP MFI was
variable between reaggregates. N=1.
Figure C5.6: A Proportion of Reaggregates Failed to Maintain Foxn1 in TEC
A
Foxn1G - ame UTI
B
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5.5. Ex vivo TEC Express Mitotic Marker Ki67 When Cultured in 
MTOC. 
To further elucidate whether the observed GFP MFI increase over time in MTOC was a 
consequence of increasing numbers of TEC within each reaggregate, an experiment was 
performed to observe evidence of TEC proliferation. This experiment also provided the first 
opportunity to perform confocal analysis on MTOC. Given that PEG is a hydrogel, principally 
comprised of water, the refractive index of the GRID3D mould should be the same water. 
Therefore, live microscopic analysis through the PEG hydrogel should be like imaging 
through the same depth of water. However, in this initial attempt at imaging thymic material 
in such a manner, it was decided to use fixed tissue to mitigate some technical challenge. 
WT E15.5 thymic lobes were seeded into the GRID3D system at a concentration of one lobe 
per 96well or, 1/70 thymic lobes per micro-well. After seven days of culture using the above 
described process, the reaggregates were fixed within the GRID3D structure and stained for 
EpCAM and Ki67 and with 4′,6-diamidino-2-phenylindole (DAPI).  
EpCAM+Ki67+ cells were observed at a low frequency within the MTOC (Figure C5.7). This 
was taken as further evidence supporting that the observed increase in GFP MFI over time 
was due to TEC proliferation within the reaggregates rather than increased Foxn1 
expression within individual TEC. However, the technical performance of this approach to 
imaging in the GRID3D system was poor. Note the dramatically lower light penetration 
between the reaggregate and the positive control. The positive control was an E13.5 thymic 
lobe, which was used over E15.5 because of its smaller total size, suspended in phosphate-
buffered saline (PBS) in an imaging dish (IBDI). The major difference was the presence of 
the PEG hydrogel, which was concluded to reduce the penetration of light.  
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Figure C5.7: TEC Cultured in MTOC 
Express Mitotic Marker Ki67
Images depict a reaggregate that was cultured 
in MTOC for seven days and then fixed and 
stained for evidence of proliferation in the TEC 
compartment. The reaggregate was created 
from one E15.5 thymic lobe seeded into a 
96well, which contained 70 micro-wells. A. 
DAPI only. B. EpCAM only. C. Ki67 only. D. 
Composite of EpCAM and Ki67. E. A whole 
mount image of an E13.5 thymus with EpCAM 















E13.5 Thymic Lobe 
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5.6. Ex vivo TEC Cultured in MTOC for Seven Days Exhibit 
Regional Organisation. 
Following the successful imaging of Ki67+ TEC within MTOC, reaggregates were stained for 
EpCAM and ulex europaeus agglutinin I (UEA1) and with DAPI. This was performed 
concurrently to the above described confocal analysis. Given that the input E15.5 thymic 
lobes contained both cTEC and mTEC, and that mTEC are traceable using the medullary 
TEC (mTEC) marker UEA1, it was interesting to see whether MTOC exhibited this patterning 
(Figure C5.8).  
After seven days of culture in MTOC, reaggregates were fixed and stained. There were three 
possible outcomes. If there were no observable EpCAM+UEA1+ cells, the input mTEC did 
not survive the seven-day culture period. If there were EpCAM+UEA1+ cells but they were 
distributed randomly within reaggregates, mTEC were able to survive but not organise when 
cultured as MTOC. Finally, if EpCAM+UEA1+ cells were present in distinct regions, mTEC 
were able to not only survive but also organise themselves when cultured as MTOC. 
EpCAM+UEA1+ cells were found in clusters at the centre of reaggregates, providing 
evidence to support the final proposition (Figure C5.8). However, at this time there is 
insufficient data to concluded whether this pattern is the result of propagation of a single 
mTEC clone to form a medullary islet or spatial assembly of multiple input mTEC (Rodewald 
et al., 2001; Ulyanchenko et al., 2016). The positive control used for this was a sectioned 
E16.5 thymus. Arguably comparing sectioned to whole mounted samples produced a 
confounding variable. However, given that UEA1 patterning is only detectable after E15.5, 
the size of the sample would necessitate clearing, which was considered an equally large 
confounding variable.  
Again, imaging through the GRID3D created technical challenges. Given the poor light 
penetration associated with imaging through the GRID3D mould, only the centre of the 
reaggregates were kept in frame. This prevented the outer areas from saturating the 
detectors, but it was impossible to image a whole reaggregate in one stack. Furthermore, 
staining the samples in the GRID3D system created small aggregates of antibody 
represented as the bright noise prominent in the EpCAM channel. Finally, in both Figure 
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C5.7 and C5.8 the DAPI stain did not show small nuclei, which are likely to represent 
thymocytes. There are two speculative answers to this. Firstly, this could be due to sampling 
bias. The poor light penetration meant that only the smaller reaggregates were imageable. It 
could be that the smaller reaggregates were small because of a failure to establish a 
thymocyte population. However, it could equally be a product of MTOC culture and, after 
seven days, the input thymocytes within reaggregates may have failed. Finding evidence 
that MTOC could maintain a thymocyte population became the top priority. 
Overall, from these studies it was concluded that MTOC support TEC proliferation and 
mTEC viability and organisation. However, further work was required to establish whether 
the MTOC can maintain ex vivo thymocytes and whether ex vivo TEC, which are able to 
express Foxn1, can mediate thymopoiesis. Finally, further optimisation of the GRID3D 
system is required before confocal microscopy can probe live reaggregates at the single cell 
resolution. This is essential to understand whether downregulation of Foxn1 in some TEC is 
explained by the temporal or spatial mechanisms outlined above. 
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Figure C5.8: E15.5 Thymic Dissociate 
Culture in MTOC for Seven Days 
Maintained mTEC Organisation 
Images depict a reaggregate that was cultured in 
MTOC for seven days and then fixed and 
stained for evidence that input mTEC had 
organised into a medullary region. The 
reaggregate was created from one E15.5 thymic 
lobe seeded into a 96well, which contained 70 
micro-wells. A. DAPI only. B. EpCAM only. C. 
UEA1 only. D. Composite of EpCAM and UEA1. 
E. A sectioned image of an E16.5 thymus as a 














E16.5 Thymic Lobe 
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5.7. Identifying Minimal Cellular Input of iTEC 
MTOC also has potential to be a useful tool to study iTEC. Given the inherent variability in 
cellular reprogramming, it is pertinent to evaluate iTEC using systems that are associated 
with low variability. Ultimately generating conclusions from the monolayer co-cultures in iTEC 
functionality polymer array (Chapter Four) was difficult due to the large contribution of 
stochastic variation to the results. The R2 of the ANOVA was 0.338875, indicating most of 
the variation in the screen was not due to the dependant variable (polymer condition). 
Therefore, if polymers only contributed a small amount of variation it would be difficult to 
resolve from the noise of the technical variation. As discussed above, MTOC is more likely to 
fill this niche as it can provide a dramatic increase in the number of technical observations, 
while maintaining a 3D architecture. 
The principal function of iTEC is to emulate TEC function, which is to mediate thymopoiesis. 
To what extend iTEC can do this was covered extensively in Chapter Three. For MTOC to 
be a useful culture method for iTEC, I needed to test two criteria. Firstly, whether iTEC could 
form reaggregates and secondly how to seed the haematopoietic component so it correctly 
interacted with the iTEC. There were two potential methods to introduce haemopoietic cells 
to the iTEC, allowing both to simultaneously reaggregate or testing whether the 
haematopoietic component could colonise pre-reaggregated iTEC. To answer these 
questions, the GRID3D system was set up in a 24-well plate. Each well contained 350 micro-
wells with a diameter of 200 μm. iTEC were seeded into these wells at a concentration of 
 iTEC per 24well, or 100 iTEC per micro-well. The iTEC reaggregated over 24 
hours at which time point,  haematopoietic stem cells (Lin-SCA-1+c-KIT+) (LSKs) were 
added into the system (Figure C5.9 and C5.10A). Not all LSKs were able to infiltrate the 
iTEC-structure and these ‘excluded cells’ started to proliferate and adopted a cobble stone-
like morphology (Figure C5.10B). By day, seven the LSKs had overgrown the micro-wells 
(Figure C5.10C). This failure prompted changes in the experimental design. Firstly, Adult 
ETPs were used in place of LSKs as it was assumed ETPs would have less proliferative 
capacity (Figure C4.17 outlines the ETP sorting strategy). ETPs were considered too scarce 
to be compatible with the 24-well plate format so this was changed to the 96-well plate 
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format, in which each 96well contained 70 micro-wells with a diameter of 500 μm. iTEC were 
seeded at 50, 100, 500 and 1000 iTEC plus 20 ETPS per micro-well, as 20 cells was 
indicated by SUN Bioscience to be the minimal number of cells necessary to ensure normal 
distribution of cells through all micro-wells. Bright field images were taken at 24 and 48 
hours, seven and 14 days (Figure C5.11). All concentrations produced satisfactory 
reaggregates, which was a strikingly different result to that observed in the ex vivo thymic 
dissociate experiment. It maybe that purified TEC would also be able to reaggregate at any 
seeding density. The upper limit of 1000 iTEC per micro-well was justified by the total tissue 
requirement for a whole 96-well plate, which at this seeding density requires cells 
and is the upper limit of what it is possible to produce using fluorescence activated cell 
sorting (FACS) over a period of two to three hours. For the next experiment, I wanted to test 
whether iTEC culture in MTOC were able to mediate T-cell differentiation. As discussed 
previously, low cell numbers limit the application of flow cytometric analysis to MTOC, so it 
was justified to make the aggregates as large as possible to mitigate this limitation in cell 
number.
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Figure C5.9: FACS Isolation Strategy for Post-Natal Murine Bone Marrow LSKs 
The strategy use to FACS isolate LSKs from six-week post-natal murine bone marrow. LSKs were 
defined as Lineage-SCA-1+c-KIT+ cells. The lineage cocktail included: CD3 , CD4, CD5, CD11b, 
B220, Gr-1, TER-119. 
229
Figure C5.10: Seeding LSKs with iTEC Post-Reaggregation Failed to Control 
Proliferation
Images show iTEC seeded into the GRID3D system and allowed to reaggregate independently 
for 24 hours. This GRID3D mould used a diameter of 200 m. A. LSKs were then seeded into the 
system to understand whether cells could infiltrate pre-aggregated structures. B. After a further 24 
hours, LSKs that did not infiltrate the reaggregate adopted a cobble stone-like morphology. C. By 















































































































































































































































































5.8. iTEC Cultured in MTOC Mediate T-cell Differentiation More 
Consistently than Monolayers or RTOC 
5.8.A. Enzymatic Digestion with TrypLE Express Affects Markers of 
Thymopoiesis 
Flow cytometry was used to determine whether iTEC were able to mediate T-cell 
differentiation in MTOC. Given the success of TrypLE Express in disassociating 
reaggregates of ex vivo thymic tissue in MTOC, the same strategy was employed to prepare 
the iTEC-based reaggregates. Firstly, the action of TrypLE express on the markers of 
thymopoiesis was measured. WT thymocytes were isolated from a four-week postnatal 
thymus and separated into two groups. One was enzymatically digested with TrypLE 
express for five minutes at 37°C and agitated at 1400 rpm while one was incubated in FACS 
buffer. The cell suspensions were stained with the same panel outlined in Chapter Three to 
map thymopoiesis. CD25 and CD62L were undetectable in the treated group, while CD4, 
CD8, CD3ε and CD44 had decreased MFIs but were still effective as markers (Figure C5.1). 
Note that as in Chapter Three, the CD25 staining was not completely effective. TCRβ and 
CD69 were unperturbed in addition to the proportion of cells that were either 7-
aminoactinomycin D (7AAD) or lineage positive. The lineage cocktail included: CD11b, 
CD11c, B220, Gr-1, Nk1.1, EpCAM, Ter119. Ultimately, it was decided that even with some 
perturbation of key markers, digestion with TrypLE express did not invalidate the flow 
cytometric readout. 
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Figure C5.12: Characterising Enzymatic Action on Markers of Thymopoiesis 
MTOC generates reaggregates with a small diameter, which are difficult to physically dissociate. 
An enymatic treatment protocol was optimised utilising TrypLE Express. Thymocytes were 
isolated from a four-week thymus and split into up groups. A. represented the untreated control. 
B. showed the effects of digestion. CD25 and CD62L were heavily effected while CD4, CD8 and 
CD44 showed a small decrease in MFI. Note the single cells plot was not biologically interesting 




5.8.B. iTEC Cultured in MTOC with Adult ETPs and WT MEFs Mediated T-
cell Differentiation 
An experiment was designed to find evidence that iTEC-based RTOC could mediate T-cell 
differentiation of adult ETPs. It was noted that mesenchyme is reported to be an essential 
RTOC component and MEFs are commonly used to supply mesenchymal cell function 
(Anderson et al., 1998, 1993; Anderson and Jenkinson, 2007; Suniara et al., 2000) Two 
conditions were tested as MTOC: One containing WT MEFs and one without. For the 
positive control, iTEC-based RTOC were generated using the compaction reaggregation 
method as described in Chapter Three (Sheridan et al., 2009). The numbers of input cells 
are listed in Table C5.1. The use of different input cell numbers between the MTOC and 
RTOC was unavoidable for technical reasons. Using the lower cell numbers for RTOC would 
not create a manually manipulatable cell pellet, while using higher numbers in the MTOC 
would saturate the moulds. After 14 days of culture in either method, reaggregates were 
enzymatically treated with TrypLE Express and then flow cytometrically analysed (Figures 
C5.13 – C5.20).  
Firstly, it should be noted that there was a large difference in the performance of the iRTOC 
cultures, with one containing 198 DP thymocytes and the other 42,512 Figure C5.13 and 
C5.14. This was a larger difference than was observed in Chapter Three and it may reflect 
the use of a smaller number of adult ETPs rather than embryonic DN thymocytes. Focusing 
on the more successful replicate, 20% of the live lineage- gate was CD4+CD8+ double 
positive (DP) thymocytes, which was considered successful when compared to the iRTOC of 
Chapter Three, but there was a smaller than expected population of CD4+CD8- single 
positive four (SP4) thymocytes. Furthermore, as seen previously in Chapter Three there was 
a large amount of TCRβ-CD3ε+ cells in the live, lineage- gate, which were assumed to be γδ 
T-cells and these cells aberrantly contributed to the CD4-CD8+ single positive eight (SP8) 
subset. Both the bias away from SP4 thymocytes and bias toward γδ T-cells were reasoned 
to be associated with the batch of iTEC rather than the culture techniques.   
Overall, the MTOC were considered capable of mediating T-cell differentiation however, the 
efficiency of this process was poor; much lower than in iRTOC as measured by the 
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proportion of DP thymocytes and TCRβ+CD3ε+ αβ T-cells from the total live, lineage- gate 
and there was an proportionate increase in the generation of TCRβ-CD3ε+ γδ T-cells. 
Whether, this reflects that only a very smaller number of reaggregates were able to mediate 
this process or on average the ability of each reaggregates in MTOC was much poorer 
warrants further investigation and requires confocal microscopy to interrogate individual 
reaggregates. Interestingly, in accordance with the literature, the addition of WT MEFs was 
essential to observe any evidence of T-cell differentiation in the MTOC (Anderson et al., 
1993).   
The absolute cell counts of the CD4+CD8+ (DP), CD4+CD8- (SP4), CD4-CD8+ (SP8) and 
TCRβ+CD3ε+ (αβ T-cells) were collected for each condition (Table C5.2). Note that 
monolayer data were taken from the iTEC Functionality Polymer Array, (Chapter Four) 0.1% 
gelatin, from independent experiment B. Although this was not collected concurrently and 
should not be directly compared to this experiment, it is representative of iTEC – ETP co-
culture in monolayers and is useful for visualising the variance found in these experiments 
(Figure C5.21). It was decided that a comparison of means between iTEC-based RTOC and 
MTOC would be invalid. This is for two reasons. Firstly, the iRTOC was seeded with a 10-
fold increase in ETPs compared to MTOC and the total thymocyte number is assumed to be 
dependent upon the availability of the niche, which must be greater in the larger RTOC 
structures. The format of the GRID3D system used in this experiment was a confounding 
variable. To compare RTOC with MTOC, the GRID3D system would need to contain just one 
micro-well, which would allow the same number of cells to be seeded into both culture 
methods. This would isolate the reaggregation process, which is likely to be slower in MTOC 
but free of the manual manipulation necessitated by RTOC. Secondly, the experiment was 
only performed once and comparing the means of just one technical replicate is unlikely to 
generate generalisable conclusions due to a lack of statistical power.  
Given the ambition to develop MTOC as a methodology able to generate consistent outputs, 
the Coefficient of Variation (CoV) found between all technical replicates was compared 
(Table C5.3). Again, these data were collected from only one independent experiment, so no 
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statistics were performed. However, the variation was dramatically lower in the MTOC than 
the RTOC and monolayer groups.  
Overall, these data indicate that iTEC cultured in RTOC outperform those cultured in MTOC, 
in terms of mediating T-cell differentiation. Whether the poor efficiency shown in MTOC was 
a product of only a few reaggregates being able to mediate T-cell differentiation or a lower 
ability on average across each 96well warrants further investigation. However, MTOC 
produced a much more consistant data set, and therefore would be a more suitable tool for 
screening experiments if the issues related to thymopoiesis could be overcome. iTEC within 
the experiment were unable to effectively support generation of SP4 thymocytes, reinforcing 
that this technology requires further optimisation. Finally, WT MEFs were found to be 
beneficial when included in MTOC and supported iTEC to mediate more efficient T-cell 
differentiation in MTOC. 
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Figure C5.13: MTOC Mediated Thymopoiesis is Less Variable than Other 
Culture Methods - iRTOC A
iTEC, adult ETPS and WT MEFs were cultured using RTOC and MTOC. After 14 days of co-
culture the structures were enzymatically disassociated. The plots show the thymocyte subset 
profile of iRTOC replicate A. Note that CD25, CD44 and CD62L were omitted from this thesis' 
routine panel due to the enzymatic digestion and the build up of TCR +CD3 +CD4-CD8- 
thymocytes. Lineage cocktail includes: CD11b, CD11c, B220, Gr-1, Nk1.1, EpCAM, Ter119. N=1. 
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Figure C5.14: MTOC Mediated Thymopoiesis is Less Variable than Other 
Culture Methods - iRTOC B
iTEC, adult ETPS and WT MEFs were cultured using RTOC and MTOC. After 14 days of co-
culture the structures were enzymatically disassociated. The plots show the thymocyte subset 
profile of iRTOC replicate B. Note that CD25, CD44 and CD62L were omitted from this thesis' 
routine panel due to the enzymatic digestion. Lineage cocktail includes: CD11b, CD11c, B220, 
Gr-1, Nk1.1, EpCAM, Ter119. N=1. 
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Figure C5.15: MTOC Mediated Thymopoiesis is Less Variable than Other 
Culture Methods - MTOC with MEFs A
iTEC, adult ETPS and WT MEFs were cultured in MTOC. After 14 days, all reaggreagtes were 
removed from the GRID3D system and enzymatically disassociated. The plots show the 
thymocyte subset profile of MTOC with MEFs  replicate A. Note that CD25, CD44 and CD62L 
were omitted from this thesis' routine panel due to the enzymatic digestion. Lineage cocktail 
includes: CD11b, CD11c, B220, Gr-1, Nk1.1, EpCAM, Ter119. N=1. 
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Figure C5.16: MTOC Mediated Thymopoiesis is Less Variable than Other 
Culture Methods - MTOC with MEFs B
iTEC, adult ETPS and WT MEFs were cultured using RTOC and MTOC. After 14 days of co-
culture the reaggregates were enzymatically disassociated. The plots show the thymocyte subset 
profile of MTOC with MEFs replicate B. Note that CD25, CD44 and CD62L were omitted from this 
thesis' routine panel due to the enzymatic digestion. Lineage cocktail includes: CD11b, CD11c, 
B220, Gr-1, Nk1.1, EpCAM, Ter119. N=1. 
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Figure C5.17: MTOC Mediated Thymopoiesis is Less Variable than Other 
Culture Methods - MTOC with MEFs C
iTEC and adult ETPS were cultured using MTOC. After 14 days of co-culture the reaggregates 
were enzymatically disassociated. The plots show the thymocyte subset profile of MTOC with 
MEFs replicate C. Note that CD25, CD44 and CD62L were omitted from this thesis' routine panel 
due to the enzymatic digestion. Lineage cocktail includes: CD11b, CD11c, B220, Gr-1, Nk1.1, 
EpCAM, Ter119. N=1.  
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Figure C5.18: MTOC Mediated Thymopoiesis is Less Variable than Other 
Culture Methods - MTOC without MEFs A
iTEC and adult ETPS were cultured using MTOC. After 14 days of co-culture the reaggregates 
were enzymatically disassociated. The plots show the thymocyte subset profile of MTOC without 
MEFs replicate A. Note that CD25, CD44 and CD62L were omitted from this thesis' routine panel 
due to the enzymatic digestion. Lineage cocktail includes: CD11b, CD11c, B220, Gr-1, Nk1.1, 
EpCAM, Ter119. N=1. 
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Figure C5.19: MTOC Mediated Thymopoiesis is Less Variable than Other 
Culture Methods - MTOC without MEFs B
iTEC and adult ETPS were cultured using MTOC. After 14 days of co-culture the reaggregates 
were enzymatically disassociated. The plots show the thymocyte subset profile of MTOC without 
MEFs replicate B. Note that CD25, CD44 and CD62L were omitted from this thesis' routine panel 
due to the enzymatic digestion. Lineage cocktail includes: CD11b, CD11c, B220, Gr-1, Nk1.1, 
EpCAM, Ter119. N=1. 
243
Figure C5.20: MTOC Mediated Thymopoiesis is Less Variable than Other 
Culture Methods - MTOC without MEFs C
iTEC and adult ETPS were cultured using MTOC. After 14 days of co-culture the reaggregates 
were enzymatically disassociated. The plots show the thymocyte subset profile of MTOC without 
MEFs replicate C. Note that CD25, CD44 and CD62L were omitted from this thesis' routine panel 
due to the enzymatic digestion. Lineage cocktail includes: CD11b, CD11c, B220, Gr-1, Nk1.1, 





















































































































































































































































































































Table C5.1: Input Cell Numbers Used in the T-cell Differentiation Variation Test. 
The table depicts the input cell numbers used in each condition 
Cell Type RTOC per 
Reaggregate 
MTOC with 
MEFS per well 
(i.e. per 70 
micro-wells) 
MTOC without 
MEFs per well 




iTEC     
ETP     
MEF   - - 
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Table C5.2: The Absolute Cell Count Collected from Each Culture Method in the T-
cell Differentiation Variation Test. 
The table shows the absolute cell counts of the thymocyte subsets found in each culture 
method per iRTOC or 96well of 70 reaggregates. 








iRTOC A 4054 25507 42512 6333 
iRTOC B 46 148 198 92 
MTOC with MEF A 287 1627 417 267 
MTOC with MEF B 169 1940 956 245 
MTOC with MEF C 193 808 723 230 
MTOC without MEF A 52 151 10 17 
MTOC without MEF B 27 44 1 1 
MTOC without MEF C 30 90 11 26 
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Table C5.3: CoVs in T-cell Differentiation Variation Test. 













CD4+CD8- 138.2% 28.8% 37.6% 113.5% 
CD4-CD8+ 139.8% 40.1% 56.5% 120.9% 
CD4+CD8+ 140.1% 38.7% 75.1% 131.5% 
TCRβ+CD3ε+ 137.4% 7.5% 86.3% 124.8% 
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5.9. iTEC Differentiate into UEA1 Expressing mTEC-like Cells in 
MTOC 
In the initial publication, it was reported that iTEC were able to differentiate into mTEC-like 
cells and form medullary regions when engrafted onto the kidney capsule of a syngeneic 
mouse (Bredenkamp et al., 2014). Thus, to test whether iTEC were able to differentiate into 
mTEC-like cells using the marker UEA1 in MTOC, 1000 iTEC were seeded into each micro-
well of the 24well format, containing 350 micro-wells with a diameter of 200 μm, as 
previously described. After 14 days, the reaggregates were fixed and stained for cytokeratins 
and UEA1 and with DAPI. The confocal imaging was performed differently than in previous 
experiments, in that reaggregates were removed from the GRID3D system before imaging. 
This removed the factor limiting the penetration of light into reaggregates. Most reaggregates 
contained a central Cytokeratin+UEA1+ cell, which was taken to be evidence of iTEC 
differentiating into a mTEC-like cell (Figure C5.22). Note, as explained in Chapter Four, 
UEA1 is not a functional marker of mTEC. However, these data represent an interesting first 
step in using iTEC as a tool to identify factors that promote medulla differentiation. Overall, 
this was taken as evidence that iTEC could differentiate into mTEC-like cells, but further 
investigation is warranted to observe whether such cells are genuinely mTEC, and were 
capable of promiscuous gene expression.  
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Figure C5.22: iTEC Differentiated into UEA1 Positive mTEC-like Cells when 
cultured in MTOC
Images show a reaggregate, created by seeding only iTEC into the GRID3D system and 
culturing for seven days as MTOC. At this point, all reaggregates were removed from the 
GRID3D system, fixed and stained for evidence of mTEC-like cells. Figure shows the 
representative, central UEA1+ iTEC found in reaggregates. A. DAPI only. B. Cytokeratins only. 












5.10. Concluding Remarks. 
Chapters Three and Four employed RTOC and monolayer culture, respectively. These 
techniques ultimately comprise the entire traditional range of culture methods for thymus 
biology. However, this thesis identified that these methods are not optimal for screening 
experiments and there exists a technical niche to develop a tool for thymus biology that is 
able to deliver precision on specific readouts and in high throughput. While this chapter relies 
on some preliminary data (N=1), it argues that MTOC have the potential to fill that niche. 
Currently, MTOC requires further optimisation, this thesis has highlighted that areas in which 
the system should be improved, particularly to perform real time microscopy at the single cell 
resolution. However, MTOC proved to be able to meet the criteria of maintaining Foxn1 
expression in ex vivo TEC and for iTEC-based reaggregates to mediate T-cell differentiation. 
Further work is required to increase the number of replicates for these experiments, but 
confidence is conferred upon these conclusions as MTOC employs a large number of 
technical observations. 
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6. Chapter Six: Concluding Remarks
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6.1. Summary of Experimental Results 
This thesis investigated the manufacture of iTEC; whether novel polymer matrices could 
reduce the variation associated with iTEC culture in monolayers; and a new method of three-
dimensional (3D) culture, which specifically aimed to deliver precision in a high throughput 
context.  
In Chapter Three, I defined a process to maximise the number of iTEC produced from a 
single embryo, by increasing the number of passages that MEFs underwent before initiation 
of reprogramming and testing the possibility of including a cryopreservation step. I also 
optimised the medium conditions, concentration of (Z)-4-Hydroxytamoxifen (4OHT) and 
reprogramming length. To ensure the optimised method for manufacturing iTEC did not 
compromise on functionality, I compared the in vitro behaviour of iTEC to ex vivo TEC using 
reaggregate thymic organ culture (RTOC). From this I demonstrated that iTEC were able to 
efficiently mediate thymocyte transition from the CD4-CD8- double negative (DN) stage to 
CD4+CD8+ double positive (DP) phase but there were differences between ex vivo TEC and 
iTEC in mediating positive selection and the transition between DP to CD4+CD8- or 
CD4+CD8- single positive (SP) phases, particularly in thymocyte expression of CD3ε, TCRβ, 
CD69. I also demonstrated that the outcomes of iTEC-mediated thymopoiesis remained 
highly variable both within a single batch, represented by differences between iTEC-based 
RTOC (iRTOC), and between batches.  
In Chapter Four, I tested whether synthetic polymers that could specifically bind TEC rather 
than MEFs could be identified by screening a library of polymers; I was able to identify a 
panel of 12 polymers with this property.  A major observation was that iTEC share a similar 
adhesion profile to ex vivo TEC, based on their compatibility with a similar set of synthetic 
polymers to native TEC. When I tested the effect of culturing iTEC upon the selected 
synthetic polymers, polymers 396 and 427 showed promise for both reducing the variablity 
shown by the iTEC system and improving the ability of iTEC to mediate T-cell differentiation, 
although this result did not produce significance. I also showed that culture on select 
polymers did not promote a functional medullary phenotype in iTEC. Furthermore, I showed 
253
that culture of ex vivo TEC on the selected polymers was not sufficient to produce an 
environment conducive to the maintenance of Foxn1 expression, either in the presence of 
serum or in serum-free medium supplemented with growth factors BMP4, FGF7 and EGF.  
In Chapter Five, I employed the GRID3D system (SUN Bioscience), which uses the synthetic 
polymer polyethylene glycol, which does not allow cell adhesion, to create a miniaturised-
reaggregate thymic organ culture (MTOC) system. I showed that MTOC was able to 
maintain Foxn1 expression in ex vivo TEC when cultured as whole E14.5 and E15.5 thymic 
dissociates. However, it remains a striking observation that not all TEC were able to do this. 
Some reaggregates, within the same well and created from the same suspension of thymic 
dissociate, were unable to maintain Foxn1 expression. Furthermore, I demonstrated that 
MTOC was able to mediate T-cell differentiation to produce more consistent results than in 
concurrent RTOC using the iTEC system.  
6.2. Conclusions and Future Work 
The overall hypothesis detailed in Chapter One was that iTEC in conjunction with synthetic 
matrices, could be used generate thymic organoids that recapitulate the fundamental 
processes via which TEC mediate T cell differentiation and repertoire selection. This 
overarching hypothesis was broken down into smaller hypotheses for each chapter and 
these will be discussed before returning to conclude the extent it was found to be true or 
false. 
I tested the hypothesis in Chapter Three that the iTEC system could produce a large quantity 
of cells competent to recapitulate ex vivo TEC function in vitro. The first part was found to be 
true since increasing the passage number of MEFs increased the total yield of iTEC without 
comprising on functionally. Although expanding MEFs will not be able to generate the same 
number of cells as using cell lines such as the OP9-DLL1 and MS5-hDLL1, the number of 
iTEC that can be produced in a given timeframe is no longer limited by sourcing sufficient 
MEFs but in separating the GFP+ from the GFP- fractions.  
With respect to how competent iTEC are in recapitulating the ex vivo behaviour of TEC in 
RTOC, it was concluded that iTEC were able to mediate T-cell differentiation, albeit at 
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reduced kinetics compared to ex vivo TEC, but may not able to mediate normal positive 
selection based on expression of CD3ε , TCRβ and CD69. 
Therefore, I concluded that iTEC were able to be scaled up to provide a more abundant 
source of cells than the native thymus and iTEC were able to recapitulate some aspects of 
ex vivo TEC behaviour. However, whilst I made progress in progressing the iTEC system 
into a standardised tool, further optimisation is still required to reduce variation in the system, 
and to confer full TEC functionality as revealed by assays of fine details. Furthermore, given 
that iTEC express much of the machinery required to process and present peptides in a 
physiologically relevant manner, the differences between the ability of iTEC and ex vivo TEC 
to mediate positive selection warrants further investigation. Certainly, the reprogramming 
process can be further explored for instance by producing a serum-free strategy, which aims 
to both reduce variation and further phenocopy TEC (Parent et al., 2013; Sun et al., 2013), 
and by determining what elements of the TEC gene expression programme is missing from 
the current iTEC protocol. Furthermore, I begin to explore the idea that iTEC requires 
supplementation with non-epithelial thymic stroma and mTEC to completely recapitulate 
thymopoiesis. 
Chapter Four tested the hypothesis that using defined culture substrates could create a more 
consistant iTEC phenotype, with respect to the essential functions of TEC. I concluded that, 
although culture on synthetic polymers did not enforce native TEC behaviour on ex vivo 
TEC, as demonstrated by a downregulation of Foxn1, or promote medullary differentiation in 
iTEC-progeny, there was potential for the selected polymers to decrease the variablity 
associated with the iTEC system and T-cell differentiation. Future work will focus on testing 
whether the polymers are capable of selectively binding iTEC that share a similar adhesion 
profile with native TEC. This mechanism will then be explored as a replacement for 
fluorescence activated cell sorting (FACS) to isolate MEFs that had successfully entered 
reprogramming based upon GFP expression, which will further increase the scale up 
capacity of the iTEC system but also may improve function and reduce variation. Throughout 
Chapter Four, I was critical of the monolayer co-culture system, which represents the most 
commonly used tool to perform in vitro T-cell specification when performed using OP9-DLL1. 
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I highlighted that monolayer culture could not produce effective positive controls as ex vivo 
TEC did not maintain Foxn1 expression and that two-dimensional culture produced large 
amounts of technical variation, which may have been a result of the low cell density 
promoting thymocyte sampling biases. 
In Chapter Five, given the technical limitations I observed in Chapter Four, I examined the 
hypothesis that: miniaturising the RTOC process could be conducive to creating a culture 
system for thymus biology that is amenable to high throughput screening applications but 
retained a 3D stature and a high cell density. I found evidence for this and concluded that 
MTOC has the potential to be a useful tool in thymus biology by providing a method for 
producing large numbers of micro-physiological thymi for testing specific hypotheses. I 
concluded that not all reaggregates within a well were able to maintain Foxn1 expression in 
ex vivo TEC, despite being in the same culture conditions and being generated from the 
same input pool of cells. I also concluded that MTOC could mediate much more consistent 
T-cell differentiation processes than RTOC, albeit with a much lower efficiency. Further effort 
is required to clarify if this was a product of the reductionist nature of MTOC and that the 
small reaggregates were on average much less efficient that the concurrent iRTOC, or 
whether only a few, of the 70 in total, reaggregates were successful and that the failed 
reaggregates diluted the result. Therefore, MTOC has the potential to be a variant of RTOC 
that inhabits a 3D, high content screening niche. Future work will focus on increasing the 
number of biological replicates to satisfactory levels and overcoming highlighted technical 
limitations such a poor light penetration through the GRID3D system. 
Therefore, with respect to the overarching hypothesis: this thesis presents evidence that 
iTEC, like the OP9-DLL1 and MS5-Dll1 can be used to overcome tissue limitation in thymus 
biology, but unlike the aforementioned systems, without comprising the extent that the 
fundamental processes associated with TEC are recapitulated. However, iTEC in its current 
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